subject.id,manuscript.id,arm,treatment,visit,study.day,lab.category,lab.test,lab.value,lab.unit,lower.limit.normal,upper.limit.normal
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Alkaline Phosphatase,142,U/L,0,130
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,BUN,16,mg/dL,6,20
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Creatinine,1.0,mg/dL,0.6,1.1
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,LDH,283,U/L,130,250
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Lipase,10,U/L,0,78
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Magnesium,2.3,mg/dL,1.9,2.6
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Sodium,137,mEq/L,133,143
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Chemistry,Urea,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,Hematocrit,36,%,34.3,46
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,Hemoglobin,11.8,g/dL,11.2,15.4
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,Neutrophils abs,2.7,K/mcL,1.5,7.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,Platelet,162,K/mcL,160,400
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Hematology,WBC,5.5,K/mcL,4,11
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.76,mcU/mL,0.6,4.8
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-34,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),10,U/L,0,55
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,97,U/L,0,130
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,15,mg/dL,6,20
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,331,U/L,130,250
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,10,U/L,0,78
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mEq/L,133,143
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.6,%,34.3,46
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.5,g/dL,11.2,15.4
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.7,K/mcL,1.5,7.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,171,K/mcL,160,400
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.1,K/mcL,4,11
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.86,mcU/mL,0.6,4.8
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alanine Transferase (SGPT),70,U/L,0,55
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alkaline Phosphatase,197,U/L,0,130
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Aspartate Transferase (SGOT),37,U/L,0,37
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,BUN,23,mg/dL,6,20
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Direct Bilirubin,0.6,mg/dL,0,0.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,LDH,545,U/L,130,250
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Lipase,10,U/L,0,78
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Sodium,132,mEq/L,133,143
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Total Bilirubin,1.2,mg/dL,0,1.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Urea,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hematocrit,35.1,%,34.3,46
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hemoglobin,11.4,g/dL,11.2,15.4
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Neutrophils abs,5.2,K/mcL,1.5,7.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Platelet,186,K/mcL,160,400
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,WBC,7.0,K/mcL,4,11
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.88,mcU/mL,0.6,4.8
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,110,U/L,0,130
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,37
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,12,mg/dL,6,20
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,843,U/L,130,250
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,10,U/L,0,78
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,130,mEq/L,133,143
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,31.8,%,34.3,46
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,10.6,g/dL,11.2,15.4
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,180,K/mcL,160,400
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,5.1,K/mcL,4,11
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.41,mcU/mL,0.6,4.8
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Alanine Transferase (SGPT),25,U/L,0,55
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Alkaline Phosphatase,120,U/L,0,130
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Aspartate Transferase (SGOT),49,U/L,0,37
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,BUN,13,mg/dL,6,20
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Direct Bilirubin,0.6,mg/dL,0,0.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Indirect Bilirubin,,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,LDH,ND,U/L,130,250
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Lipase,ND,U/L,0,78
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Magnesium,ND,mg/dL,1.9,2.6
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Sodium,134,mEq/L,133,143
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Total Bilirubin,1.0,mg/dL,0,1.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Chemistry,Urea,,,NA,NA
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,Hematocrit,36.5,%,34.3,46
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,Hemoglobin,11.6,g/dL,11.2,15.4
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,Neutrophils abs,7.3,K/mcL,1.5,7.5
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,Platelet,229,K/mcL,160,400
101-0001,001,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,54,Hematology,WBC,10.2,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Alkaline Phosphatase,88,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,BUN,27,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,LDH,264,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Lipase,26,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Magnesium,2.5,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Sodium,141,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Hematocrit,27.9,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Hemoglobin,8.7,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Neutrophils abs,1.7,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Platelet,296,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,WBC,3.1,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.02,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,92,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,28,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,293,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,26,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31.7,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.0,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,1.8,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,249,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,2.7,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.87,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),24,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,121,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,23,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,265,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,24,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,31.5,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,9.7,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.3,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,266,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,3.6,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.27,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.32,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Alkaline Phosphatase,102,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,BUN,24,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,LDH,335,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Lipase,27,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Sodium,137,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,Hematocrit,29.9,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,Hemoglobin,9.2,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,Lymphocytes abs,0.7,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,Neutrophils abs,2.7,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,Platelet,284,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Hematology,WBC,3.9,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.35,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,45,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),12,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,90,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,21,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,354,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,23,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,139,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,28.3,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,8.8,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,2.5,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,280,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,3.7,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.30,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.33,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Alanine Transferase (SGPT),3.7,U/L,0,55
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Alkaline Phosphatase,86,U/L,0,130
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,BUN,22,mg/dL,6,20
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Creatinine,1.0,mg/dL,0.6,1.1
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,LDH,424,U/L,130,250
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Lipase,29,U/L,0,78
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Sodium,139,mEq/L,133,143
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Urea,ND,,NA,NA
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Hematocrit,26.9,%,34.3,46
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Hemoglobin,8.5,g/dL,11.2,15.4
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Platelet,281,K/mcL,160,400
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,WBC,3.21,K/mcL,4,11
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.54,mcU/mL,0.6,4.8
101-0003,002,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Alkaline Phosphatase,52,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,BUN,19,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Creatinine,1.1,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,LDH,194,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Lipase,48,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Sodium,139,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Chemistry,Urea,ND,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,Hematocrit,32.9,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,Hemoglobin,10.3,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,Platelet,219,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Hematology,WBC,4.9,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.7,1.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Free Triiodothyronine (FT3),1.8,pg/mL,2.3,4.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.13,mcU/mL,0.6,4.8
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Triidothyronine (T3),64,ng/dL,90,168
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,42,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,16,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.1,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,ND,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.2,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,20.5,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,6.4,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,ND,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,ND,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,171,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.4,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Alanine Transferase (SGPT),10,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Alkaline Phosphatase,70,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,BUN,10,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,LDH,183,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Lipase,40,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Magnesium,1.2,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Sodium,136,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Total Bilirubin,<0.2,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Chemistry,Urea,ND,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,Hematocrit,33.0,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,Hemoglobin,10.5,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,Neutrophils abs,5.5,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,Platelet,254,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Hematology,WBC,7.1,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.66,mcU/mL,0.6,4.8
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,28,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Alkaline Phosphatase,78,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,BUN,12,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Indirect Bilirubin,<0.1,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,LDH,164,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Lipase,33,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Sodium,133,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Chemistry,Urea,,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,Hematocrit,28.4,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,Hemoglobin,9.1,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,Neutrophils abs,3.7,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,Platelet,225,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Hematology,WBC,4.9,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.23,mcU/mL,0.6,4.8
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,51,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Alanine Transferase (SGPT),36,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Alanine Transferase (SGPT),36,U/L,0,55
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Alkaline Phosphatase,98,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Alkaline Phosphatase,98,U/L,0,130
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Aspartate Transferase (SGOT),34,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Aspartate Transferase (SGOT),34,U/L,0,37
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,BUN,19,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,BUN,19,mg/dL,6,20
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Creatinine,1.0,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Creatinine,1.0,mg/dL,0.6,1.1
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Indirect Bilirubin,<0.2,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Indirect Bilirubin,<0.2,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,LDH,149,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,LDH,149,U/L,130,250
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Lipase,52,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Lipase,149,U/L,0,78
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Sodium,134,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Sodium,134,mEq/L,133,143
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Urea,,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Chemistry,Urea,,,NA,NA
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Hematocrit,31.5,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Hematocrit,31.5,%,34.3,46
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Hemoglobin,9.8,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Hemoglobin,9.8,g/dL,11.2,15.4
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Neutrophils abs,4.8,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Neutrophils abs,4.8,K/mcL,1.5,7.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Platelet,277,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,Platelet,277,K/mcL,160,400
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,WBC,6.2,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Hematology,WBC,6.2,K/mcL,4,11
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.04,mcU/mL,0.6,4.8
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.04,mcU/mL,0.6,4.8
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0004,003,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,76,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Alkaline Phosphatase,120,U/L,0,130
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,37
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,BUN,22,mg/dL,6,20
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,LDH,169,U/L,130,250
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Lipase,31,U/L,0,78
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Sodium,140,mEq/L,133,143
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Chemistry,Urea,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,Hematocrit,40.4,%,34.3,46
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,Hemoglobin,13.5,g/dL,11.2,15.4
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,Lymphocytes abs,1.5,K/mcL,0.9,3.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,Neutrophils abs,3.6,K/mcL,1.5,7.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,Platelet,214,K/mcL,160,400
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Hematology,WBC,6.2,K/mcL,4,11
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Thyroid Function Testing,Free Thyroxine (FT4),0.89,ng/dL,0.7,1.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.89,mcU/mL,0.6,4.8
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-33,Thyroid Function Testing,Triidothyronine (T3),85,ng/dL,90,168
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,113,U/L,0,130
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,19,mg/dL,6,20
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,162,U/L,130,250
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,34,U/L,0,78
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,133,143
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,36.8,%,34.3,46
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.5,K/mcL,1.5,7.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,180,K/mcL,160,400
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.6,K/mcL,4,11
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),0.85,ng/dL,0.7,1.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.49,mcU/mL,0.6,4.8
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),27,U/L,0,55
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,112,U/L,0,130
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),36,U/L,0,37
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,20,mg/dL,6,20
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,243,U/L,130,250
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,34,U/L,0,78
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.6,mEq/L,3.3,4.9
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,142,mEq/L,133,143
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,37.3,%,34.3,46
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.2,g/dL,11.2,15.4
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.1,K/mcL,1.5,7.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,175,K/mcL,160,400
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.2,K/mcL,4,11
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.27,mcU/mL,0.6,4.8
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Alkaline Phosphatase,109,U/L,0,130
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,BUN,22,mg/dL,6,20
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,LDH,172,U/L,130,250
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Lipase,42,U/L,0,78
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Sodium,139,mEq/L,133,143
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Urea,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Hematocrit,37.7,%,34.3,46
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Neutrophils abs,3.3,K/mcL,1.5,7.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Platelet,179,K/mcL,160,400
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,WBC,5.5,K/mcL,4,11
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.27,mcU/mL,0.6,4.8
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Alanine Transferase (SGPT),34,U/L,0,55
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Alkaline Phosphatase,116,U/L,0,130
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,BUN,19,mg/dL,6,20
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,LDH,267,U/L,130,250
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Lipase,31,U/L,0,78
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Sodium,141,mEq/L,133,143
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Urea,ND,,NA,NA
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hematocrit,34.9,%,34.3,46
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hemoglobin,11.7,g/dL,11.2,15.4
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Neutrophils abs,3.3,K/mcL,1.5,7.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Platelet,187,K/mcL,160,400
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,WBC,5.6,K/mcL,4,11
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.83,mcU/mL,0.6,4.8
101-0005,004,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Triidothyronine (T3),0.9,ng/dL,90,168
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Thyroxine (FT4),0.70,ng/dL,0.7,1.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.74,mcU/mL,0.6,4.8
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Triidothyronine (T3),75,ng/dL,90,168
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),71,U/L,0,55
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,168,U/L,0,130
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),46,U/L,0,37
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,9,mg/dL,6,20
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,190,U/L,130,250
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,<10,U/L,0,78
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,141,mEq/L,133,143
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,33.9,%,37.5,49.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.1,g/dL,12.5,16.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.7,K/mcL,1.5,7.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,234,K/mcL,160,400
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.7,K/mcL,4,11
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.64,mcU/mL,0.6,4.8
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),43,U/L,0,55
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,187,U/L,0,130
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),30,U/L,0,37
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,6,mg/dL,6,20
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,179,U/L,130,250
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,<10,U/L,0,78
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mEq/L,133,143
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,31.7,%,37.5,49.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.7,g/dL,12.5,16.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,258,K/mcL,160,400
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,7.0,K/mcL,4,11
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.72,mcU/mL,0.6,4.8
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Alanine Transferase (SGPT),72,U/L,0,55
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Alkaline Phosphatase,213,U/L,0,130
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Aspartate Transferase (SGOT),65,U/L,0,37
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,BUN,5,mg/dL,6,20
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Creatinine,1.3,mg/dL,0.6,1.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,LDH,226,U/L,130,250
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Lipase,ND,U/L,0,78
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Sodium,139,mEq/L,133,143
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Chemistry,Urea,,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,Hematocrit,32.4,%,37.5,49.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,Hemoglobin,10.9,g/dL,12.5,16.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,Neutrophils abs,5.4,K/mcL,1.5,7.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,Platelet,270,K/mcL,160,400
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,48,Hematology,WBC,7.6,K/mcL,4,11
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Alanine Transferase (SGPT),33,U/L,0,55
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Alkaline Phosphatase,231,U/L,0,130
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Aspartate Transferase (SGOT),29,U/L,0,37
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,BUN,6,mg/dL,6,20
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,LDH,174,U/L,130,250
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Lipase,10,U/L,0,78
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Potassium,3.3,mEq/L,3.3,4.9
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Sodium,139,mEq/L,133,143
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Chemistry,Urea,ND,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Hematocrit,31.2,%,37.5,49.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Hemoglobin,10.6,g/dL,12.5,16.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Neutrophils abs,4.6,K/mcL,1.5,7.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,Platelet,311,K/mcL,160,400
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Hematology,WBC,6.6,K/mcL,4,11
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.74,mcU/mL,0.6,4.8
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,71,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Alanine Transferase (SGPT),25,U/L,0,55
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Alkaline Phosphatase,360,U/L,0,130
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Aspartate Transferase (SGOT),32,U/L,0,37
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,BUN,11,mg/dL,6,20
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,LDH,ND,U/L,130,250
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Lipase,ND,U/L,0,78
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Magnesium,ND,mg/dL,1.9,2.6
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Potassium,4.6,mEq/L,3.3,4.9
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Sodium,140,mEq/L,133,143
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Chemistry,Urea,ND,,NA,NA
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,Hematocrit,34.1,%,37.5,49.3
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,Hemoglobin,11.1,g/dL,12.5,16.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,Neutrophils abs,6.2,K/mcL,1.5,7.5
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,Platelet,320,K/mcL,160,400
101-0006,005,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,133,Hematology,WBC,8.6,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Alanine Transferase (SGPT),12,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,BUN,18,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,LDH,ND,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Lipase,32,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Magnesium,2.4,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Sodium,138,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,Hematocrit,37.6,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,Hemoglobin,12.3,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,Lymphocytes abs,13.2,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,Neutrophils abs,78.6,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,Platelet,180,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Hematology,WBC,4.7,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.35,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-29,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Alkaline Phosphatase,62,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,BUN,15,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,LDH,1.38,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Lipase,27,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Magnesium,2.3,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Sodium,135,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,Hematocrit,33.2,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,Hemoglobin,11.2,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,Lymphocytes abs,0.4,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,Neutrophils abs,3.29,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,Platelet,157,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Hematology,WBC,5.3,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.63,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,6,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,BUN,20,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,LDH,138,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Lipase,35,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Magnesium,2.4,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Sodium,139,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hematocrit,32.1,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hemoglobin,10.4,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Lymphocytes abs,11.7,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Neutrophils abs,78.5,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Platelet,143,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,WBC,4.3,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.41,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Alkaline Phosphatase,71,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,BUN,22,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,LDH,145,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Lipase,27,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Sodium,137,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,Hematocrit,33.0,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,Hemoglobin,10.9,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,Lymphocytes abs,0.5,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,Neutrophils abs,3.8,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,Platelet,178,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Hematology,WBC,4.7,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.51,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,41,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alkaline Phosphatase,68,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,BUN,16,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Direct Bilirubin,<0.3,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Indirect Bilirubin,<0.3,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,LDH,141,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Lipase,11,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Sodium,135,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hematocrit,32.1,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hemoglobin,10.4,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Platelet,166,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,WBC,5.1,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.51,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Alanine Transferase (SGPT),13,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Alkaline Phosphatase,66,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,BUN,15,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,LDH,178,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Lipase,14,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Sodium,135,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Hematocrit,34.1,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Hemoglobin,11.2,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Neutrophils abs,4.2,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Platelet,188,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,WBC,5.5,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.95,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Alkaline Phosphatase,66,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,BUN,20,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,LDH,150,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Lipase,12,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Sodium,140,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,Hematocrit,35.5,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,Hemoglobin,11.7,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,Lymphocytes abs,14.2,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,Neutrophils abs,3.3,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,Platelet,181,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Hematology,WBC,4.5,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.84,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,111,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Alkaline Phosphatase,86,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,BUN,26,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,LDH,158,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Lipase,13,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Sodium,140,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,Hematocrit,33.2,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,Hemoglobin,10.8,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,Neutrophils abs,3.7,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,Platelet,188,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Hematology,WBC,4.8,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Thyroid Function Testing,Free Thyroxine (FT4),0.87,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.10,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,139,Thyroid Function Testing,Triidothyronine (T3),72,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Alanine Transferase (SGPT),24,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Alkaline Phosphatase,74,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,BUN,21,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,LDH,165,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Lipase,18,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Sodium,140,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,Hematocrit,36.3,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,Neutrophils abs,4.2,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,Platelet,189,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Hematology,WBC,5.6,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Thyroid Function Testing,Free Thyroxine (FT4),0.95,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.49,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,167,Thyroid Function Testing,Triidothyronine (T3),72,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Alanine Transferase (SGPT),12,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Alkaline Phosphatase,75,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,BUN,19,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,LDH,157,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Lipase,<10,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Sodium,140,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Chemistry,Urea,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,Hematocrit,35.9,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,Neutrophils abs,4.9,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,Platelet,200,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Hematology,WBC,6.2,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.18,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,195,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,BUN,21,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,LDH,152,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Lipase,<10,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Sodium,141,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Chemistry,Urea,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,Hematocrit,39.8,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,Hemoglobin,13.0,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,Platelet,211,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Hematology,WBC,5.6,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.77,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,223,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Alkaline Phosphatase,64,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,BUN,23,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,LDH,157,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Lipase,12,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Sodium,140,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Chemistry,Urea,ND,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,Hematocrit,41.2,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,Hemoglobin,12.9,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,Neutrophils abs,4.54,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,Platelet,182,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Hematology,WBC,5.9,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.57,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,279,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,370,Thyroid Function Testing,Free Thyroxine (FT4),0.87,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,370,Thyroid Function Testing,Free Triiodothyronine (FT3),3.4,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,370,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.81,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,370,Thyroid Function Testing,Triidothyronine (T3),75,ng/dL,90,168
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Alkaline Phosphatase,69,U/L,0,130
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,37
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,BUN,20,mg/dL,6,20
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Indirect Bilirubin,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,LDH,161,U/L,130,250
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Lipase,16,U/L,0,78
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Sodium,141,mEq/L,133,143
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Chemistry,Urea,,,NA,NA
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,Hematocrit,43.2,%,34.3,46
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,Hemoglobin,14.4,g/dL,11.2,15.4
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,Neutrophils abs,4.4,K/mcL,1.5,7.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,Platelet,167,K/mcL,160,400
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Hematology,WBC,5.8,K/mcL,4,11
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.38,mcU/mL,0.6,4.8
101-0007,006,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,426,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Aspartate Transferase (SGOT),28,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,BUN,12,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Indirect Bilirubin,<0.1,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,LDH,314,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Lipase,28,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Sodium,141,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Chemistry,Urea,UN,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,Hematocrit,31.8,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,Hemoglobin,10.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,Neutrophils abs,2.6,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,Platelet,175,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Hematology,WBC,4.3,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.26,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,66,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,15,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,381,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,52,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,134,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,32.7,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.3,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,190,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.7,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.12,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.82,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alkaline Phosphatase,64,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,BUN,13,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Indirect Bilirubin,<0.1,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,LDH,299,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Lipase,156,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Urea,UN,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hematocrit,30.8,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hemoglobin,9.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Platelet,260,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,WBC,5.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.43,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Alkaline Phosphatase,67,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,BUN,19,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Indirect Bilirubin,<0.1,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,LDH,233,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Lipase,76,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Sodium,135,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Chemistry,Urea,UN,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Hematocrit,29.0,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Hemoglobin,8.7,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Neutrophils abs,2.6,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,Platelet,197,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Hematology,WBC,4.3,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.58,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,44,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alkaline Phosphatase,65,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,BUN,17,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,LDH,196,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Lipase,69,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Sodium,137,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hematocrit,35.5,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hemoglobin,10.7,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Platelet,184,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,WBC,4.4,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.20,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,13,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,198,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,49,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,37.6,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,12.0,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,2.3,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,161,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,4.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.18,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,16,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,189,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,51,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,138,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,40.4,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,13.0,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,183,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,5.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),0.88,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.13,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),106,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Alkaline Phosphatase,59,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,BUN,15,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,LDH,183,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Lipase,38,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Hematocrit,39.4,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Hemoglobin,12.6,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Neutrophils abs,3.5,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Platelet,165,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,WBC,5.4,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Free Thyroxine (FT4),0.94,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),11.41,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Alkaline Phosphatase,58,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,BUN,14,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,LDH,212,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Lipase,50,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Hematocrit,39.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Hemoglobin,12.8,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Platelet,188,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,WBC,5.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Free Thyroxine (FT4),0.87,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),11.72,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,BUN,14,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,LDH,204,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Lipase,42,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Hematocrit,40.1,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Hemoglobin,13.0,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Platelet,174,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,WBC,5.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Free Thyroxine (FT4),0.97,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),43.05,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Alkaline Phosphatase,62,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,BUN,14,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,LDH,186,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Lipase,40,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,Hematocrit,40.9,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,Hemoglobin,13.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,Neutrophils abs,3.9,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,Platelet,189,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Hematology,WBC,5.6,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Thyroid Function Testing,Free Thyroxine (FT4),0.73,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),58.59,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,225,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Alkaline Phosphatase,52,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,BUN,9,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,LDH,174,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Lipase,43,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,Hematocrit,38.4,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,Hemoglobin,12.7,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,Neutrophils abs,3.0,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,Platelet,174,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Hematology,WBC,4.6,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Thyroid Function Testing,Free Thyroxine (FT4),0.91,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),16.98,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,258,Thyroid Function Testing,Triidothyronine (T3),85,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Alkaline Phosphatase,58,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,BUN,11,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,LDH,243,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Lipase,40,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Sodium,138,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,Hematocrit,38.8,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,Hemoglobin,12.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,Neutrophils abs,3.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,Platelet,185,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Hematology,WBC,5.5,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Thyroid Function Testing,Free Thyroxine (FT4),1.12,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),16.98,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,281,Thyroid Function Testing,Triidothyronine (T3),70,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,309,Thyroid Function Testing,Free Thyroxine (FT4),0.93,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,309,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,309,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),55.58,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,309,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Alkaline Phosphatase,62,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,BUN,12,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,LDH,193,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Lipase,44,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,Hematocrit,38.7,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,Platelet,159,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Hematology,WBC,4.8,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),16.07,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,335,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Alkaline Phosphatase,59,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,BUN,18,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,LDH,191,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Lipase,54,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Sodium,141,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,Hematocrit,38.1,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,Neutrophils abs,3.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,Platelet,170,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Hematology,WBC,5.6,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),20.47,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,364,Thyroid Function Testing,Triidothyronine (T3),81,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Alkaline Phosphatase,61,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,BUN,14,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,LDH,204,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Lipase,51,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,Hematocrit,39.7,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,Hemoglobin,12.8,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,Neutrophils abs,3.0,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,Platelet,170,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Hematology,WBC,4.8,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Thyroid Function Testing,Free Thyroxine (FT4),1.12,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),8.58,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,398,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,BUN,9,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,LDH,214,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Lipase,45,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Sodium,1411,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,Hematocrit,38.2,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,Neutrophils abs,2.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,Platelet,159,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Hematology,WBC,3.9,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Thyroid Function Testing,Free Thyroxine (FT4),1.19,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),8.59,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,426,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Alkaline Phosphatase,57,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,BUN,13,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,LDH,204,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Lipase,44,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,Hematocrit,39.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,Platelet,157,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Hematology,WBC,4.2,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.88,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,454,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Alkaline Phosphatase,138,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,BUN,19,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Creatinine,1.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,LDH,213,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Lipase,37,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Sodium,134,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,Hematocrit,41.9,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,Hemoglobin,13.9,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,Neutrophils abs,4.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,Platelet,226,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Hematology,WBC,6.6,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.99,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,482,Thyroid Function Testing,Triidothyronine (T3),93,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Alkaline Phosphatase,54,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,BUN,15,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,LDH,206,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Lipase,54,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Sodium,142,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,Hematocrit,39.1,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,Hemoglobin,12.2,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,Neutrophils abs,2.0,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,Platelet,160,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Hematology,WBC,3.5,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.03,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,510,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Alkaline Phosphatase,57,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,BUN,12,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,LDH,208,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Lipase,43,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Sodium,138,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,Hematocrit,38.1,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,Neutrophils abs,2.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,Platelet,172,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Hematology,WBC,4.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Thyroid Function Testing,Free Thyroxine (FT4),1.46,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.34,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,538,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Alkaline Phosphatase,51,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Aspartate Transferase (SGOT),28,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,BUN,10,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,LDH,303,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Lipase,54,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Potassium,6.9,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,Hematocrit,37.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,Platelet,192,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Hematology,WBC,4.9,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.82,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,566,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,BUN,13,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,LDH,220,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Lipase,35,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Sodium,138,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,Hematocrit,39.2,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,Neutrophils abs,4.6,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,Platelet,211,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Hematology,WBC,6.5,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Thyroid Function Testing,Free Thyroxine (FT4),1.32,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.36,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,594,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Alkaline Phosphatase,49,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,BUN,12,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,LDH,228,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Lipase,73,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Sodium,139,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,Hematocrit,38.2,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,Hemoglobin,4.21,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,Platelet,182,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Hematology,WBC,5.8,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Thyroid Function Testing,Free Thyroxine (FT4),1.29,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),ND,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,622,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Alanine Transferase (SGPT),25,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Alkaline Phosphatase,51,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,BUN,18,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,LDH,242,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Lipase,60,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,Hematocrit,39.2,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,Hemoglobin,12.7,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,Neutrophils abs,3.3,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,Platelet,155,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Hematology,WBC,5.0,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Thyroid Function Testing,Free Thyroxine (FT4),1.19,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),14.46,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,650,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Alkaline Phosphatase,53,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,BUN,15,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,LDH,234,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Lipase,52,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Sodium,142,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,Hematocrit,39.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,Hemoglobin,12.1,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,Neutrophils abs,3.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,Platelet,198,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Hematology,WBC,5.3,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.15,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,678,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Alkaline Phosphatase,45,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,BUN,17,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Direct Bilirubin,,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,LDH,220,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Lipase,56,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,Hematocrit,37.1,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,Hemoglobin,11.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,Platelet,186,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Hematology,WBC,4.8,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.69,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,706,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Alkaline Phosphatase,49,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,BUN,12,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,LDH,265,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Lipase,53,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Sodium,142,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,Hematocrit,36.8,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,Hemoglobin,11.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,Neutrophils abs,2.7,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,Platelet,189,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Hematology,WBC,4.1,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.95,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,735,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Alkaline Phosphatase,46,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,BUN,7,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,LDH,262,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Lipase,36,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Sodium,133,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,Hematocrit,34.9,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,Hemoglobin,10.8,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,Platelet,188,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Hematology,WBC,4.5,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.75,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,762,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Alkaline Phosphatase,44,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,BUN,8,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,LDH,300,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Lipase,33,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Sodium,136,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,Hematocrit,37.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,Hemoglobin,11.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,Platelet,204,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Hematology,WBC,4.6,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.42,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,790,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Alkaline Phosphatase,40,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,BUN,11,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,LDH,294,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Lipase,34,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,Hematocrit,36.3,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,Hemoglobin,11.1,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,Neutrophils abs,2.6,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,Platelet,172,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Hematology,WBC,3.9,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Thyroid Function Testing,Free Thyroxine (FT4),1.29,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.31,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,818,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Alkaline Phosphatase,44,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,BUN,15,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,LDH,299,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Lipase,44,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Sodium,138,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Chemistry,Urea,ND,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,Hematocrit,37.8,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,Hemoglobin,11.4,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,Platelet,201,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Hematology,WBC,4.1,K/mcL,4,11
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.64,mcU/mL,0.6,4.8
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,846,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,BUN,13,mg/dL,6,20
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Indirect Bilirubin,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,LDH,ND,U/L,130,250
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Lipase,ND,U/L,0,78
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Sodium,140,mEq/L,133,143
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Chemistry,Urea,,,NA,NA
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,Hematocrit,33.7,%,34.3,46
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,Hemoglobin,10.5,g/dL,11.2,15.4
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,Lymphocytes abs,0.7,K/mcL,0.9,3.2
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,Neutrophils abs,3.5,K/mcL,1.5,7.5
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,Platelet,93,K/mcL,160,400
101-0008,007,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,932,Hematology,WBC,4.8,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),1.78,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),86,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,129,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,17,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,185,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,<10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,7.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,309,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,10.1,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alanine Transferase (SGPT),13,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alkaline Phosphatase,122,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,LDH,179,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Lipase,<10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Potassium,3.3,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Urea,UN,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hematocrit,39.3,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hemoglobin,12.8,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Neutrophils abs,5.3,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Platelet,290,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,WBC,8.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Thyroxine (FT4),1.57,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alkaline Phosphatase,134,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,BUN,19,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Indirect Bilirubin,0.2,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,LDH,148,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Lipase,13,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Urea,UN,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hematocrit,41.6,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hemoglobin,13.8,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Lymphocytes abs,1.8,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Platelet,222,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,WBC,8.0,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Thyroxine (FT4),1.66,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Alanine Transferase (SGPT),34,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Alkaline Phosphatase,161,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,BUN,17,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,LDH,238,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Potassium,4.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,Hematocrit,41.5,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,Hemoglobin,13.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,Neutrophils abs,4.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,Platelet,236,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Hematology,WBC,7.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Thyroid Function Testing,Free Thyroxine (FT4),1.59,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.08,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,70,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Alkaline Phosphatase,126,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,LDH,149,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Lipase,11,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,Hematocrit,40.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,Hemoglobin,13.6,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,Lymphocytes abs,2.1,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,Platelet,241,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Hematology,WBC,8.1,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Thyroid Function Testing,Free Thyroxine (FT4),1.73,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,91,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Alkaline Phosphatase,167,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,BUN,18,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,LDH,143,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Lipase,23,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,Hematocrit,41.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,Hemoglobin,13.6,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,Neutrophils abs,4.3,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,Platelet,266,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Hematology,WBC,7.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Thyroid Function Testing,Free Thyroxine (FT4),1.55,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.34,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,131,Thyroid Function Testing,Triidothyronine (T3),82,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Alkaline Phosphatase,127,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,BUN,19,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,LDH,158,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Lipase,13,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,Hematocrit,42.6,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,Hemoglobin,13.8,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,Lymphocytes abs,2.1,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,Neutrophils abs,5.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,Platelet,268,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Hematology,WBC,8.7,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Thyroid Function Testing,Free Thyroxine (FT4),1.88,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,159,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Alkaline Phosphatase,126,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,BUN,19,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,LDH,210,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Lipase,17,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Hematocrit,42.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Hemoglobin,14.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Lymphocytes abs,1.8,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Neutrophils abs,4.7,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Platelet,209,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,WBC,7.6,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Alkaline Phosphatase,122,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,BUN,18,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,LDH,151,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Lipase,13,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,Hematocrit,43.2,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,Hemoglobin,14.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,Lymphocytes abs,2.0,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,Neutrophils abs,5.1,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,Platelet,206,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Hematology,WBC,8.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Thyroid Function Testing,Free Thyroxine (FT4),1.66,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,223,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Alkaline Phosphatase,124,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,BUN,20,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,LDH,140,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Lipase,18,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,Hematocrit,43.3,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,Hemoglobin,14.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,Lymphocytes abs,2.2,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,Platelet,231,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Hematology,WBC,7.6,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Thyroid Function Testing,Free Thyroxine (FT4),1.79,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,251,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Alkaline Phosphatase,126,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,BUN,19,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,LDH,136,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Lipase,21,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,Hematocrit,44.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,Hemoglobin,14.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,Lymphocytes abs,1.8,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,Neutrophils abs,5.9,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,Platelet,224,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Hematology,WBC,9.0,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Thyroid Function Testing,Free Thyroxine (FT4),1.82,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Thyroid Function Testing,Free Triiodothyronine (FT3),3.4,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,307,Thyroid Function Testing,Triidothyronine (T3),75,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Alkaline Phosphatase,3.7,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,LDH,155,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Lipase,16,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Sodium,141,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Thyroid Function Testing,Free Thyroxine (FT4),1.63,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,337,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Alkaline Phosphatase,119,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,BUN,15,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Direct Bilirubin,0.7,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,LDH,142,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Lipase,17,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,Hematocrit,44.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,Hemoglobin,14.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,Lymphocytes abs,2.2,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,Neutrophils abs,5.6,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,Platelet,209,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Hematology,WBC,9.0,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Thyroid Function Testing,Free Thyroxine (FT4),1.78,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,369,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Alkaline Phosphatase,133,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,BUN,18,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,LDH,164,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,Hematocrit,43.6,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,Hemoglobin,15.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,Lymphocytes abs,2.3,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,Neutrophils abs,5.8,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,Platelet,204,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Hematology,WBC,9.5,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Thyroid Function Testing,Free Thyroxine (FT4),1.73,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,397,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Alkaline Phosphatase,108,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,BUN,18,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,LDH,156,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,Hematocrit,42.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,Hemoglobin,14.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,Neutrophils abs,6.0,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,Platelet,210,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Hematology,WBC,9.2,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,425,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Alkaline Phosphatase,114,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,LDH,137,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Potassium,6.9,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Sodium,142,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,Hematocrit,42.9,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,Hemoglobin,14.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,Lymphocytes abs,2.3,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,Platelet,213,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Hematology,WBC,8.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Thyroid Function Testing,Free Thyroxine (FT4),1.42,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,454,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Alanine Transferase (SGPT),22,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Alkaline Phosphatase,115,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,BUN,17,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,LDH,146,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,Hematocrit,42.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,Hemoglobin,14.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,Neutrophils abs,5.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,Platelet,168,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Hematology,WBC,8.2,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,488,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Alanine Transferase (SGPT),24,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Alkaline Phosphatase,106,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,LDH,139,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Lipase,10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,Hematocrit,41.9,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,Hemoglobin,13.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,Lymphocytes abs,1.8,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,Neutrophils abs,3.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,Platelet,196,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Hematology,WBC,6.5,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Thyroid Function Testing,Free Thyroxine (FT4),1.63,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,516,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Alkaline Phosphatase,122,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,BUN,21,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,LDH,147,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Lipase,16,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Potassium,3.3,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,Hematocrit,45.5,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,Hemoglobin,14.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,Neutrophils abs,4.9,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,Platelet,211,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Hematology,WBC,7.8,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Thyroid Function Testing,Free Thyroxine (FT4),1.72,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,544,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Alanine Transferase (SGPT),22,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Alkaline Phosphatase,113,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,BUN,20,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,LDH,131,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Lipase,17,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Sodium,141,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,Hematocrit,43.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,Hemoglobin,14.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,Lymphocytes abs,2.0,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,Platelet,212,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Hematology,WBC,7.9,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Thyroid Function Testing,Free Thyroxine (FT4),1.90,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,572,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Alkaline Phosphatase,116,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,BUN,17,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,LDH,175,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Lipase,16,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,Hematocrit,41.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,Hemoglobin,14.3,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,Lymphocytes abs,2.4,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,Neutrophils abs,5.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,Platelet,216,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Hematology,WBC,9.0,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Thyroid Function Testing,Free Thyroxine (FT4),1.62,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,602,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Alkaline Phosphatase,116,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,BUN,19,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,LDH,140,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Lipase,17,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Sodium,7.0,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,Hematocrit,42.4,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,Hemoglobin,14.4,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,Neutrophils abs,6.1,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,Platelet,214,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Hematology,WBC,9.0,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Thyroid Function Testing,Free Thyroxine (FT4),1.62,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.06,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,628,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Alkaline Phosphatase,119,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,BUN,20,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,LDH,149,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Sodium,141,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,Hematocrit,44.1,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,Hemoglobin,15.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,Neutrophils abs,4.8,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,Platelet,198,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Hematology,WBC,7.7,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Thyroid Function Testing,Free Thyroxine (FT4),1.81,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,656,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Alkaline Phosphatase,118,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,BUN,23,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,LDH,156,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Lipase,14,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,Hematocrit,43.5,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,Hemoglobin,14.8,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,Neutrophils abs,5.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,Platelet,187,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Hematology,WBC,8.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.08,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,684,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,Hematocrit,45.2,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,Hemoglobin,15.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,Lymphocytes abs,2.3,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,Neutrophils abs,4.9,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,Platelet,144,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Hematology,WBC,8.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Thyroid Function Testing,Free Thyroxine (FT4),1.62,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.06,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,712,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Alkaline Phosphatase,124,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,BUN,20,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,LDH,174,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Lipase,18,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Potassium,3.3,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,Hematocrit,43.5,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,Hemoglobin,14.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,Lymphocytes abs,1.5,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,Neutrophils abs,4.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,Platelet,200,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Hematology,WBC,7.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Thyroid Function Testing,Free Thyroxine (FT4),1.48,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,740,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Alkaline Phosphatase,107,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,BUN,22,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,LDH,159,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Lipase,16,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,Hematocrit,42.9,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,Hemoglobin,14.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,Neutrophils abs,5.6,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,Platelet,203,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Hematology,WBC,8.6,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Thyroid Function Testing,Free Thyroxine (FT4),1.51,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.08,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,769,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Alkaline Phosphatase,113,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,BUN,12,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,LDH,161,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Lipase,14,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,Hematocrit,45.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,Hemoglobin,15.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,Lymphocytes abs,2.4,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,Neutrophils abs,6.6,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,Platelet,216,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Hematology,WBC,10.5,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Thyroid Function Testing,Free Thyroxine (FT4),1.85,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,810,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Alanine Transferase (SGPT),26,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Alkaline Phosphatase,110,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,BUN,16,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,LDH,215,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Lipase,18,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,Hematocrit,44.9,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,Hemoglobin,14.8,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,Neutrophils abs,5.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,Platelet,212,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Hematology,WBC,8.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Thyroid Function Testing,Free Thyroxine (FT4),1.75,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,838,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Alkaline Phosphatase,138,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,BUN,16,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,LDH,160,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Lipase,15,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Chemistry,Urea,ND,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,Hematocrit,41.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,Hemoglobin,13.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,Neutrophils abs,8.0,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,Platelet,302,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Hematology,WBC,10.8,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Thyroid Function Testing,Free Thyroxine (FT4),1.36,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.76,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,873,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Alkaline Phosphatase,127,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,BUN,13,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,LDH,150,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Lipase,19,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Sodium,141,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,Hematocrit,41.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,Hemoglobin,13.4,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,Neutrophils abs,6.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,Platelet,248,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Hematology,WBC,9.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Thyroid Function Testing,Free Thyroxine (FT4),1.30,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.96,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,901,Thyroid Function Testing,Triidothyronine (T3),73,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,Hematocrit,41.5,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,Hemoglobin,13.4,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,Lymphocytes abs,2.4,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,Neutrophils abs,6.0,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,Platelet,228,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,929,Hematology,WBC,9.8,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Alkaline Phosphatase,135,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,LDH,160,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Lipase,12,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Sodium,141,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,Hematocrit,43.4,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,Hemoglobin,14.2,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,Neutrophils abs,5.5,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,Platelet,217,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Hematology,WBC,8.5,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Thyroid Function Testing,Free Thyroxine (FT4),1.54,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.06,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,957,Thyroid Function Testing,Triidothyronine (T3),73,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Alkaline Phosphatase,131,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,BUN,13,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,LDH,152,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Lipase,12,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,Hematocrit,42.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,Hemoglobin,14.1,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,Lymphocytes abs,2.0,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,Neutrophils abs,6.0,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,Platelet,219,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Hematology,WBC,9.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.08,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,985,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Alkaline Phosphatase,127,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,LDH,152,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Lipase,12,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,Hematocrit,41.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,Hemoglobin,14.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,Lymphocytes abs,2.2,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,Neutrophils abs,6.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,Platelet,257,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Hematology,WBC,9.8,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Thyroid Function Testing,Free Thyroxine (FT4),1.47,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.15,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1020,Thyroid Function Testing,Triidothyronine (T3),65,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Alanine Transferase (SGPT),13,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Alkaline Phosphatase,136,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,LDH,157,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Lipase,10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Sodium,139,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,Hematocrit,41.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,Hemoglobin,14.0,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,Neutrophils abs,6.4,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,Platelet,282,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Hematology,WBC,9.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Thyroid Function Testing,Free Thyroxine (FT4),1.70,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.09,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1048,Thyroid Function Testing,Triidothyronine (T3),2.5,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Alkaline Phosphatase,118,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,BUN,22,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,LDH,157,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Lipase,13,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,Hematocrit,41.4,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,Hemoglobin,13.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,Neutrophils abs,6.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,Platelet,266,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Hematology,WBC,8.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Thyroid Function Testing,Free Thyroxine (FT4),1.62,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.11,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1076,Thyroid Function Testing,Triidothyronine (T3),70,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Alkaline Phosphatase,116,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,LDH,157,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Lipase,13,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Sodium,140,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,Hematocrit,41.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,Hemoglobin,13.7,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,Lymphocytes abs,2.1,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,Neutrophils abs,4.9,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,Platelet,279,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Hematology,WBC,8.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Thyroid Function Testing,Free Thyroxine (FT4),1.45,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.12,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1090,Thyroid Function Testing,Triidothyronine (T3),63,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Alkaline Phosphatase,125,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,LDH,161,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Lipase,10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Sodium,137,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,Hematocrit,39.0,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,Hemoglobin,12.9,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,Neutrophils abs,5.8,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,Platelet,321,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Hematology,WBC,8.2,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Thyroid Function Testing,Free Thyroxine (FT4),1.40,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.46,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1119,Thyroid Function Testing,Triidothyronine (T3),60,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Alkaline Phosphatase,119,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,BUN,17,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,LDH,180,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Lipase,12,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Potassium,2.7,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Sodium,137,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,Hematocrit,39.7,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,Hemoglobin,13.4,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,Neutrophils abs,6.7,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,Platelet,349,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Hematology,WBC,9.4,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.22,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1147,Thyroid Function Testing,Triidothyronine (T3),53,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Alkaline Phosphatase,123,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,BUN,11,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,LDH,202,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Lipase,10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Potassium,3.2,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,Hematocrit,37.8,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,Hemoglobin,12.6,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,Neutrophils abs,7.2,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,Platelet,339,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Hematology,WBC,9.7,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Thyroid Function Testing,Free Thyroxine (FT4),1.59,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.64,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1175,Thyroid Function Testing,Triidothyronine (T3),70,ng/dL,90,168
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Alkaline Phosphatase,126,U/L,0,130
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,BUN,14,mg/dL,6,20
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Indirect Bilirubin,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,LDH,164,U/L,130,250
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Lipase,10,U/L,0,78
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Sodium,138,mEq/L,133,143
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Chemistry,Urea,,,NA,NA
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,Hematocrit,38.1,%,37.5,49.3
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,Hemoglobin,12.5,g/dL,12.5,16.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,Neutrophils abs,7.1,K/mcL,1.5,7.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,Platelet,283,K/mcL,160,400
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Hematology,WBC,9.3,K/mcL,4,11
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Thyroid Function Testing,Free Thyroxine (FT4),1.56,ng/dL,0.7,1.5
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2.3,4.2
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.34,mcU/mL,0.6,4.8
101-0010,008,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1203,Thyroid Function Testing,Triidothyronine (T3),66,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Alanine Transferase (SGPT),49,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Alkaline Phosphatase,120,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Aspartate Transferase (SGOT),35,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,BUN,7,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Indirect Bilirubin,UN,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,LDH,236,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Lipase,45,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Potassium,4.5,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Sodium,139,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Chemistry,Urea,UN,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,Hematocrit,37.2,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,Hemoglobin,11.8,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,Neutrophils abs,4.1,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,Platelet,280,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Hematology,WBC,6.5,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.12,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-1,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),48,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,127,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),39,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,6,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,247,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,44,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.3,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.7,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,138,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.5,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.1,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,276,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.2,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.53,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Alanine Transferase (SGPT),51,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Alkaline Phosphatase,120,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Aspartate Transferase (SGOT),37,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,BUN,12,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Indirect Bilirubin,0.2,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,LDH,256,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Lipase,73,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Potassium,5.1,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Sodium,133,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Chemistry,Urea,UN,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,Hematocrit,36.5,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,Hemoglobin,12.2,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,Neutrophils abs,5.2,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,Platelet,378,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Hematology,WBC,7.4,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.80,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,19,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),68,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,169,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),50,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,12,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,337,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,68,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,5.1,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,138,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,UN,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,37.9,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,12.3,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,5.3,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,384,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,7.4,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.80,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),UN,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alanine Transferase (SGPT),93,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Alkaline Phosphatase,243,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Aspartate Transferase (SGOT),70,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,BUN,11,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,LDH,462,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Lipase,130,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Potassium,4.4,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Sodium,137,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Chemistry,Urea,ND,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hematocrit,39.4,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Neutrophils abs,7.2,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,Platelet,376,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Hematology,WBC,9.6,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.53,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,62,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Alanine Transferase (SGPT),106,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Alkaline Phosphatase,339,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Aspartate Transferase (SGOT),73,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,BUN,9,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,LDH,343,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Lipase,284,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Magnesium,2.0,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Potassium,4.8,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Sodium,138,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Urea,ND,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Hematocrit,37.7,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Neutrophils abs,7.5,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Platelet,314,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,WBC,10.2,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Free Thyroxine (FT4),1.03,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.25,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Triidothyronine (T3),73,ng/dL,90,168
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Alanine Transferase (SGPT),146,U/L,0,55
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Alkaline Phosphatase,431,U/L,0,130
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Aspartate Transferase (SGOT),89,U/L,0,37
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,BUN,10,mg/dL,6,20
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,LDH,401,U/L,130,250
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Lipase,205,U/L,0,78
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Magnesium,1.9,mg/dL,1.9,2.6
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Potassium,4.7,mEq/L,3.3,4.9
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Sodium,137,mEq/L,133,143
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Chemistry,Urea,ND,,NA,NA
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,Hematocrit,40.7,%,34.3,46
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,Hemoglobin,13.1,g/dL,11.2,15.4
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,Neutrophils abs,6.7,K/mcL,1.5,7.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,Platelet,339,K/mcL,160,400
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Hematology,WBC,8.9,K/mcL,4,11
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Thyroid Function Testing,Free Thyroxine (FT4),0.99,ng/dL,0.7,1.5
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2.3,4.2
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.62,mcU/mL,0.6,4.8
101-0011,009,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,99,Thyroid Function Testing,Triidothyronine (T3),76,ng/dL,90,168
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Alkaline Phosphatase,66,U/L,0,130
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,37
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,BUN,12,mg/dL,6,20
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Indirect Bilirubin,,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,LDH,231,U/L,130,250
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Lipase,20,U/L,0,78
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Magnesium,2.1,mg/dL,1.9,2.6
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Sodium,139,mEq/L,133,143
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Urea,,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Hematocrit,34.2,%,37.5,49.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Hemoglobin,11.2,g/dL,12.5,16.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Neutrophils abs,2.5,K/mcL,1.5,7.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Platelet,192,K/mcL,160,400
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,WBC,4.3,K/mcL,4,11
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2.3,4.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.23,mcU/mL,0.6,4.8
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Triidothyronine (T3),95,ng/dL,90,168
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alkaline Phosphatase,82,U/L,0,130
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Aspartate Transferase (SGOT),35,U/L,0,37
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,BUN,19,mg/dL,6,20
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,LDH,438,U/L,130,250
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Lipase,20,U/L,0,78
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Potassium,4.4,mEq/L,3.3,4.9
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Sodium,137,mEq/L,133,143
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Urea,,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hematocrit,35.0,%,37.5,49.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hemoglobin,11.5,g/dL,12.5,16.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Neutrophils abs,1.8,K/mcL,1.5,7.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Platelet,194,K/mcL,160,400
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,WBC,3.0,K/mcL,4,11
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.04,mcU/mL,0.6,4.8
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),26,U/L,0,55
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,110,U/L,0,130
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),37,U/L,0,37
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,14,mg/dL,6,20
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,240,U/L,130,250
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,17,U/L,0,78
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.3,mg/dL,1.9,2.6
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,136,mEq/L,133,143
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,33.9,%,37.5,49.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.0,g/dL,12.5,16.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.2,K/mcL,1.5,7.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,184,K/mcL,160,400
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,3.2,K/mcL,4,11
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.81,mcU/mL,0.6,4.8
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,173,U/L,0,130
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),34,U/L,0,37
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,12,mg/dL,6,20
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,217,U/L,130,250
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,13,U/L,0,78
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.2,mg/dL,1.9,2.6
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.4,mEq/L,3.3,4.9
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mEq/L,133,143
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,32.2,%,37.5,49.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,10.3,g/dL,12.5,16.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.2,K/mcL,1.5,7.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,282,K/mcL,160,400
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,4.8,K/mcL,4,11
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.14,mcU/mL,0.6,4.8
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Alkaline Phosphatase,256,U/L,0,130
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Aspartate Transferase (SGOT),81,U/L,0,37
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,BUN,16,mg/dL,6,20
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,LDH,381,U/L,130,250
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Lipase,ND,U/L,0,78
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Magnesium,2.4,mg/dL,1.9,2.6
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Sodium,133,mEq/L,133,143
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Urea,,,NA,NA
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Hematocrit,33.6,%,37.5,49.3
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Hemoglobin,10.6,g/dL,12.5,16.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Neutrophils abs,9.8,K/mcL,1.5,7.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Platelet,375,K/mcL,160,400
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,WBC,12.3,K/mcL,4,11
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Thyroid Function Testing,Free Thyroxine (FT4),8.6,ng/dL,0.7,1.5
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Thyroid Function Testing,Free Triiodothyronine (FT3),1.7,pg/mL,2.3,4.2
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.83,mcU/mL,0.6,4.8
101-0013,010,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Thyroid Function Testing,Triidothyronine (T3),<35,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Alkaline Phosphatase,49,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,BUN,8,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,LDH,696,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Lipase,35,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Magnesium,1,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Sodium,139,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Chemistry,Urea,,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Hematocrit,34.4,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Hemoglobin,11.2,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Neutrophils abs,4.6,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,Platelet,179,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Hematology,WBC,6.4,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Free Thyroxine (FT4),0.80,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.59,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-6,Thyroid Function Testing,Triidothyronine (T3),78,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),10,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,41,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,7,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,ND,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,29,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,ND,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,141,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,ND,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,33.9,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,11.1,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,3.1,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,190,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,4.8,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alkaline Phosphatase,48,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,BUN,13,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Creatinine,0.5,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,LDH,348,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Lipase,61,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Sodium,140,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Urea,ND,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hematocrit,33.6,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hemoglobin,10.7,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Platelet,213,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,WBC,5.8,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Thyroxine (FT4),0.84,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Triiodothyronine (FT3),3.4,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.25,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Triidothyronine (T3),78,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Alkaline Phosphatase,58,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Aspartate Transferase (SGOT),10,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,BUN,9,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,LDH,224,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Lipase,33,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Potassium,3.3,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Sodium,141,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Chemistry,Urea,,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Thyroid Function Testing,Free Thyroxine (FT4),1.46,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Thyroid Function Testing,Free Triiodothyronine (FT3),5.5,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,54,Thyroid Function Testing,Triidothyronine (T3),154,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Alkaline Phosphatase,55,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,BUN,7,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,LDH,246,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Lipase,32,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Sodium,138,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Chemistry,Urea,ND,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,Hematocrit,38.2,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,Hemoglobin,12.2,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,Neutrophils abs,6.2,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,Platelet,238,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Hematology,WBC,8.4,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.01,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,75,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Alkaline Phosphatase,78,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,BUN,9,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Indirect Bilirubin,,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,LDH,379,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Lipase,29,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Potassium,3.4,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Sodium,140,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Chemistry,Urea,,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,Hematocrit,38.0,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,Hemoglobin,12.1,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,Neutrophils abs,2.6,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,Platelet,247,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Hematology,WBC,5.5,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Thyroid Function Testing,Free Thyroxine (FT4),<0.40,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.08,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,96,Thyroid Function Testing,Triidothyronine (T3),50,ng/dL,90,168
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Alanine Transferase (SGPT),<10,U/L,0,55
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Aspartate Transferase (SGOT),11,U/L,0,37
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,BUN,12,mg/dL,6,20
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,LDH,387,U/L,130,250
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Lipase,35,U/L,0,78
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Magnesium,1.8,mg/dL,1.9,2.6
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Potassium,3.5,mEq/L,3.3,4.9
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Sodium,141,mEq/L,133,143
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Chemistry,Urea,,,NA,NA
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,Hematocrit,35.6,%,34.3,46
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,Hemoglobin,11.1,g/dL,11.2,15.4
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,Platelet,170,K/mcL,160,400
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Hematology,WBC,5.3,K/mcL,4,11
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.7,1.5
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.09,mcU/mL,0.6,4.8
101-0015,011,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,117,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Alanine Transferase (SGPT),22,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Alkaline Phosphatase,50,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,BUN,21,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Indirect Bilirubin,0.2,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,LDH,203,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Lipase,36,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Sodium,139,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,Hematocrit,37.8,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,Hemoglobin,12.9,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,Neutrophils abs,4.4,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,Platelet,186,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Hematology,WBC,5.6,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.08,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,SCREENING,-3,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,50,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,BUN,21,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,LDH,209,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.5,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.3,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.3,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Platelet,226,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,WBC,4.6,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.52,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Alanine Transferase (SGPT),19,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Alkaline Phosphatase,53,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,BUN,21,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Indirect Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,LDH,235,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Lipase,47,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Sodium,138,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Urea,ND,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Hematocrit,35.9,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Hemoglobin,11.6,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Neutrophils abs,3.6,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Platelet,191,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,WBC,5.1,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.24,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,46,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,46,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,46,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.43,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,46,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,67,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,67,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,67,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.90,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,67,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,95,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,95,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,95,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.34,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,95,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Alanine Transferase (SGPT),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Alkaline Phosphatase,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Aspartate Transferase (SGOT),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,BUN,ND,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Creatinine,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Direct Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Indirect Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,LDH,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Lipase,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Magnesium,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Potassium,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Sodium,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Total Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,Hematocrit,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,Hemoglobin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,Lymphocytes abs,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,Neutrophils abs,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,Platelet,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Hematology,WBC,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Thyroid Function Testing,Free Thyroxine (FT4),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,109,Thyroid Function Testing,Triidothyronine (T3),,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Alanine Transferase (SGPT),29,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Alkaline Phosphatase,61,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Aspartate Transferase (SGOT),40,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,BUN,18,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,LDH,371,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Lipase,47,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Sodium,140,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,Hematocrit,35.2,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,Hemoglobin,11.9,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,Neutrophils abs,3.9,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,Platelet,331,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Hematology,WBC,5.5,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.89,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,136,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,BUN,22,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Indirect Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,LDH,276,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Lipase,32,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Sodium,138,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,Hematocrit,36.6,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,Hemoglobin,11.4,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,Neutrophils abs,6.4,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,Platelet,402,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Hematology,WBC,8.5,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.36,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,154,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,BUN,18,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Indirect Bilirubin,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,LDH,340,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Lipase,39,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Sodium,137,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,Hematocrit,35.4,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,Hemoglobin,11.0,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,Neutrophils abs,4.4,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,Platelet,309,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Hematology,WBC,6.3,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.65,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,175,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Alanine Transferase (SGPT),22,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Alkaline Phosphatase,77,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Aspartate Transferase (SGOT),30,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,BUN,19,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,LDH,442,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Lipase,62,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Sodium,137,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,Hematocrit,33.9,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,Hemoglobin,10.4,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,Neutrophils abs,2.6,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,Platelet,312,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Hematology,WBC,4.1,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Thyroid Function Testing,Free Thyroxine (FT4),0.99,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.33,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,END OF TREATMENT,191,Thyroid Function Testing,Triidothyronine (T3),101,ng/dL,90,168
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Alanine Transferase (SGPT),20,U/L,0,55
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,BUN,29,mg/dL,6,20
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Creatinine,1.1,mg/dL,0.6,1.1
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.5
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,LDH,204,U/L,130,250
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Lipase,52,U/L,0,78
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Potassium,4.4,mEq/L,3.3,4.9
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Sodium,141,mEq/L,133,143
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Chemistry,Urea,,,NA,NA
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,Hematocrit,36.1,%,34.3,46
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,Hemoglobin,11.3,g/dL,11.2,15.4
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,Lymphocytes abs,1.1,K/mcL,0.9,3.2
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,Neutrophils abs,2.0,K/mcL,1.5,7.5
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,Platelet,225,K/mcL,160,400
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Hematology,WBC,3.5,K/mcL,4,11
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.50,mcU/mL,0.6,4.8
101-0017,073,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,254,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Alanine Transferase (SGPT),15,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Alkaline Phosphatase,94,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,BUN,11,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Indirect Bilirubin,0.2,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,LDH,219,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Lipase,14,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Magnesium,1.6,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Sodium,138,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Chemistry,Urea,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,Hematocrit,36.2,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,Hemoglobin,11.2,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,Neutrophils abs,4.6,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,Platelet,312,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Hematology,WBC,7.3,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.62,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-2,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),16,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,97,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,12,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.4,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,176,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,15,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,ND,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,38.9,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.7,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,6.8,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,377,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,9.4,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.94,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alkaline Phosphatase,100,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,BUN,7,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Indirect Bilirubin,0.2,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,LDH,190,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Lipase,25,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Sodium,139,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Urea,ND,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hematocrit,34.8,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hemoglobin,10.5,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Lymphocytes abs,1.0,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Neutrophils abs,4.0,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Platelet,284,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,WBC,5.8,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.22,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Alanine Transferase (SGPT),32,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Alkaline Phosphatase,104,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,BUN,18,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Indirect Bilirubin,0.5,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,LDH,214,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Lipase,62,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Magnesium,1.7,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Sodium,137,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Chemistry,Urea,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,Hematocrit,32.8,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,Hemoglobin,10.1,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,Lymphocytes abs,0.7,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,Neutrophils abs,4.3,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,Platelet,195,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Hematology,WBC,5.7,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.26,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,99,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Alanine Transferase (SGPT),13,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Alkaline Phosphatase,105,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,BUN,9,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,LDH,198,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Lipase,23,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Sodium,143,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Chemistry,Urea,ND,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,Hematocrit,34.6,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,Hemoglobin,10.3,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,Lymphocytes abs,0.5,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,Neutrophils abs,4.6,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,Platelet,287,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Hematology,WBC,5.8,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.38,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,120,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,140,Thyroid Function Testing,Free Thyroxine (FT4),0.93,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,140,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,140,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.08,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,140,Thyroid Function Testing,Triidothyronine (T3),105,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Alanine Transferase (SGPT),18,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Alkaline Phosphatase,118,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,BUN,14,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Indirect Bilirubin,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,LDH,193,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Lipase,49,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Sodium,137,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Chemistry,Urea,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,Hematocrit,35.5,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,Hemoglobin,10.7,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,Lymphocytes abs,0.7,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,Neutrophils abs,6.1,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,Platelet,250,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Hematology,WBC,7.3,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Thyroid Function Testing,Free Thyroxine (FT4),5.8,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.56,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,197,Thyroid Function Testing,Triidothyronine (T3),75,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Alanine Transferase (SGPT),10,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Alkaline Phosphatase,118,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,BUN,16,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Indirect Bilirubin,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,LDH,181,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Lipase,63,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Potassium,4.5,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Sodium,138,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Chemistry,Urea,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,Hematocrit,35.4,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,Hemoglobin,10.5,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,Lymphocytes abs,0.6,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,Neutrophils abs,7.8,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,Platelet,308,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Hematology,WBC,8.8,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Thyroid Function Testing,Free Thyroxine (FT4),0.92,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.53,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,225,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Alanine Transferase (SGPT),12,U/L,0,55
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Alkaline Phosphatase,94,U/L,0,130
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Aspartate Transferase (SGOT),10,U/L,0,37
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,BUN,12,mg/dL,6,20
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Creatinine,0.6,mg/dL,0.6,1.1
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Indirect Bilirubin,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,LDH,169,U/L,130,250
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Lipase,34,U/L,0,78
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Sodium,138,mEq/L,133,143
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Chemistry,Urea,,,NA,NA
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,Hematocrit,35.2,%,34.3,46
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,Hemoglobin,10.7,g/dL,11.2,15.4
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,Neutrophils abs,3.7,K/mcL,1.5,7.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,Platelet,268,K/mcL,160,400
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Hematology,WBC,5.1,K/mcL,4,11
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.23,mcU/mL,0.6,4.8
101-0019,012,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,253,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Alanine Transferase (SGPT),13,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Alkaline Phosphatase,70,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,BUN,12,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,LDH,212,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Lipase,25,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Sodium,139,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,Hematocrit,39.1,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,Hemoglobin,12.7,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,Neutrophils abs,3.9,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,Platelet,246,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Hematology,WBC,5.6,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.21,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-4,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),4.1,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,64,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,16,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,185,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,17,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.1,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,138,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,39.0,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.7,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.4,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,294,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.6,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),ND,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),57,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Alanine Transferase (SGPT),31,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Alkaline Phosphatase,56,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,BUN,14,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,LDH,239,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Lipase,21,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Sodium,139,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,Hematocrit,34.6,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,Hemoglobin,11.2,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,Lymphocytes abs,0.7,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,Neutrophils abs,1.9,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,Platelet,182,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Hematology,WBC,3.0,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.91,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Alanine Transferase (SGPT),60,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Alkaline Phosphatase,74,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Aspartate Transferase (SGOT),33,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,BUN,13,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Indirect Bilirubin,0.3,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,LDH,278,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Lipase,26,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Sodium,141,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,Hematocrit,35.5,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,Hemoglobin,11.6,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,Lymphocytes abs,0.8,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,Neutrophils abs,2.8,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,Platelet,213,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Hematology,WBC,4.4,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Thyroid Function Testing,Free Thyroxine (FT4),2.47,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,58,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Alanine Transferase (SGPT),30,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Alkaline Phosphatase,54,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,BUN,16,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Creatinine,0.7,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,LDH,201,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Lipase,21,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Potassium,3.8,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Sodium,139,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Chemistry,Urea,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,Hematocrit,35.7,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,Hemoglobin,11.6,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,Lymphocytes abs,0.9,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,Neutrophils abs,3.5,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,Platelet,233,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Hematology,WBC,5.3,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Thyroid Function Testing,Free Thyroxine (FT4),1.20,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Thyroid Function Testing,Free Triiodothyronine (FT3),3.7,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.01,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,78,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Alanine Transferase (SGPT),32,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Alkaline Phosphatase,63,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,BUN,17,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Indirect Bilirubin,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,LDH,245,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Lipase,29,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Magnesium,1.2,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Sodium,137,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Chemistry,Urea,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,Hematocrit,40.9,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,Hemoglobin,13.1,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,Neutrophils abs,4.9,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,Platelet,305,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Hematology,WBC,7.7,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Thyroid Function Testing,Free Thyroxine (FT4),<0.40,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Thyroid Function Testing,Free Triiodothyronine (FT3),<1.5,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),16.06,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,110,Thyroid Function Testing,Triidothyronine (T3),39,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Alanine Transferase (SGPT),14,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Alkaline Phosphatase,65,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,BUN,11,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,LDH,261,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Lipase,17,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Magnesium,1.2,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Potassium,3.6,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Sodium,131,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Chemistry,Urea,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,Hematocrit,36.2,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,Hemoglobin,12.2,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,Lymphocytes abs,1.3,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,Neutrophils abs,3.1,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,Platelet,266,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Hematology,WBC,5.2,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Thyroid Function Testing,Free Triiodothyronine (FT3),,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,136,Thyroid Function Testing,Triidothyronine (T3),,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Alanine Transferase (SGPT),22,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Alkaline Phosphatase,55,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,BUN,15,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,LDH,226,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Lipase,22,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Sodium,140,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,Hematocrit,36.4,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,Hemoglobin,11.5,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,Lymphocytes abs,1.4,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,Neutrophils abs,4.4,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,Platelet,280,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Hematology,WBC,6.5,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Thyroid Function Testing,Free Thyroxine (FT4),3.2,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Thyroid Function Testing,Free Triiodothyronine (FT3),<1.5,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),31.85,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,166,Thyroid Function Testing,Triidothyronine (T3),<35,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Alanine Transferase (SGPT),17,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Alkaline Phosphatase,53,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,BUN,19,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,LDH,246,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Lipase,25,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Magnesium,1.3,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Potassium,3.9,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Sodium,139,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,Hematocrit,36.6,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,Hemoglobin,11.8,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,Lymphocytes abs,1.9,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,Neutrophils abs,4.7,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,Platelet,280,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Hematology,WBC,8.2,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Thyroid Function Testing,Free Thyroxine (FT4),0.67,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Thyroid Function Testing,Free Triiodothyronine (FT3),<1.5,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),32.71,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,194,Thyroid Function Testing,Triidothyronine (T3),<35,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Alanine Transferase (SGPT),21,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Alkaline Phosphatase,52,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,BUN,20,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Creatinine,1.0,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,LDH,249,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Lipase,25,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Potassium,4.0,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Sodium,136,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,Hematocrit,39.2,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,Hemoglobin,12.5,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,Lymphocytes abs,1.7,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,Neutrophils abs,5.0,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,Platelet,256,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Hematology,WBC,7,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.32,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,222,Thyroid Function Testing,Triidothyronine (T3),64,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Alanine Transferase (SGPT),12,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Alkaline Phosphatase,46,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,BUN,21,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Creatinine,0.9,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,LDH,205,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Lipase,25,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Magnesium,1.5,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Potassium,4.3,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Sodium,138,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Chemistry,Urea,ND,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,Hematocrit,39.5,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,Hemoglobin,12.4,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,Lymphocytes abs,1.2,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,Neutrophils abs,6.3,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,Platelet,261,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Hematology,WBC,8.5,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Thyroid Function Testing,Free Thyroxine (FT4),1.67,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.18,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,250,Thyroid Function Testing,Triidothyronine (T3),95,ng/dL,90,168
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Alanine Transferase (SGPT),11,U/L,0,55
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Alkaline Phosphatase,50,U/L,0,130
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,37
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,BUN,16,mg/dL,6,20
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Creatinine,0.8,mg/dL,0.6,1.1
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Indirect Bilirubin,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,LDH,201,U/L,130,250
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Lipase,33,U/L,0,78
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Magnesium,1.4,mg/dL,1.9,2.6
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Potassium,3.7,mEq/L,3.3,4.9
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Sodium,139,mEq/L,133,143
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Chemistry,Urea,,,NA,NA
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,Hematocrit,37.9,%,34.3,46
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,Hemoglobin,12.1,g/dL,11.2,15.4
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,Lymphocytes abs,1.6,K/mcL,0.9,3.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,Neutrophils abs,3.7,K/mcL,1.5,7.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,Platelet,232,K/mcL,160,400
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Hematology,WBC,6.1,K/mcL,4,11
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Thyroid Function Testing,Free Thyroxine (FT4),1.57,ng/dL,0.7,1.5
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2.3,4.2
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.48,mcU/mL,0.6,4.8
101-0020,013,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,278,Thyroid Function Testing,Triidothyronine (T3),79,ng/dL,90,168
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),22,U/L,0,41
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,85,U/L,40,129
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,40
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,19,mg/dL,6,23
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.03,mg/dL,0.67,1.17
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,183,U/L,135,225
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,143,mEq/L,136,145
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,41.4,%,40,54
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.3,g/dL,14,18
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.78,K/ul,1,4.8
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.80,K/ul,1.7,7.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,228,K/ul,140,440
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.8,K/ul,4,11
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),21,U/L,0,41
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,86,U/L,40,129
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,40
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,21,mg/dL,6,23
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.93,mg/dL,0.67,1.17
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,192,U/L,135,225
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,104,U/L,13,60
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mEq/L,136,145
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,41.2,%,40,54
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.5,g/dL,14,18
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.55,K/ul,1,4.8
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.33,K/ul,1.7,7.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,242,K/ul,140,440
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,6.1,K/ul,4,11
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.27,ng/dL,0.93,1.7
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.13,µIU/mL,0.27,4.2
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),125,ng/mL,80,200
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Alanine Transferase (SGPT),20,U/L,0,41
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Alkaline Phosphatase,85,U/L,40,129
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,40
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,BUN,13,mg/dL,6,23
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Creatinine,0.83,mg/dL,0.67,1.17
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,LDH,UN,U/L,135,225
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Lipase,114,U/L,13,60
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Sodium,137,mEq/L,136,145
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Chemistry,Urea,UN,,NA,NA
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,Hematocrit,36,%,40,54
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,Hemoglobin,11.8,g/dL,14,18
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,Lymphocytes abs,0.52,K/ul,1,4.8
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,Neutrophils abs,4.69,K/ul,1.7,7.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,Platelet,234,K/ul,140,440
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Hematology,WBC,5.3,K/ul,4,11
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Thyroid Function Testing,Free Thyroxine (FT4),1.32,ng/dL,0.93,1.7
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.54,µIU/mL,0.27,4.2
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,45,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,Hematocrit,40.6,%,40,54
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,Hemoglobin,13,g/dL,14,18
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,Lymphocytes abs,UN,K/ul,1,4.8
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,Neutrophils abs,UN,K/ul,1.7,7.3
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,Platelet,260,K/ul,140,440
102-0001,014,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,101,Hematology,WBC,11.1,K/ul,4,11
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),1.23,ng/dL,0.93,1.7
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1,µIU/mL,0.27,4.2
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),85,ng/mL,80,200
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,6,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,6,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,6,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.09,µIU/mL,0.27,4.2
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,6,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),7,U/L,0,41
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),7,U/L,0,41
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,77,U/L,40,129
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,77,U/L,40,129
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,40
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,40
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,19,mg/dL,6,23
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,19,mg/dL,6,23
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.49,mg/dL,0.67,1.17
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.49,mg/dL,0.67,1.17
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,UN,U/L,135,225
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,UN,U/L,135,225
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,ND,U/L,13,60
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,UN,U/L,13,60
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,3.0,mEq/L,3.5,5.1
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,3.0,mEq/L,3.5,5.1
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,150,mEq/L,136,145
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,150,mEq/L,136,145
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,UN,,NA,NA
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,UN,,NA,NA
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,28.8,%,40,54
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,28.8,%,40,54
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,9.3,g/dL,14,18
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,9.3,g/dL,14,18
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,2.24,K/ul,1,4.8
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,2.24,K/ul,1,4.8
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,2.13,K/ul,1.7,7.3
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,2.13,K/ul,1.7,7.3
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,375,K/ul,140,440
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,375,K/ul,140,440
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,5.2,K/ul,4,11
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,5.2,K/ul,4,11
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.09,µIU/mL,0.27,4.2
102-0006,015,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),0.9,ng/dL,0.93,1.7
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.6,µIU/mL,0.27,4.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),96,ng/mL,80,200
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alanine Transferase (SGPT),14,U/L,0,41
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alkaline Phosphatase,152,U/L,40,129
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,40
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,BUN,21,mg/dL,6,23
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Creatinine,1.45,mg/dL,0.67,1.17
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,LDH,275,U/L,135,225
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Lipase,17,U/L,13,60
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Sodium,138,mEq/L,136,145
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Urea,UN,,NA,NA
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hematocrit,30.9,%,40,54
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hemoglobin,9.1,g/dL,14,18
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Lymphocytes abs,0.57,K/ul,1,4.8
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Neutrophils abs,10.64,K/ul,1.7,7.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Platelet,449,K/ul,140,440
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,WBC,13.7,K/ul,4,11
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Thyroxine (FT4),1.38,ng/dL,0.93,1.7
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.55,µIU/mL,0.27,4.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Triidothyronine (T3),122,ng/mL,80,200
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,114,U/L,40,129
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,40
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,21,mg/dL,6,23
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.43,mg/dL,0.67,1.17
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,328,U/L,135,225
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,12,U/L,13,60
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mEq/L,136,145
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,26.4,%,40,54
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,7.8,g/dL,14,18
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.59,K/ul,1,4.8
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,8.5,K/ul,1.7,7.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,306,K/ul,140,440
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,11.8,K/ul,4,11
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.03,ng/dL,0.93,1.7
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.01,µIU/mL,0.27,4.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),78,ng/mL,80,200
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),13,U/L,0,41
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,156,U/L,40,129
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,26,mg/dL,6,23
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.48,mg/dL,0.67,1.17
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,418,U/L,135,225
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,11,U/L,13,60
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,132,mEq/L,136,145
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,NA,,NA,NA
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,35,%,40,54
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,10.7,g/dL,14,18
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.91,K/ul,1,4.8
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,6.57,K/ul,1.7,7.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,387,K/ul,140,440
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,10.1,K/ul,4,11
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.22,ng/dL,0.93,1.7
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.12,µIU/mL,0.27,4.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Alkaline Phosphatase,102,U/L,40,129
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,40
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,BUN,14,mg/dL,6,23
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Creatinine,1.07,mg/dL,0.67,1.17
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,LDH,ND,U/L,135,225
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Lipase,ND,U/L,13,60
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Sodium,143,mEq/L,136,145
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Urea,UN,,NA,NA
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Hematocrit,37.4,%,40,54
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Hemoglobin,11.4,g/dL,14,18
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Lymphocytes abs,0.43,K/ul,1,4.8
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Neutrophils abs,7.7,K/ul,1.7,7.3
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Platelet,226,K/ul,140,440
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,WBC,8.6,K/ul,4,11
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.21,µIU/mL,0.27,4.2
102-0010,016,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),1.41,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),3.6,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.03,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),139,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alanine Transferase (SGPT),37,U/L,0,41
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alkaline Phosphatase,189,U/L,40,129
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Aspartate Transferase (SGOT),53,U/L,0,40
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,BUN,10,mg/dL,6,23
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Creatinine,0.66,mg/dL,0.67,1.17
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,LDH,348,U/L,135,225
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Lipase,73,U/L,13,60
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Sodium,136,mEq/L,136,145
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Urea,UN,,NA,NA
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hematocrit,32.2,%,40,54
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hemoglobin,10.2,g/dL,14,18
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Lymphocytes abs,1.44,K/ul,1,4.8
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Neutrophils abs,5.91,K/ul,1.7,7.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Platelet,129,K/ul,140,440
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,WBC,8.3,K/ul,4,11
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Thyroxine (FT4),1.37,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.16,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Triidothyronine (T3),130,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),40,U/L,0,41
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,214,U/L,40,129
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),58,U/L,0,40
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,11,mg/dL,6,23
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.69,mg/dL,0.67,1.17
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,319,U/L,135,225
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,48,U/L,13,60
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mEq/L,136,145
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,33,%,40,54
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.5,g/dL,14,18
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.39,K/ul,1,4.8
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,6.3,K/ul,1.7,7.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,101,K/ul,140,440
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,8.6,K/ul,4,11
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.55,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),36,U/L,0,41
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,241,U/L,40,129
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),72,U/L,0,40
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,7,mg/dL,6,23
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.57,mg/dL,0.67,1.17
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,326,U/L,135,225
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,29,U/L,13,60
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.5,mEq/L,3.5,5.1
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mEq/L,136,145
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,1.2,mg/dL,0,1.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,NA,,NA,NA
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,34.6,%,40,54
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.0,g/dL,14,18
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.52,K/ul,1,4.8
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,5.14,K/ul,1.7,7.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,80,K/ul,140,440
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,6.3,K/ul,4,11
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.53,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.88,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),NA,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),44,U/L,0,41
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),44,U/L,0,41
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,350,U/L,40,129
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,350,U/L,40,129
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),94,U/L,0,40
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),94,U/L,0,40
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,5,mg/dL,6,23
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,5,mg/dL,6,23
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.42,mg/dL,0.67,1.17
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.42,mg/dL,0.67,1.17
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.8,mg/dL,0,0.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.8,mg/dL,0,0.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,1.0,mg/dL,0,0.9
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,1.0,mg/dL,0,0.9
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,326,U/L,135,225
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,326,U/L,135,225
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,1.25,U/L,13,60
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,125,U/L,13,60
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,131,mEq/L,136,145
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,1.31,mEq/L,136,145
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,1.8,mg/dL,0,1.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,1.8,mg/dL,0,1.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,UN,,NA,NA
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,UN,,NA,NA
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,33.5,%,40,54
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,33.5,%,40,54
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,10.7,g/dL,14,18
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,10.7,g/dL,14,18
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.65,K/ul,1,4.8
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.65,K/ul,1,4.8
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,9.18,K/ul,1.7,7.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,9.18,K/ul,1.7,7.3
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,103,K/ul,140,440
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,103,K/ul,140,440
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,10.8,K/ul,4,11
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,10.8,K/ul,4,11
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.73,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.73,ng/dL,0.93,1.7
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.20,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.20,µIU/mL,0.27,4.2
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0011,017,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-36,Thyroid Function Testing,Free Thyroxine (FT4),0.86,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-36,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-36,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),10.96,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-36,Thyroid Function Testing,Triidothyronine (T3),126,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),19,U/L,0,41
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,107,U/L,40,129
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,17,mg/dL,6,23
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.06,mg/dL,0.67,1.17
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,221,U/L,135,225
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,32,U/L,13,60
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,138,mEq/L,136,145
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.2,%,40,54
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.1,g/dL,14,18
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.77,K/ul,1,4.8
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.98,K/ul,1.7,7.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,83,K/ul,140,440
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.4,K/ul,4,11
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),11.94,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),116,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),25,U/L,0,41
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,120,U/L,40,129
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),41,U/L,0,40
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,17,mg/dL,6,23
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.19,mg/dL,0.67,1.17
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,236,U/L,135,225
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,32,U/L,13,60
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mEq/L,136,145
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,41.7,%,40,54
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.9,g/dL,14,18
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.85,K/ul,1,4.8
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.14,K/ul,1.7,7.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,106,K/ul,140,440
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,4.8,K/ul,4,11
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),0.86,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),8.6,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),0.75,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),37.9,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),0.75,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),29.99,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,126,U/L,40,129
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,16,mg/dL,6,23
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,1.21,mg/dL,0.67,1.17
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,208,U/L,135,225
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,25,U/L,13,60
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.8,mEq/L,3.5,5.1
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,140,mEq/L,136,145
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,UN,,NA,NA
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,39.1,%,40,54
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,0.74,K/ul,1,4.8
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,3.02,K/ul,1.7,7.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,80,K/ul,140,440
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,5.3,K/ul,4,11
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.03,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.16,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),98,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.00,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),0.93,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),13.93,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),106,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,162,Thyroid Function Testing,Free Thyroxine (FT4),0.75,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,162,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,162,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),18.58,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,162,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Alanine Transferase (SGPT),16,U/L,0,41
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Alkaline Phosphatase,117,U/L,40,129
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,BUN,15,mg/dL,6,23
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Creatinine,1.13,mg/dL,0.67,1.17
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,LDH,189,U/L,135,225
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Lipase,31,U/L,13,60
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Sodium,137,mEq/L,136,145
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Urea,UN,,NA,NA
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Hematocrit,37.9,%,40,54
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Hemoglobin,12.6,g/dL,14,18
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Lymphocytes abs,0.65,K/ul,1,4.8
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Neutrophils abs,2.56,K/ul,1.7,7.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Platelet,79,K/ul,140,440
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,WBC,3.8,K/ul,4,11
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Free Thyroxine (FT4),0.77,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),35.29,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Alkaline Phosphatase,112,U/L,40,129
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Aspartate Transferase (SGOT),28,U/L,0,40
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,BUN,17,mg/dL,6,23
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Creatinine,1.23,mg/dL,0.67,1.17
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,LDH,191,U/L,135,225
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Lipase,27,U/L,13,60
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Sodium,140,mEq/L,136,145
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Urea,UN,,NA,NA
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Hematocrit,41.3,%,40,54
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Hemoglobin,13.6,g/dL,14,18
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Lymphocytes abs,0.72,K/ul,1,4.8
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Neutrophils abs,2.96,K/ul,1.7,7.3
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Platelet,95,K/ul,140,440
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,WBC,4.4,K/ul,4,11
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Free Thyroxine (FT4),0.74,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),29.39,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,274,Thyroid Function Testing,Free Thyroxine (FT4),0.80,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,274,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,274,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),35.89,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,274,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,302,Thyroid Function Testing,Free Thyroxine (FT4),0.88,ng/dL,0.93,1.7
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,302,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,302,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),17.78,µIU/mL,0.27,4.2
102-0013,018,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,302,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.81,µIU/mL,0.27,4.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Triidothyronine (T3),120,ng/mL,80,200
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),30,U/L,0,33
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,312,U/L,35,104
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),33,U/L,0,32
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,13,mg/dL,6,23
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.63,mg/dL,0.51,0.95
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,205,U/L,135,214
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,31,U/L,13,60
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,138,mEq/L,136,145
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,34.9,%,37,47
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,10.9,g/dL,12,16
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,1.42,K/ul,1,4.8
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,6.89,K/ul,1.7,7.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,261,K/ul,140,440
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,9.4,K/ul,4,11
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),17,U/L,0,33
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,163,U/L,35,104
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,32
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,4,mg/dL,6,23
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,0.46,mg/dL,0.51,0.95
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,UN,U/L,135,214
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,UN,U/L,13,60
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,137,mEq/L,136,145
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,UN,,NA,NA
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,34.5,%,37,47
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,11.4,g/dL,12,16
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,1.32,K/ul,1,4.8
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,4.28,K/ul,1.7,7.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,125,K/ul,140,440
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,6.3,K/ul,4,11
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alanine Transferase (SGPT),27,U/L,0,33
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alkaline Phosphatase,700,U/L,35,104
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Aspartate Transferase (SGOT),64,U/L,0,32
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,BUN,24,mg/dL,6,23
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Creatinine,0.81,mg/dL,0.51,0.95
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Direct Bilirubin,0.6,mg/dL,0,0.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Indirect Bilirubin,0.7,mg/dL,0,0.9
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,LDH,487,U/L,135,214
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Lipase,14,U/L,13,60
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Sodium,134,mEq/L,136,145
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Total Bilirubin,2.0,mg/dL,0,1.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Urea,UN,,NA,NA
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hematocrit,32.4,%,37,47
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hemoglobin,10.4,g/dL,12,16
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Lymphocytes abs,1.24,K/ul,1,4.8
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Neutrophils abs,5.35,K/ul,1.7,7.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Platelet,236,K/ul,140,440
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,WBC,7.8,K/ul,4,11
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.93,1.7
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.89,µIU/mL,0.27,4.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Triidothyronine (T3),108,ng/mL,80,200
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alanine Transferase (SGPT),39,U/L,0,33
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alkaline Phosphatase,669,U/L,35,104
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Aspartate Transferase (SGOT),80,U/L,0,32
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,BUN,11,mg/dL,6,23
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Creatinine,0.56,mg/dL,0.51,0.95
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Direct Bilirubin,1.5,mg/dL,0,0.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Indirect Bilirubin,0.9,mg/dL,0,0.9
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,LDH,263,U/L,135,214
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Lipase,30,U/L,13,60
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Sodium,131,mEq/L,136,145
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Total Bilirubin,2.4,mg/dL,0,1.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Urea,UN,,NA,NA
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hematocrit,33.5,%,37,47
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hemoglobin,10.4,g/dL,12,16
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Lymphocytes abs,0.81,K/ul,1,4.8
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Neutrophils abs,6.11,K/ul,1.7,7.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Platelet,276,K/ul,140,440
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,WBC,8.2,K/ul,4,11
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.61,µIU/mL,0.27,4.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Alanine Transferase (SGPT),34,U/L,0,33
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Alkaline Phosphatase,530,U/L,35,104
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Aspartate Transferase (SGOT),65,U/L,0,32
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,BUN,2,mg/dL,6,23
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Creatinine,0.38,mg/dL,0.51,0.95
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Direct Bilirubin,0.6,mg/dL,0,0.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Indirect Bilirubin,1.3,mg/dL,0,0.9
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,LDH,UN,U/L,135,214
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Lipase,UN,U/L,13,60
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Potassium,3.4,mEq/L,3.5,5.1
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Sodium,136,mEq/L,136,145
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Total Bilirubin,1.9,mg/dL,0,1.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Chemistry,Urea,UN,,NA,NA
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,Hematocrit,28.4,%,37,47
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,Hemoglobin,8.5,g/dL,12,16
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,Neutrophils abs,4.84,K/ul,1.7,7.3
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,Platelet,268,K/ul,140,440
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Hematology,WBC,6.7,K/ul,4,11
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.93,1.7
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Thyroid Function Testing,Free Triiodothyronine (FT3),,pg/mL,2,4.4
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,µIU/mL,0.27,4.2
102-0015,019,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,53,Thyroid Function Testing,Triidothyronine (T3),,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Free Thyroxine (FT4),1.30,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.71,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Triidothyronine (T3),98,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),9,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,94,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),9,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,11,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,1.05,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,412,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,15,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,1.3,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,135,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),7,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,93,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),11,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,12,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.98,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,435,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,10,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.5,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,NA,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,30.2,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.9,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,2.08,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,6.72,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,343,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,16,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),NA,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),NA,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),92,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),8,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,89,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,12,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.06,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,450,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,10,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.5,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,135,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,31.6,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,9.6,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.68,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,7.07,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,349,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,9.1,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),NA,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),NA,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.35,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),91,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,84,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,12,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.02,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,389,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,17,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,30.2,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.5,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.25,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,339,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,5.1,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.18,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.95,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),107,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Alanine Transferase (SGPT),10,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Alkaline Phosphatase,77,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,BUN,12,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Creatinine,1.07,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,LDH,428,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Lipase,13,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Sodium,130,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Hematocrit,36.1,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Hemoglobin,11.4,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Lymphocytes abs,0.85,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Neutrophils abs,4.69,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Platelet,336,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,WBC,6.6,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.86,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Triidothyronine (T3),106,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Alanine Transferase (SGPT),7,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Alkaline Phosphatase,82,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Aspartate Transferase (SGOT),11,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,BUN,15,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Creatinine,1.17,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,LDH,373,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Lipase,22,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Sodium,135,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,Hematocrit,31.4,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,Hemoglobin,10.1,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,Neutrophils abs,4.31,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,Platelet,337,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Hematology,WBC,6.5,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Thyroid Function Testing,Free Thyroxine (FT4),1.18,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.60,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,89,Thyroid Function Testing,Triidothyronine (T3),113,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Alanine Transferase (SGPT),13,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Alkaline Phosphatase,86,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,BUN,9,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Creatinine,1.17,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,LDH,359,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Lipase,12,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Sodium,133,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,Hematocrit,29.3,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,Hemoglobin,9.1,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,Lymphocytes abs,1.31,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,Neutrophils abs,5.89,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,Platelet,392,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Hematology,WBC,8.4,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.92,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,110,Thyroid Function Testing,Triidothyronine (T3),95,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Alanine Transferase (SGPT),7,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Alkaline Phosphatase,83,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Aspartate Transferase (SGOT),12,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,BUN,14,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Creatinine,1.08,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,LDH,512,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Lipase,16,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Sodium,133,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Hematocrit,26.2,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Hemoglobin,8.0,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Lymphocytes abs,1.04,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Neutrophils abs,6.52,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Platelet,463,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,WBC,8.8,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.60,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Triidothyronine (T3),103,ng/mL,80,200
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Alanine Transferase (SGPT),14,U/L,0,41
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Alkaline Phosphatase,133,U/L,40,129
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,40
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,BUN,17,mg/dL,6,23
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Creatinine,1.17,mg/dL,0.67,1.17
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,LDH,869,U/L,135,225
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Lipase,24,U/L,13,60
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Sodium,133,mEq/L,136,145
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Urea,UN,,NA,NA
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Hematocrit,26.4,%,40,54
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Hemoglobin,8.2,g/dL,14,18
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Lymphocytes abs,0.84,K/ul,1,4.8
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Neutrophils abs,8.11,K/ul,1.7,7.3
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Platelet,464,K/ul,140,440
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,WBC,10.4,K/ul,4,11
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Free Thyroxine (FT4),1.29,ng/dL,0.93,1.7
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.16,µIU/mL,0.27,4.2
102-0016,020,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Triidothyronine (T3),76,ng/mL,80,200
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-13,Thyroid Function Testing,Free Thyroxine (FT4),1.35,ng/dL,0.93,1.7
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-13,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-13,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.60,µIU/mL,0.27,4.2
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-13,Thyroid Function Testing,Triidothyronine (T3),88,ng/mL,80,200
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),58,U/L,0,41
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,509,U/L,40,129
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),53,U/L,0,40
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,28,mg/dL,6,23
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.59,mg/dL,0.67,1.17
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,481,U/L,135,225
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,18,U/L,13,60
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.6,mg/dL,1.6,2.6
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,135,mEq/L,136,145
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,26.6,%,40,54
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,8.6,g/dL,14,18
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.91,K/ul,1,4.8
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,5.84,K/ul,1.7,7.3
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,237,K/ul,140,440
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,7.5,K/ul,4,11
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.33,ng/dL,0.93,1.7
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),1.8,pg/mL,2,4.4
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.38,µIU/mL,0.27,4.2
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),77,ng/mL,80,200
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Alanine Transferase (SGPT),59,U/L,0,41
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Alkaline Phosphatase,523,U/L,40,129
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Aspartate Transferase (SGOT),51,U/L,0,40
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,BUN,17,mg/dL,6,23
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Creatinine,1.46,mg/dL,0.67,1.17
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.3
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,LDH,UN,U/L,135,225
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Lipase,UN,U/L,13,60
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Magnesium,UN,mg/dL,1.6,2.6
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Sodium,131,mEq/L,136,145
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Chemistry,Urea,UN,,NA,NA
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Thyroid Function Testing,Free Thyroxine (FT4),1.33,ng/dL,0.93,1.7
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Thyroid Function Testing,Free Triiodothyronine (FT3),1.8,pg/mL,2,4.4
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.38,µIU/mL,0.27,4.2
102-0017,021,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,16,Thyroid Function Testing,Triidothyronine (T3),77,ng/mL,80,200
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),1.92,ng/dL,0.93,1.7
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.44,µIU/mL,0.27,4.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),98,ng/mL,80,200
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),28,U/L,0,33
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,127,U/L,35,104
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),36,U/L,0,32
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,21,mg/dL,6,23
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.35,mg/dL,0.51,0.95
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,219,U/L,135,214
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,116,U/L,13,60
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,141,mEq/L,136,145
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,UN,,NA,NA
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,35.3,%,37,47
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,12.5,g/dL,12,16
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,1.07,K/ul,1,4.8
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,1.78,K/ul,1.7,7.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,100,K/ul,140,440
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,3.8,K/ul,4,11
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),1.68,ng/dL,0.93,1.7
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.37,µIU/mL,0.27,4.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),91,ng/mL,80,200
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Alanine Transferase (SGPT),16,U/L,0,33
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Alkaline Phosphatase,120,U/L,35,104
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,32
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,BUN,16,mg/dL,6,23
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Creatinine,1.36,mg/dL,0.51,0.95
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,LDH,242,U/L,135,214
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Lipase,78,U/L,13,60
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Sodium,138,mEq/L,136,145
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Chemistry,Urea,UN,,NA,NA
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,Hematocrit,34,%,37,47
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,Lymphocytes abs,1.41,K/ul,1,4.8
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,Neutrophils abs,1.54,K/ul,1.7,7.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,Platelet,135,K/ul,140,440
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Hematology,WBC,3.8,K/ul,4,11
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.13,µIU/mL,0.27,4.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,24,Thyroid Function Testing,Triidothyronine (T3),85,ng/mL,80,200
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Alkaline Phosphatase,118,U/L,35,104
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,32
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,BUN,15,mg/dL,6,23
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Creatinine,1.19,mg/dL,0.51,0.95
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,LDH,209,U/L,135,214
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Lipase,63,U/L,13,60
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Sodium,137,mEq/L,136,145
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Chemistry,Urea,UN,,NA,NA
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,Hematocrit,37.8,%,37,47
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,Hemoglobin,12.5,g/dL,12,16
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,Lymphocytes abs,1.28,K/ul,1,4.8
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,Neutrophils abs,2.28,K/ul,1.7,7.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,Platelet,110,K/ul,140,440
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Hematology,WBC,4.3,K/ul,4,11
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.53,µIU/mL,0.27,4.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,50,Thyroid Function Testing,Triidothyronine (T3),65,ng/mL,80,200
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Alanine Transferase (SGPT),UN,U/L,0,33
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Alkaline Phosphatase,UN,U/L,35,104
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Aspartate Transferase (SGOT),UN,U/L,0,32
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,BUN,16,mg/dL,6,23
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Creatinine,1.23,mg/dL,0.51,0.95
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,LDH,UN,U/L,135,214
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Lipase,UN,U/L,13,60
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Magnesium,UN,mg/dL,1.6,2.6
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Sodium,142,mEq/L,136,145
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Total Bilirubin,UN,mg/dL,0,1.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Chemistry,Urea,UN,,NA,NA
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,Hematocrit,36,%,37,47
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,Lymphocytes abs,0.93,K/ul,1,4.8
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,Neutrophils abs,1.70,K/ul,1.7,7.3
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,Platelet,103,K/ul,140,440
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Hematology,WBC,3.2,K/ul,4,11
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.93,1.7
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Thyroid Function Testing,Free Triiodothyronine (FT3),,pg/mL,2,4.4
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,µIU/mL,0.27,4.2
102-0018,022,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,85,Thyroid Function Testing,Triidothyronine (T3),,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Free Thyroxine (FT4),0.95,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.61,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-14,Thyroid Function Testing,Triidothyronine (T3),81,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,52,U/L,40,129
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,21,mg/dL,6,23
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.79,mg/dL,0.67,1.17
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,305,U/L,135,225
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,31,U/L,13,60
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,142,mEq/L,136,145
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,33.6,%,40,54
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.9,g/dL,14,18
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.47,K/ul,1,4.8
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.79,K/ul,1.7,7.3
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,203,K/ul,140,440
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.0,K/ul,4,11
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.77,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),107,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.16,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),95,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.74,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),86,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Alanine Transferase (SGPT),20,U/L,0,41
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Alkaline Phosphatase,70,U/L,40,129
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,40
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,BUN,33,mg/dL,6,23
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Creatinine,0.93,mg/dL,0.67,1.17
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,LDH,UN,U/L,135,225
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Lipase,UN,U/L,13,60
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Sodium,139,mEq/L,136,145
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Chemistry,Urea,UN,,NA,NA
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,Hematocrit,30.1,%,40,54
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,Hemoglobin,9.7,g/dL,14,18
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,Lymphocytes abs,0.43,K/ul,1,4.8
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,Neutrophils abs,3.72,K/ul,1.7,7.3
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,Platelet,192,K/ul,140,440
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Hematology,WBC,5.5,K/ul,4,11
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),14.62,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,63,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,91,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,91,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,91,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.73,µIU/mL,0.27,4.2
102-0019,023,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,91,Thyroid Function Testing,Triidothyronine (T3),51,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),0.84,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),10.72,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),88,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),13,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,59,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,13,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.62,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,278,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,40,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,38.3,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,12.3,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,2.22,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,5.28,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,264,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,8.3,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,56,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,14,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.65,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,251,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,31,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.0,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.48,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.98,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,238,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,7.3,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.76,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),84,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,74,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,15,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.64,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,213,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,36,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,31.9,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.1,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.89,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.87,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,321,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,7.6,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.05,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),105,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,70,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,18,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.59,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,213,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,37,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,34.4,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,10.9,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,2.68,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,4.15,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,338,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,7.8,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.74,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),88,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),16,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,75,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,11,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.50,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,268,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,41,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,136,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,33.6,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,10.6,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.85,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,5.30,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,358,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,8.0,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.21,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.06,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),73,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),15,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,77,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,14,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.70,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,242,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,46,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,3.5,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,141,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,34.8,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,10.7,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,2.52,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,4.29,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,252,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,7.7,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.14,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.82,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),85,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,76,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,17,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.65,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,199,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,47,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,34.2,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,10.5,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,2.70,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,3.48,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,288,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,7.1,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),0.96,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.38,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),15,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,72,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,19,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,0.72,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,193,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,44,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,138,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,34.5,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,10.4,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,2.23,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,3.73,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,295,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,6.7,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.85,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alkaline Phosphatase,71,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,BUN,16,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Creatinine,0.61,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,LDH,211,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Lipase,58,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Sodium,138,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hematocrit,31.9,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hemoglobin,31.9,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Lymphocytes abs,1.98,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Neutrophils abs,3.48,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Platelet,287,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,WBC,6.1,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.14,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Triidothyronine (T3),71,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alkaline Phosphatase,63,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,BUN,16,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Creatinine,0.58,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,LDH,206,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Lipase,55,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Sodium,142,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hematocrit,31,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hemoglobin,9.2,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Lymphocytes abs,1.90,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Neutrophils abs,3.68,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Platelet,298,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,WBC,6.3,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Thyroxine (FT4),1.27,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.33,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Triidothyronine (T3),81,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Alkaline Phosphatase,61,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,BUN,15,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Creatinine,0.53,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,LDH,263,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Lipase,0.2,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Sodium,144,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Hematocrit,31.6,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Hemoglobin,9.5,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Lymphocytes abs,2.02,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Neutrophils abs,4.80,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Platelet,329,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,WBC,7.7,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Free Thyroxine (FT4),1.13,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.68,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Triidothyronine (T3),72,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Alkaline Phosphatase,60,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,BUN,13,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Creatinine,0.58,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,LDH,276,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Lipase,37,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Sodium,139,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Hematocrit,33.2,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Hemoglobin,9.6,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Lymphocytes abs,1.38,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Neutrophils abs,5.03,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Platelet,359,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,WBC,7.0,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Free Thyroxine (FT4),1.22,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.55,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Triidothyronine (T3),81,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alkaline Phosphatase,65,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,BUN,10,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Creatinine,0.64,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,LDH,248,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Lipase,39,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Potassium,3.1,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Sodium,141,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hematocrit,32.3,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hemoglobin,9.7,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Lymphocytes abs,1.8,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Neutrophils abs,4.2,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Platelet,291,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,WBC,6.8,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Thyroxine (FT4),1.04,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Triiodothyronine (FT3),1.7,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.26,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Triidothyronine (T3),69,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Alkaline Phosphatase,64,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,BUN,16,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Creatinine,0.56,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,LDH,233,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Lipase,49,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Sodium,141,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Chemistry,Urea,UN,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,Hematocrit,33.7,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,Hemoglobin,10.3,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,Lymphocytes abs,2.05,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,Neutrophils abs,4.12,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,Platelet,342,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Hematology,WBC,7.1,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Thyroid Function Testing,Free Thyroxine (FT4),1,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.44,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,292,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Alkaline Phosphatase,58,U/L,35,104
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,BUN,15,mg/dL,6,23
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Creatinine,0.53,mg/dL,0.51,0.95
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,LDH,231,U/L,135,214
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Lipase,47,U/L,13,60
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Sodium,140,mEq/L,136,145
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Chemistry,Urea,,,NA,NA
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,Hematocrit,34.1,%,37,47
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,Hemoglobin,10.2,g/dL,12,16
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,Lymphocytes abs,1.41,K/ul,1,4.8
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,Neutrophils abs,3.92,K/ul,1.7,7.3
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,Platelet,380,K/ul,140,440
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Hematology,WBC,6.1,K/ul,4,11
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.93,1.7
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Thyroid Function Testing,Free Triiodothyronine (FT3),2.00,pg/mL,2,4.4
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.02,µIU/mL,0.27,4.2
102-0021,024,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,330,Thyroid Function Testing,Triidothyronine (T3),73,ng/mL,80,200
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-10,Thyroid Function Testing,Free Thyroxine (FT4),1.14,ng/dL,0.93,1.7
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-10,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-10,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.45,µIU/mL,0.27,4.2
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-10,Thyroid Function Testing,Triidothyronine (T3),105,ng/mL,80,200
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Alkaline Phosphatase,111,U/L,35,104
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Aspartate Transferase (SGOT),14,U/L,0,32
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,BUN,21,mg/dL,6,23
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Creatinine,0.99,mg/dL,0.51,0.95
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,LDH,305,U/L,135,214
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Lipase,18,U/L,13,60
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Potassium,5.2,mEq/L,3.5,5.1
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Sodium,141,mEq/L,136,145
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Chemistry,Urea,UN,,NA,NA
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,Hematocrit,36.5,%,37,47
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,Hemoglobin,11.1,g/dL,12,16
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,Lymphocytes abs,1.17,K/ul,1,4.8
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,Neutrophils abs,5.18,K/ul,1.7,7.3
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,Platelet,243,K/ul,140,440
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Hematology,WBC,7.2,K/ul,4,11
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Thyroid Function Testing,Free Thyroxine (FT4),1.22,ng/dL,0.93,1.7
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.20,µIU/mL,0.27,4.2
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,11,Thyroid Function Testing,Triidothyronine (T3),122,ng/mL,80,200
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,109,U/L,35,104
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,BUN,21,mg/dL,6,23
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Creatinine,1.03,mg/dL,0.51,0.95
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,LDH,323,U/L,135,214
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Lipase,16,U/L,13,60
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Potassium,4.9,mEq/L,3.5,5.1
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Sodium,135,mEq/L,136,145
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Urea,UN,,NA,NA
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hematocrit,37.6,%,37,47
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,0.66,K/ul,1,4.8
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,7.24,K/ul,1.7,7.3
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Platelet,260,K/ul,140,440
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,WBC,8.8,K/ul,4,11
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.93,1.7
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.25,µIU/mL,0.27,4.2
102-0023,025,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),105,ng/mL,80,200
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Thyroxine (FT4),0.98,ng/dL,0.93,1.7
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.19,µIU/mL,0.27,4.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Triidothyronine (T3),113,ng/mL,80,200
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),31,U/L,0,41
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,108,U/L,40,129
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,13,mg/dL,6,23
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.95,mg/dL,0.67,1.17
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,226,U/L,135,225
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,17,U/L,13,60
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,139,mEq/L,136,145
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,39.9,%,40,54
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.5,g/dL,14,18
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.13,K/ul,1,4.8
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.66,K/ul,1.7,7.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,156,K/ul,140,440
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.7,K/ul,4,11
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.48,µIU/mL,0.27,4.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),120,ng/mL,80,200
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),38,U/L,0,41
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,104,U/L,40,129
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,14,mg/dL,6,23
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.83,mg/dL,0.67,1.17
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,245,U/L,135,225
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,18,U/L,13,60
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,135,mEq/L,136,145
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,40,%,40,54
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.7,g/dL,14,18
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.25,K/ul,1,4.8
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.92,K/ul,1.7,7.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,151,K/ul,140,440
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.5,K/ul,4,11
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.35,µIU/mL,0.27,4.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Alanine Transferase (SGPT),50,U/L,0,41
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Alkaline Phosphatase,78,U/L,40,129
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,BUN,24,mg/dL,6,23
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Creatinine,0.92,mg/dL,0.67,1.17
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,LDH,252,U/L,135,225
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Lipase,29,U/L,13,60
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Sodium,139,mEq/L,136,145
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Chemistry,Urea,UN,,NA,NA
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,Hematocrit,39.9,%,40,54
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,Hemoglobin,13.3,g/dL,14,18
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,Lymphocytes abs,0.87,K/ul,1,4.8
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,Neutrophils abs,8.23,K/ul,1.7,7.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,Platelet,160,K/ul,140,440
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Hematology,WBC,10.0,K/ul,4,11
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Thyroid Function Testing,Free Triiodothyronine (FT3),1.5,pg/mL,2,4.4
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.61,µIU/mL,0.27,4.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,52,Thyroid Function Testing,Triidothyronine (T3),52,ng/mL,80,200
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Alanine Transferase (SGPT),31,U/L,0,41
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Alkaline Phosphatase,76,U/L,40,129
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,40
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,BUN,28,mg/dL,6,23
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Creatinine,1.06,mg/dL,0.67,1.17
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,LDH,242,U/L,135,225
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Lipase,UN,U/L,13,60
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Sodium,137,mEq/L,136,145
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Chemistry,Urea,UN,,NA,NA
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,Hematocrit,36.5,%,40,54
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,Hemoglobin,12.3,g/dL,14,18
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,Lymphocytes abs,1.79,K/ul,1,4.8
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,Neutrophils abs,5.89,K/ul,1.7,7.3
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,Platelet,121,K/ul,140,440
102-0024,026,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,117,Hematology,WBC,8.7,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Free Thyroxine (FT4),1.71,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.29,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-30,Thyroid Function Testing,Triidothyronine (T3),107,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,65,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,ND,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.92,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,225,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,20,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,ND,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,142,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.24,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),110,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),13,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,63,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,BUN,16,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Creatinine,1.06,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,LDH,319,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Lipase,26,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Sodium,139,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hematocrit,39.1,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hemoglobin,12.4,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,4.83,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Platelet,245,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,WBC,6.6,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),130,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alanine Transferase (SGPT),16,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alkaline Phosphatase,74,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,BUN,19,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Creatinine,0.96,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,LDH,457,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Lipase,35,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Sodium,139,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hematocrit,39.8,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hemoglobin,12.9,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Lymphocytes abs,1.05,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Neutrophils abs,3.96,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Platelet,233,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,WBC,6,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Thyroxine (FT4),2.11,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Triiodothyronine (FT3),4.2,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Triidothyronine (T3),153,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Thyroxine (FT4),1.54,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.17,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Triidothyronine (T3),100,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alkaline Phosphatase,68,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,BUN,15,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Creatinine,1.05,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,LDH,UN,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Lipase,36,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Potassium,5.1,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Sodium,140,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hematocrit,39.1,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hemoglobin,12.3,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Lymphocytes abs,1.08,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Neutrophils abs,3.82,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Platelet,244,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,WBC,5.7,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Thyroxine (FT4),1.20,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.24,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Triidothyronine (T3),89,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Alanine Transferase (SGPT),15,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Alkaline Phosphatase,83,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,BUN,17,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Creatinine,0.79,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,LDH,460,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Lipase,24,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Sodium,141,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Hematocrit,40.0,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Hemoglobin,12.8,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Lymphocytes abs,1.06,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Neutrophils abs,5.10,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Platelet,302,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,WBC,6.9,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Free Thyroxine (FT4),1.49,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.67,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Triidothyronine (T3),106,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Alkaline Phosphatase,73,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,BUN,14,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Creatinine,0.8,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,LDH,298,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Lipase,23,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Sodium,142,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Hematocrit,37.0,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Lymphocytes abs,0.86,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Neutrophils abs,5.92,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Platelet,255,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,WBC,7.7,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Free Thyroxine (FT4),1.14,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.50,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Triidothyronine (T3),99,ng/mL,80,200
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Alkaline Phosphatase,75,U/L,35,104
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,BUN,14,mg/dL,6,23
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Creatinine,0.87,mg/dL,0.51,0.95
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,LDH,702,U/L,135,214
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Lipase,27,U/L,13,60
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Sodium,139,mEq/L,136,145
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Chemistry,Urea,UN,,NA,NA
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,Hematocrit,38.2,%,37,47
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,Hemoglobin,12.4,g/dL,12,16
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,Lymphocytes abs,0.93,K/ul,1,4.8
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,Neutrophils abs,6.63,K/ul,1.7,7.3
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,Platelet,249,K/ul,140,440
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Hematology,WBC,8.5,K/ul,4,11
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Thyroid Function Testing,Free Thyroxine (FT4),1.39,ng/dL,0.93,1.7
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.3,µIU/mL,0.27,4.2
102-0025,027,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,154,Thyroid Function Testing,Triidothyronine (T3),86,ng/mL,80,200
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),1.31,ng/dL,0.93,1.7
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.16,µIU/mL,0.27,4.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),135,ng/mL,80,200
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,102,U/L,35,104
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,32
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,12,mg/dL,6,23
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.64,mg/dL,0.51,0.95
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,252,U/L,135,214
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,34,U/L,13,60
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31.9,%,37,47
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.9,g/dL,12,16
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.31,K/ul,1,4.8
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.28,K/ul,1.7,7.3
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,400,K/ul,140,440
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.6,K/ul,4,11
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.69,µIU/mL,0.27,4.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),97,ng/mL,80,200
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alanine Transferase (SGPT),19,U/L,0,33
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Alkaline Phosphatase,144,U/L,35,104
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Aspartate Transferase (SGOT),34,U/L,0,32
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,BUN,16,mg/dL,6,23
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Creatinine,0.65,mg/dL,0.51,0.95
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,LDH,388,U/L,135,214
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Lipase,7,U/L,13,60
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Sodium,135,mEq/L,136,145
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Chemistry,Urea,UN,,NA,NA
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hematocrit,31.6,%,37,47
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Hemoglobin,9.9,g/dL,12,16
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Lymphocytes abs,2.08,K/ul,1,4.8
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Neutrophils abs,5.61,K/ul,1.7,7.3
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,Platelet,411,K/ul,140,440
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Hematology,WBC,8.9,K/ul,4,11
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.99,µIU/mL,0.27,4.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,20,Thyroid Function Testing,Triidothyronine (T3),91,ng/mL,80,200
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,28,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,28,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,28,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.95,µIU/mL,0.27,4.2
102-0026,028,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,28,Thyroid Function Testing,Triidothyronine (T3),63,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Thyroxine (FT4),0.88,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Triiodothyronine (FT3),1.4,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),9.73,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Triidothyronine (T3),49,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),8,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,87,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,14,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.25,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,240,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,26,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,33.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.78,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.96,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,236,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),10.71,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),55,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),16,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,87,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),29,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,15,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.12,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,305,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,26,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.5,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,35.9,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.90,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.30,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,268,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),9.97,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),74,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,102,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,19,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.23,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,216,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,25,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,144,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,NA,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,35.7,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.3,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.93,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.84,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,223,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,6.2,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.50,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.69,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),100,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,105,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,19,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.31,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,218,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,26,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,144,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,36.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,2.60,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,230,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,4.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.83,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.27,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),82,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Alanine Transferase (SGPT),5,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Alkaline Phosphatase,100,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Aspartate Transferase (SGOT),13,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,BUN,25,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Creatinine,1.22,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,LDH,183,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Lipase,25,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Sodium,139,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,Hematocrit,36.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,Lymphocytes abs,1.01,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,Neutrophils abs,3.01,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,Platelet,206,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Hematology,WBC,5.3,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Thyroid Function Testing,Free Thyroxine (FT4),1.75,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.13,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,87,Thyroid Function Testing,Triidothyronine (T3),77,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Alkaline Phosphatase,104,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,BUN,21,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Creatinine,1.34,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,LDH,199,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Lipase,20,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,Hematocrit,38.4,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,Hemoglobin,12.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,Lymphocytes abs,0.28,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,Neutrophils abs,3.08,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,Platelet,183,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Hematology,WBC,4.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Thyroid Function Testing,Free Thyroxine (FT4),1.80,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.10,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,108,Thyroid Function Testing,Triidothyronine (T3),86,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Alkaline Phosphatase,116,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Creatinine,1.31,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,LDH,198,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Lipase,22,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Sodium,145,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,Hematocrit,38.4,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,Hemoglobin,12,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,Lymphocytes abs,1.03,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,Neutrophils abs,2.25,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,Platelet,175,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Hematology,WBC,4.1,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Thyroid Function Testing,Free Thyroxine (FT4),1.80,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.1,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,129,Thyroid Function Testing,Triidothyronine (T3),88,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Alkaline Phosphatase,103,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Creatinine,1.07,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,LDH,192,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Lipase,22,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,Hematocrit,37.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,Hemoglobin,12.5,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,Lymphocytes abs,1.22,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,Neutrophils abs,2.88,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,Platelet,190,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Hematology,WBC,5.1,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Thyroid Function Testing,Free Thyroxine (FT4),1.54,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.55,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,157,Thyroid Function Testing,Triidothyronine (T3),66,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Alkaline Phosphatase,104,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Creatinine,1.30,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,LDH,213,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Lipase,25,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Potassium,3.1,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Sodium,145,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,Hematocrit,35.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,Hemoglobin,11.7,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,Lymphocytes abs,1.20,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,Neutrophils abs,3.78,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,Platelet,200,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Hematology,WBC,6.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Thyroid Function Testing,Free Thyroxine (FT4),1.67,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.81,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,185,Thyroid Function Testing,Triidothyronine (T3),62,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Alkaline Phosphatase,113,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,BUN,14,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Creatinine,1.36,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,LDH,207,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Lipase,22,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Sodium,148,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,Hematocrit,40.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,Hemoglobin,12.9,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,Lymphocytes abs,1.01,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,Neutrophils abs,3.38,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,Platelet,195,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Hematology,WBC,5.5,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Thyroid Function Testing,Free Thyroxine (FT4),1.54,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.95,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,213,Thyroid Function Testing,Triidothyronine (T3),67,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Alanine Transferase (SGPT),13,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Alkaline Phosphatase,96,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,BUN,18,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Creatinine,1.27,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,LDH,198,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Lipase,20,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,Hematocrit,36.5,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,Hemoglobin,12.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,Neutrophils abs,3.09,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,Platelet,194,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Hematology,WBC,5.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Thyroid Function Testing,Free Thyroxine (FT4),1.49,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.68,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,241,Thyroid Function Testing,Triidothyronine (T3),78,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Alkaline Phosphatase,111,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,BUN,16,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Creatinine,1.19,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,LDH,218,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Lipase,15,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Chemistry,Urea,UN,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,Hematocrit,34.1,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,Hemoglobin,10.6,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,Neutrophils abs,11.55,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,Platelet,253,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Hematology,WBC,14.9,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Thyroid Function Testing,Free Thyroxine (FT4),1.44,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.03,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,269,Thyroid Function Testing,Triidothyronine (T3),76,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alkaline Phosphatase,80,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Creatinine,1.28,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,LDH,197,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Lipase,17,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Urea,,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hematocrit,38.1,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Lymphocytes abs,1.28,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Neutrophils abs,2.02,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Platelet,247,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,WBC,4.4,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Thyroxine (FT4),1.67,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Triiodothyronine (FT3),2.40,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.51,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Triidothyronine (T3),67,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Alkaline Phosphatase,79,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Creatinine,1.27,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,LDH,198,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Lipase,14,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,Hematocrit,35.7,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,Lymphocytes abs,0.77,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,Neutrophils abs,10.66,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,Platelet,220,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Hematology,WBC,13.1,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Thyroid Function Testing,Free Thyroxine (FT4),1.42,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Thyroid Function Testing,Free Triiodothyronine (FT3),1.80,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.19,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,325,Thyroid Function Testing,Triidothyronine (T3),48,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Alkaline Phosphatase,98,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Creatinine,1.21,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,LDH,196,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Lipase,18,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Potassium,3.4,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Chemistry,Urea,NA,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,Hematocrit,36.2,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,Lymphocytes abs,1.17,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,Neutrophils abs,2.34,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,Platelet,212,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Hematology,WBC,4.5,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Thyroid Function Testing,Free Thyroxine (FT4),1.64,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Thyroid Function Testing,Free Triiodothyronine (FT3),2.20,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.33,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,353,Thyroid Function Testing,Triidothyronine (T3),68,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Alkaline Phosphatase,101,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,BUN,18,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Creatinine,1.47,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Direct Bilirubin,0.01,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Indirect Bilirubin,0.02,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,LDH,ND,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Lipase,15,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Potassium,4.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Total Bilirubin,0.03,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,Hematocrit,40.5,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,Hemoglobin,13.0,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,Lymphocytes abs,1.11,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,Neutrophils abs,2.91,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,Platelet,214,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Hematology,WBC,5.3,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Thyroid Function Testing,Free Thyroxine (FT4),1.70,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Thyroid Function Testing,Free Triiodothyronine (FT3),2.60,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.67,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,381,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Alkaline Phosphatase,80,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,BUN,16,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Creatinine,1.30,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,LDH,235,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Lipase,14,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Potassium,3.5,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Sodium,143,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,Hematocrit,38.2,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,Lymphocytes abs,1.17,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,Neutrophils abs,2.91,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,Platelet,250,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Hematology,WBC,5.2,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Thyroid Function Testing,Free Thyroxine (FT4),8.6,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Thyroid Function Testing,Free Triiodothyronine (FT3),2.30,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.75,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,428,Thyroid Function Testing,Triidothyronine (T3),75,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Alkaline Phosphatase,89,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,BUN,15,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Creatinine,1.31,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,LDH,204,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Lipase,17,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Sodium,144,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,Hematocrit,39.4,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,Hemoglobin,12.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,Neutrophils abs,2.66,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,Platelet,210,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Hematology,WBC,4.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Thyroid Function Testing,Free Thyroxine (FT4),1.49,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.85,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,458,Thyroid Function Testing,Triidothyronine (T3),75,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Alkaline Phosphatase,87,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,BUN,21,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Creatinine,1.16,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,LDH,209,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Lipase,14,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Sodium,144,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,Hematocrit,37.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,Hemoglobin,11.4,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,Lymphocytes abs,1.12,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,Neutrophils abs,2.66,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,Platelet,248,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Hematology,WBC,5.2,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Thyroid Function Testing,Free Thyroxine (FT4),1.78,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.32,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,493,Thyroid Function Testing,Triidothyronine (T3),78,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Alkaline Phosphatase,84,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,BUN,14,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Creatinine,1.28,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,LDH,250,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Lipase,18,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,Hematocrit,39.4,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,Hemoglobin,12.7,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,Lymphocytes abs,1.32,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,Neutrophils abs,3.09,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,Platelet,226,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Hematology,WBC,5.4,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Thyroid Function Testing,Free Thyroxine (FT4),1.87,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.27,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,521,Thyroid Function Testing,Triidothyronine (T3),82,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Alkaline Phosphatase,89,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Creatinine,1.33,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,LDH,225,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Lipase,15,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,Hematocrit,38.1,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,Hemoglobin,12.3,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,Lymphocytes abs,1.38,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,Neutrophils abs,2.83,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,Platelet,219,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Hematology,WBC,5.4,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Thyroid Function Testing,Free Thyroxine (FT4),1.75,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.39,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,549,Thyroid Function Testing,Triidothyronine (T3),68,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Alkaline Phosphatase,99,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,BUN,21,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Creatinine,1.41,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,LDH,202,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Lipase,17,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,Hematocrit,38.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,Hemoglobin,12.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,Lymphocytes abs,1.21,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,Neutrophils abs,3.63,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,Platelet,228,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Hematology,WBC,6.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Thyroid Function Testing,Free Thyroxine (FT4),1.68,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.33,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,577,Thyroid Function Testing,Triidothyronine (T3),64,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Alkaline Phosphatase,98,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,BUN,19,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Creatinine,1.57,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,LDH,234,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Lipase,13,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Sodium,139,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,Hematocrit,42.2,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,Hemoglobin,13.4,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,Lymphocytes abs,1.40,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,Neutrophils abs,3.03,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,Platelet,225,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Hematology,WBC,5.5,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Thyroid Function Testing,Free Thyroxine (FT4),1.27,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.06,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,605,Thyroid Function Testing,Triidothyronine (T3),55,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Alanine Transferase (SGPT),8,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Alkaline Phosphatase,99,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,BUN,18,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Creatinine,1.46,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,LDH,227,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Lipase,19,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Total Bilirubin,ND,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,Hematocrit,39.4,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,Hemoglobin,12.6,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,Lymphocytes abs,1.28,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,Neutrophils abs,2.37,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,Platelet,216,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Hematology,WBC,4.7,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Thyroid Function Testing,Free Thyroxine (FT4),1.56,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.05,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,633,Thyroid Function Testing,Triidothyronine (T3),71,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Alkaline Phosphatase,95,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Creatinine,1.18,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,LDH,230,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Lipase,20,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,Hematocrit,37.9,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,Lymphocytes abs,1.27,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,Neutrophils abs,2.78,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,Platelet,218,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Hematology,WBC,5.1,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Thyroid Function Testing,Free Thyroxine (FT4),1.68,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.16,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,659,Thyroid Function Testing,Triidothyronine (T3),74,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Alkaline Phosphatase,98,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Creatinine,1.37,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,LDH,218,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Lipase,17,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,Hematocrit,38.2,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,Lymphocytes abs,1.24,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,Neutrophils abs,2.79,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,Platelet,230,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Hematology,WBC,5.2,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Thyroid Function Testing,Free Thyroxine (FT4),1.71,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.62,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,689,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Alkaline Phosphatase,89,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,BUN,21,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Creatinine,1.25,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,LDH,230,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Lipase,17,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Potassium,3.3,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,Hematocrit,38.3,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,Hemoglobin,12.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,Lymphocytes abs,0.72,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,Neutrophils abs,2.70,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,Platelet,196,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Hematology,WBC,4.5,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.40,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,738,Thyroid Function Testing,Triidothyronine (T3),66,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Alkaline Phosphatase,97,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,BUN,12,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Creatinine,1.29,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,LDH,239,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Lipase,16,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Chemistry,Urea,,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,Hematocrit,37.5,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,Hemoglobin,12.0,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,Lymphocytes abs,1.77,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,Neutrophils abs,4.72,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,Platelet,225,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Hematology,WBC,8.3,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Thyroid Function Testing,Free Thyroxine (FT4),1.67,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.22,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,766,Thyroid Function Testing,Triidothyronine (T3),74,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Alkaline Phosphatase,90,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,BUN,14,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Creatinine,1.26,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,LDH,223,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Lipase,18,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,Hematocrit,36.0,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,Hemoglobin,11.4,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,Lymphocytes abs,1.35,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,Neutrophils abs,2.66,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,Platelet,202,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Hematology,WBC,5.3,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Thyroid Function Testing,Free Thyroxine (FT4),1.74,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.21,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,794,Thyroid Function Testing,Triidothyronine (T3),73,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,830,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,830,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,830,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.02,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,830,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Alkaline Phosphatase,106,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,BUN,27,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Creatinine,1.58,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,LDH,205,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Lipase,22,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Sodium,139,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,Hematocrit,36.5,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,Hemoglobin,11.4,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,Lymphocytes abs,1.08,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,Neutrophils abs,3.90,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,Platelet,225,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Hematology,WBC,6.0,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Thyroid Function Testing,Free Thyroxine (FT4),1.48,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.59,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,857,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Alkaline Phosphatase,114,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,BUN,22,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Creatinine,1.47,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,LDH,206,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Lipase,20,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Chemistry,Urea,,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,Hematocrit,35.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,Hemoglobin,11.5,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,Lymphocytes abs,2.39,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,Neutrophils abs,0,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,Platelet,221,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Hematology,WBC,4.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Thyroid Function Testing,Free Thyroxine (FT4),1.37,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.93,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,885,Thyroid Function Testing,Triidothyronine (T3),80,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Alkaline Phosphatase,107,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,BUN,19,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Creatinine,1.39,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,LDH,227,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Lipase,23,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Sodium,144,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,Hematocrit,6.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,Hemoglobin,3.74,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,Neutrophils abs,4.03,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,Platelet,208,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Hematology,WBC,6.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.22,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,913,Thyroid Function Testing,Triidothyronine (T3),71,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Alkaline Phosphatase,105,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,BUN,21,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Creatinine,1.49,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,LDH,207,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Lipase,ND,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Sodium,140,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,Hematocrit,33.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,Hemoglobin,10.7,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,Lymphocytes abs,1.29,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,Neutrophils abs,4.13,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,Platelet,348,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Hematology,WBC,6.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),9.47,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,953,Thyroid Function Testing,Triidothyronine (T3),63,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Alkaline Phosphatase,94,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Creatinine,1.34,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,LDH,230,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Lipase,19,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Sodium,145,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,Hematocrit,37.8,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,Lymphocytes abs,1.43,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,Neutrophils abs,2.81,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,Platelet,199,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Hematology,WBC,5.5,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Thyroid Function Testing,Free Thyroxine (FT4),1.33,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.45,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,981,Thyroid Function Testing,Triidothyronine (T3),82,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1010,Thyroid Function Testing,Free Thyroxine (FT4),1.64,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1010,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1010,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.69,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,1010,Thyroid Function Testing,Triidothyronine (T3),75,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Alkaline Phosphatase,98,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Creatinine,1.41,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,LDH,189,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Lipase,19,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Potassium,4.8,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Sodium,137,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,Hematocrit,34.6,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,Hemoglobin,11.0,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,Lymphocytes abs,1.19,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,Neutrophils abs,4.00,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,Platelet,349,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Hematology,WBC,6.3,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Thyroid Function Testing,Free Thyroxine (FT4),1.57,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.54,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,1039,Thyroid Function Testing,Triidothyronine (T3),68,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Alanine Transferase (SGPT),7,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Alkaline Phosphatase,90,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,BUN,17,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Creatinine,1.46,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,LDH,176,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Lipase,16,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Sodium,137,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,Hematocrit,33.3,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,Hemoglobin,10.5,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,Lymphocytes abs,1.12,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,Neutrophils abs,4.26,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,Platelet,281,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Hematology,WBC,6.7,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Thyroid Function Testing,Free Thyroxine (FT4),1.51,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.50,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,1067,Thyroid Function Testing,Triidothyronine (T3),79,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Alkaline Phosphatase,122,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,BUN,23,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Creatinine,1.43,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,LDH,218,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Lipase,21,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Potassium,3.4,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Sodium,143,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,Hematocrit,31.2,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,Hemoglobin,9.7,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,Lymphocytes abs,1.24,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,Neutrophils abs,4.20,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,Platelet,305,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Hematology,WBC,6.9,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Thyroid Function Testing,Free Thyroxine (FT4),1.48,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.76,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1116,Thyroid Function Testing,Triidothyronine (T3),84,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1145,Thyroid Function Testing,Free Thyroxine (FT4),1.57,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1145,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1145,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.24,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1145,Thyroid Function Testing,Triidothyronine (T3),95,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Alkaline Phosphatase,104,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,BUN,15,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Creatinine,1.63,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,LDH,203,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Lipase,20,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Sodium,141,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,Hematocrit,36.0,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,Hemoglobin,11.3,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,Lymphocytes abs,1.31,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,Neutrophils abs,2.56,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,Platelet,231,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Hematology,WBC,5.2,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Thyroid Function Testing,Free Thyroxine (FT4),1.5,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.31,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1186,Thyroid Function Testing,Triidothyronine (T3),78,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Alkaline Phosphatase,120,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,BUN,14,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Creatinine,1.75,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,LDH,229,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Lipase,33,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Sodium,142,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,Hematocrit,37.5,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,Lymphocytes abs,0.98,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,Neutrophils abs,4.17,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,Platelet,248,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Hematology,WBC,6.4,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Thyroid Function Testing,Free Thyroxine (FT4),1.59,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.87,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1214,Thyroid Function Testing,Triidothyronine (T3),68,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Alanine Transferase (SGPT),9,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Alkaline Phosphatase,98,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,BUN,16,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Creatinine,1.60,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,LDH,235,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Lipase,18,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Sodium,138,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Total Bilirubin,<0.3,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,Hematocrit,35.1,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,Hemoglobin,11.0,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,Lymphocytes abs,1.31,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,Neutrophils abs,4.54,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,Platelet,216,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Hematology,WBC,7.1,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.98,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1228,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Alkaline Phosphatase,119,U/L,35,104
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,BUN,20,mg/dL,6,23
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Creatinine,1.59,mg/dL,0.51,0.95
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,LDH,ND,U/L,135,214
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Lipase,18,U/L,13,60
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Sodium,138,mEq/L,136,145
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Total Bilirubin,6.8,mg/dL,0,1.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Chemistry,Urea,ND,,NA,NA
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,Hematocrit,36.3,%,37,47
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,Hemoglobin,11.1,g/dL,12,16
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,Lymphocytes abs,1.62,K/ul,1,4.8
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,Neutrophils abs,2.63,K/ul,1.7,7.3
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,Platelet,217,K/ul,140,440
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Hematology,WBC,5.6,K/ul,4,11
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.62,µIU/mL,0.27,4.2
102-0027,029,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,1305,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.67,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Triidothyronine (T3),110,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alanine Transferase (SGPT),24,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alkaline Phosphatase,68,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,BUN,15,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Creatinine,0.68,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,LDH,166,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Lipase,73,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Sodium,143,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hematocrit,35.1,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hemoglobin,11.5,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Lymphocytes abs,0.49,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Neutrophils abs,1.19,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Platelet,152,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,WBC,2.1,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.99,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Triidothyronine (T3),115,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),20,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,76,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,BUN,16,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Creatinine,0.66,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,LDH,170,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Lipase,64,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Sodium,141,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hematocrit,33.9,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hemoglobin,11.1,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,0.50,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,1.99,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Platelet,182,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,WBC,2.9,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.72,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),117,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.93,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),119,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Alanine Transferase (SGPT),15,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Alkaline Phosphatase,77,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,BUN,17,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Creatinine,0.65,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,LDH,174,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Lipase,43,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Sodium,144,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Hematocrit,35.4,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Hemoglobin,11.5,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Lymphocytes abs,0.55,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Neutrophils abs,1.41,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Platelet,188,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,WBC,2.5,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Thyroxine (FT4),1.01,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.55,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Triidothyronine (T3),99,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alkaline Phosphatase,89,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,BUN,14,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Creatinine,0.68,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Direct Bilirubin,NA,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Indirect Bilirubin,NA,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,LDH,165,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Lipase,175,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Potassium,4.6,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Sodium,140,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hematocrit,39.4,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hemoglobin,12.4,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Lymphocytes abs,0.71,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Neutrophils abs,2.16,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Platelet,222,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,WBC,3.5,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.05,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Triidothyronine (T3),112,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Hematocrit,38.7,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Hemoglobin,12.5,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Lymphocytes abs,0.76,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Neutrophils abs,1.33,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,Platelet,224,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Hematology,WBC,2.5,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Free Thyroxine (FT4),1.02,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.44,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,105,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Alanine Transferase (SGPT),26,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Alkaline Phosphatase,88,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,BUN,19,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Creatinine,0.61,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,LDH,164,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Lipase,55,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Magnesium,2.5,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Sodium,139,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Hematocrit,37.1,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Lymphocytes abs,0.51,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Neutrophils abs,2.54,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,Platelet,215,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Hematology,WBC,3.5,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Free Thyroxine (FT4),1.23,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.32,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,126,Thyroid Function Testing,Triidothyronine (T3),115,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Alkaline Phosphatase,92,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,BUN,9,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Creatinine,0.67,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,LDH,179,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Lipase,47,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Sodium,141,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,Hematocrit,37.8,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,Hemoglobin,12.2,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,Lymphocytes abs,0.39,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,Neutrophils abs,1.47,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,Platelet,184,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Hematology,WBC,2.3,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.3,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,154,Thyroid Function Testing,Triidothyronine (T3),97,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Alanine Transferase (SGPT),85,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Alkaline Phosphatase,131,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Aspartate Transferase (SGOT),74,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,BUN,17,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Creatinine,0.63,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,LDH,173,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Lipase,46,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Magnesium,2,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Sodium,140,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,Hematocrit,35.8,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,Lymphocytes abs,0.13,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,Neutrophils abs,1.49,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,Platelet,136,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Hematology,WBC,2.1,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.92,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,182,Thyroid Function Testing,Triidothyronine (T3),123,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Alanine Transferase (SGPT),44,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Alkaline Phosphatase,116,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Aspartate Transferase (SGOT),43,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,BUN,10,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Creatinine,0.67,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,LDH,163,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Lipase,69,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Sodium,144,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Hematocrit,36.9,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Lymphocytes abs,0.25,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Neutrophils abs,1.66,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Platelet,122,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,WBC,2.5,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Free Thyroxine (FT4),7.3,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.96,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Triidothyronine (T3),102,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Alanine Transferase (SGPT),35,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Alkaline Phosphatase,289,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Aspartate Transferase (SGOT),35,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,BUN,19,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Creatinine,0.58,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,LDH,155,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Lipase,109,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Sodium,141,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,Hematocrit,34.8,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,Lymphocytes abs,0.24,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,Neutrophils abs,1.46,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,Platelet,171,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Hematology,WBC,2.7,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Thyroid Function Testing,Free Thyroxine (FT4),1.14,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.55,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,238,Thyroid Function Testing,Triidothyronine (T3),127,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Alanine Transferase (SGPT),36,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Alkaline Phosphatase,176,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Aspartate Transferase (SGOT),40,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,BUN,16,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Creatinine,0.59,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,LDH,208,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Lipase,132,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Sodium,144,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Chemistry,Urea,UN,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,Hematocrit,34.7,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,Hemoglobin,11.1,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,Lymphocytes abs,0.25,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,Neutrophils abs,2.6,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,Platelet,169,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Hematology,WBC,4.9,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.57,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,266,Thyroid Function Testing,Triidothyronine (T3),111,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Alanine Transferase (SGPT),25,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Alkaline Phosphatase,190,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,BUN,16,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Creatinine,0.47,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,LDH,174,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Lipase,178,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Sodium,142,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Chemistry,Urea,,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,Hematocrit,32.8,%,37,47
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,Hemoglobin,10.7,g/dL,12,16
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,Lymphocytes abs,0.15,K/ul,1,4.8
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,Neutrophils abs,2.50,K/ul,1.7,7.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,Platelet,151,K/ul,140,440
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Hematology,WBC,5.0,K/ul,4,11
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Thyroid Function Testing,Free Triiodothyronine (FT3),2.40,pg/mL,2,4.4
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.68,µIU/mL,0.27,4.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,294,Thyroid Function Testing,Triidothyronine (T3),101,ng/mL,80,200
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,319,Thyroid Function Testing,Free Thyroxine (FT4),,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,319,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,319,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,319,Thyroid Function Testing,Triidothyronine (T3),,,NA,NA
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Alanine Transferase (SGPT),45,U/L,0,33
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Alkaline Phosphatase,334,U/L,35,104
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Aspartate Transferase (SGOT),48,U/L,0,32
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,BUN,17,mg/dL,6,23
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Creatinine,0.57,mg/dL,0.51,0.95
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,LDH,194,U/L,135,214
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Lipase,391,U/L,13,60
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Sodium,138,mEq/L,136,145
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0029,030,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,337,Chemistry,Urea,,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.71,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Triidothyronine (T3),110,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),26,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,68,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,32,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,1.22,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,195,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,21,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,140,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,41,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,13.6,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,0.87,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,3.47,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,124,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,5.0,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),42,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,64,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),34,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,29,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.09,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,217,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,25,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.9,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.69,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.11,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,105,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.5,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.79,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),107,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),257,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,73,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),93,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,25,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.11,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,221,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,20,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,39.7,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.1,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.76,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.62,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,119,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,4.0,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.66,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),130,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alanine Transferase (SGPT),67,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alkaline Phosphatase,75,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Aspartate Transferase (SGOT),40,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,BUN,30,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Creatinine,1.08,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,LDH,219,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Lipase,25,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Sodium,138,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hematocrit,41.5,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hemoglobin,13.6,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Lymphocytes abs,0.79,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Neutrophils abs,2.97,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Platelet,118,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,WBC,4.4,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.71,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),102,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),35,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,73,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,31,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.23,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,210,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,23,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,138,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,39.4,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.76,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,3.20,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,117,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,4.7,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),6.2,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.78,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),99,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Alanine Transferase (SGPT),34,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Alkaline Phosphatase,78,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Aspartate Transferase (SGOT),29,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,BUN,27,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Creatinine,1.06,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,LDH,210,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Lipase,22,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Sodium,140,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Hematocrit,42.0,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Hemoglobin,13.7,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Lymphocytes abs,0.77,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Neutrophils abs,3.26,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,Platelet,105,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Hematology,WBC,4.8,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.65,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,90,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Alanine Transferase (SGPT),24,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Alkaline Phosphatase,73,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,BUN,25,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Creatinine,1.11,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,LDH,235,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Lipase,27,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Sodium,140,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Hematocrit,40.3,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Hemoglobin,13.3,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Lymphocytes abs,0.86,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Neutrophils abs,2.95,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Platelet,110,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,WBC,4.6,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.60,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Triidothyronine (T3),109,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Alanine Transferase (SGPT),27,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Alkaline Phosphatase,74,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,BUN,33,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Creatinine,1.10,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,LDH,213,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Lipase,21,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Potassium,4.9,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Sodium,143,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,Hematocrit,42.6,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,Hemoglobin,13.5,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,Lymphocytes abs,0.83,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,Neutrophils abs,2.96,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,Platelet,96,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Hematology,WBC,4.5,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.01,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,148,Thyroid Function Testing,Triidothyronine (T3),111,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Alanine Transferase (SGPT),26,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Alkaline Phosphatase,83,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,BUN,27,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Creatinine,0.96,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,LDH,196,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Lipase,19,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Sodium,144,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Hematocrit,40.3,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Lymphocytes abs,0.77,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Neutrophils abs,2.50,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Platelet,116,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,WBC,3.9,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.78,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Triidothyronine (T3),112,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Alanine Transferase (SGPT),27,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Alkaline Phosphatase,85,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Aspartate Transferase (SGOT),28,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,BUN,30,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Creatinine,1.15,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,LDH,229,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Lipase,19,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Sodium,142,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,Hematocrit,43.9,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,Hemoglobin,14.6,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,Lymphocytes abs,0.71,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,Neutrophils abs,2.17,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,Platelet,106,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Hematology,WBC,3.4,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.81,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,330,Thyroid Function Testing,Triidothyronine (T3),106,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Alanine Transferase (SGPT),34,U/L,0,41
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Alkaline Phosphatase,74,U/L,40,129
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,40
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,BUN,31,mg/dL,6,23
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Creatinine,1.19,mg/dL,0.67,1.17
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,LDH,223,U/L,135,225
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Lipase,24,U/L,13,60
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Sodium,141,mEq/L,136,145
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Chemistry,Urea,ND,,NA,NA
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,Hematocrit,44.9,%,40,54
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,Hemoglobin,14.5,g/dL,14,18
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,Lymphocytes abs,0.77,K/ul,1,4.8
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,Neutrophils abs,2.35,K/ul,1.7,7.3
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,Platelet,106,K/ul,140,440
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Hematology,WBC,3.7,K/ul,4,11
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.32,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,407,Thyroid Function Testing,Triidothyronine (T3),103,ng/mL,80,200
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,505,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,505,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,505,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.95,µIU/mL,0.27,4.2
102-0030,031,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,505,Thyroid Function Testing,Triidothyronine (T3),96,ng/mL,80,200
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Free Thyroxine (FT4),1.30,ng/dL,0.93,1.7
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.33,µIU/mL,0.27,4.2
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-41,Thyroid Function Testing,Triidothyronine (T3),117,ng/mL,80,200
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),29,U/L,0,33
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),29,U/L,0,33
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,134,U/L,35,104
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,134,U/L,35,104
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),63,U/L,0,32
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),63,U/L,0,32
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,22,mg/dL,6,23
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,22,mg/dL,6,23
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.81,mg/dL,0.51,0.95
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.81,mg/dL,0.51,0.95
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,1092,U/L,135,214
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,1092,U/L,135,214
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,18,U/L,13,60
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,18,U/L,13,60
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.4,%,37,47
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.4,%,37,47
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.11,K/ul,1,4.8
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.11,K/ul,1,4.8
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.07,K/ul,1.7,7.3
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.07,K/ul,1.7,7.3
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,300,K/ul,140,440
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,300,K/ul,140,440
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.3,K/ul,4,11
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.3,K/ul,4,11
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.60,µIU/mL,0.27,4.2
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.60,µIU/mL,0.27,4.2
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0031,032,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2,4.4
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.01,µIU/mL,0.27,4.2
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Triidothyronine (T3),135,ng/mL,80,200
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.53,µIU/mL,0.27,4.2
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),126,ng/mL,80,200
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.30,ng/dL,0.93,1.7
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.61,µIU/mL,0.27,4.2
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),119,ng/mL,80,200
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,Hematocrit,27.7,%,37,47
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,Hemoglobin,8.9,g/dL,12,16
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,Lymphocytes abs,0.56,K/ul,1,4.8
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,Neutrophils abs,2.68,K/ul,1.7,7.3
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,Platelet,107,K/ul,140,440
102-0032,033,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,68,Hematology,WBC,3.7,K/ul,4,11
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.84,µIU/mL,0.27,4.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),160,ng/mL,80,200
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),66,U/L,0,33
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,413,U/L,35,104
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),98,U/L,0,32
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,28,mg/dL,6,23
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.11,mg/dL,0.51,0.95
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.3
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,373,U/L,135,214
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,49,U/L,13,60
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mEq/L,136,145
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,1.0,mg/dL,0,1.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.8,%,37,47
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.8,g/dL,12,16
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.79,K/ul,1,4.8
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.91,K/ul,1.7,7.3
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,126,K/ul,140,440
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.0,K/ul,4,11
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.40,ng/dL,0.93,1.7
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.88,µIU/mL,0.27,4.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),161,ng/mL,80,200
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.40,ng/dL,0.93,1.7
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2,4.4
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.81,µIU/mL,0.27,4.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),197,ng/mL,80,200
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Alanine Transferase (SGPT),83,U/L,0,33
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Alkaline Phosphatase,509,U/L,35,104
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Aspartate Transferase (SGOT),140,U/L,0,32
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,BUN,16,mg/dL,6,23
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Creatinine,1.04,mg/dL,0.51,0.95
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Direct Bilirubin,0.8,mg/dL,0,0.3
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Indirect Bilirubin,0.8,mg/dL,0,0.9
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,LDH,383,U/L,135,214
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Lipase,27,U/L,13,60
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Potassium,3.6,mEq/L,3.5,5.1
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Sodium,135,mEq/L,136,145
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Total Bilirubin,1.6,mg/dL,0,1.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Chemistry,Urea,UN,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,Hematocrit,36.3,%,37,47
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,Hemoglobin,11.9,g/dL,12,16
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,Lymphocytes abs,0.87,K/ul,1,4.8
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,Neutrophils abs,3.57,K/ul,1.7,7.3
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,Platelet,180,K/ul,140,440
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Hematology,WBC,5.8,K/ul,4,11
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Thyroid Function Testing,Free Thyroxine (FT4),0.70,ng/dL,0.93,1.7
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Thyroid Function Testing,Free Triiodothyronine (FT3),1.3,pg/mL,2,4.4
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),162.60,µIU/mL,0.27,4.2
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,76,Thyroid Function Testing,Triidothyronine (T3),76,ng/mL,80,200
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Alanine Transferase (SGPT),200,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Alkaline Phosphatase,752,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Aspartate Transferase (SGOT),329,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,BUN,24,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Creatinine,0.79,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Direct Bilirubin,0.9,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Indirect Bilirubin,0.7,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,LDH,531,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Lipase,ND,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Magnesium,1.5,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Potassium,5.3,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Sodium,136,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Total Bilirubin,1.6,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Chemistry,Urea,ND,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,Hematocrit,38.6,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,Hemoglobin,12.4,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,Lymphocytes abs,0.48,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,Neutrophils abs,3.16,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,Platelet,153,,NA,NA
102-0033,034,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,162,Hematology,WBC,4.2,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-24,Thyroid Function Testing,Free Thyroxine (FT4),0.82,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-24,Thyroid Function Testing,Free Triiodothyronine (FT3),2.2,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-24,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),36.94,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-24,Thyroid Function Testing,Triidothyronine (T3),87,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),16,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,91,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,17,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.15,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,290,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,34,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,138,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,43.8,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,14.5,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.90,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.94,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,249,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.5,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.17,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),22.01,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),82,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Alkaline Phosphatase,99,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,BUN,18,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Creatinine,0.99,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,LDH,254,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Lipase,40,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Sodium,139,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Chemistry,Urea,UN,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hematocrit,38.5,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Hemoglobin,13,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Lymphocytes abs,1.05,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Neutrophils abs,4.03,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,Platelet,249,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Hematology,WBC,5.9,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Thyroxine (FT4),1.23,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Free Triiodothyronine (FT3),2.6,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.34,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,23,Thyroid Function Testing,Triidothyronine (T3),99,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alanine Transferase (SGPT),16,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Alkaline Phosphatase,91,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,BUN,10,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Creatinine,1.06,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,LDH,303,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Lipase,34,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Sodium,135,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Chemistry,Urea,,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hematocrit,43.2,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Hemoglobin,14.2,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Lymphocytes abs,0.89,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Neutrophils abs,5.82,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,Platelet,259,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Hematology,WBC,7.6,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Thyroxine (FT4),1.21,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.21,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,42,Thyroid Function Testing,Triidothyronine (T3),100,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Alanine Transferase (SGPT),24,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Alkaline Phosphatase,95,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,BUN,12,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Creatinine,1.13,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,LDH,307,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Lipase,0.5,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Sodium,136,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Chemistry,Urea,UN,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Hematocrit,44.1,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Hemoglobin,14.8,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Lymphocytes abs,1.26,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Neutrophils abs,5.01,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,Platelet,274,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Hematology,WBC,7.3,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Thyroxine (FT4),1.20,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.08,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,63,Thyroid Function Testing,Triidothyronine (T3),97,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Alkaline Phosphatase,83,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,BUN,9,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Creatinine,1.04,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,LDH,401,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Lipase,28,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Sodium,135,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Chemistry,Urea,UN,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hematocrit,40.9,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Hemoglobin,13.7,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Lymphocytes abs,0.89,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Neutrophils abs,6.24,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,Platelet,308,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Hematology,WBC,8.0,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),21.49,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,84,Thyroid Function Testing,Triidothyronine (T3),92,ng/mL,80,200
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Alanine Transferase (SGPT),39,U/L,0,41
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Alkaline Phosphatase,96,U/L,40,129
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Aspartate Transferase (SGOT),74,U/L,0,40
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,BUN,8,mg/dL,6,23
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Creatinine,1.03,mg/dL,0.67,1.17
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,LDH,617,U/L,135,225
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Lipase,26,U/L,13,60
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Potassium,4.9,mEq/L,3.5,5.1
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Sodium,139,mEq/L,136,145
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Chemistry,Urea,UN,,NA,NA
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,Hematocrit,38.0,%,40,54
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,Lymphocytes abs,0.76,K/ul,1,4.8
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,Neutrophils abs,8.06,K/ul,1.7,7.3
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,Platelet,347,K/ul,140,440
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Hematology,WBC,9.8,K/ul,4,11
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Thyroid Function Testing,Free Thyroxine (FT4),1,ng/dL,0.93,1.7
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4,µIU/mL,0.27,4.2
102-0035,035,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,105,Thyroid Function Testing,Triidothyronine (T3),92,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Triiodothyronine (FT3),3.4,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.91,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Triidothyronine (T3),139,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),20,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,127,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),38,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,12,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,1.38,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,365,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,67,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.5,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,138,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,41.1,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,13.4,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,0.74,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,3.59,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,173,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,5.2,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,139,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),56,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,20,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.45,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,550,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,UN,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,129,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,UN,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,41.3,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,13.4,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,0.42,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,3.11,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,145,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,4.0,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),UN,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),UN,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,203,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,19,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.23,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,184,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,140,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,41.4,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.6,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.17,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.96,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,247,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.1,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.16,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.39,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),140,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),20,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,115,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,16,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.25,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.7,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,179,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,87,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,138,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,40.8,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,14.2,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.28,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.32,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,194,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,5.7,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.16,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.94,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),117,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),3.5,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.12,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),124,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),19,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,89,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,14,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,1.25,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,186,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,62,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,137,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,UN,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,42.6,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,14.3,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.19,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,3.04,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,184,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,5.2,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),3.5,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.74,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),123,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),21,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,78,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,13,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,1.34,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,0.7,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,185,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,58,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,140,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,UN,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,44.8,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,14.7,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.09,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,2.28,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,191,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,4.6,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),0.96,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.89,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Alanine Transferase (SGPT),97,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Alkaline Phosphatase,264,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Aspartate Transferase (SGOT),30,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,BUN,29,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Creatinine,1.34,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,LDH,159,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Lipase,125,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Sodium,134,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Chemistry,Urea,ND,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Hematocrit,46.3,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Hemoglobin,14,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Lymphocytes abs,0.95,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Neutrophils abs,19.49,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,Platelet,322,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Hematology,WBC,21.7,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Free Thyroxine (FT4),1.35,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.18,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,141,Thyroid Function Testing,Triidothyronine (T3),111,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Alkaline Phosphatase,83,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,BUN,9,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Creatinine,1.02,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,LDH,ND,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Lipase,ND,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Sodium,139,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Chemistry,Urea,ND,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,Hematocrit,43.8,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,Hemoglobin,14.3,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,Lymphocytes abs,1.24,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,Neutrophils abs,4.42,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,Platelet,192,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,170,Hematology,WBC,6.5,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,184,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,184,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,184,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.07,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,184,Thyroid Function Testing,Triidothyronine (T3),118,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Free Thyroxine (FT4),1.19,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Free Triiodothyronine (FT3),3.00,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.37,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Triidothyronine (T3),99,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,280,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,280,Thyroid Function Testing,Free Triiodothyronine (FT3),3.30,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,280,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.74,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,280,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Alanine Transferase (SGPT),17,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Alanine Transferase (SGPT),17,U/L,0,41
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Alkaline Phosphatase,98,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Alkaline Phosphatase,98,U/L,40,129
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,40
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,BUN,21,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,BUN,21,mg/dL,6,23
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Creatinine,1.28,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Creatinine,1.28,mg/dL,0.67,1.17
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,LDH,ND,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,LDH,134,U/L,135,225
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Lipase,51,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Lipase,51,U/L,13,60
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Sodium,138,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Sodium,138,mEq/L,136,145
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Urea,ND,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Chemistry,Urea,ND,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Hematocrit,42.4,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Hematocrit,42.4,%,40,54
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Hemoglobin,13.9,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Hemoglobin,13.9,g/dL,14,18
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Lymphocytes abs,1.18,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Lymphocytes abs,1.18,K/ul,1,4.8
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Neutrophils abs,3.7,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Neutrophils abs,3.70,K/ul,1.7,7.3
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Platelet,211,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,Platelet,211,K/ul,140,440
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,WBC,5.5,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,333,Hematology,WBC,5.5,K/ul,4,11
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,336,Thyroid Function Testing,Free Thyroxine (FT4),1.03,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,336,Thyroid Function Testing,Free Triiodothyronine (FT3),3.20,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,336,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.43,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,336,Thyroid Function Testing,Triidothyronine (T3),116,ng/mL,80,200
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,378,Thyroid Function Testing,Free Thyroxine (FT4),,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,378,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,378,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,378,Thyroid Function Testing,Triidothyronine (T3),,,NA,NA
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,441,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,441,Thyroid Function Testing,Free Triiodothyronine (FT3),6.4,pg/mL,2,4.4
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,441,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.57,µIU/mL,0.27,4.2
102-0037,036,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,441,Thyroid Function Testing,Triidothyronine (T3),109,ng/mL,80,200
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),1.31,ng/dL,0.93,1.7
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),2.1,pg/mL,2,4.4
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.05,µIU/mL,0.27,4.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),73,ng/mL,80,200
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),13,U/L,0,41
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,61,U/L,40,129
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,7,mg/dL,6,23
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.80,mg/dL,0.67,1.17
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,432,U/L,135,225
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,10,U/L,13,60
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,137,mEq/L,136,145
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,40.4,%,40,54
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,13.0,g/dL,14,18
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,0.48,K/ul,1,4.8
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,3.53,K/ul,1.7,7.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,218,K/ul,140,440
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,5.1,K/ul,4,11
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,66,U/L,40,129
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,10,mg/dL,6,23
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.85,mg/dL,0.67,1.17
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,435,U/L,135,225
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,10,U/L,13,60
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mEq/L,136,145
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,40.6,%,40,54
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.9,g/dL,14,18
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.61,K/ul,1,4.8
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.74,K/ul,1.7,7.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,222,K/ul,140,440
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.2,K/ul,4,11
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),UN,ng/dL,0.93,1.7
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),UN,pg/mL,2,4.4
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.63,µIU/mL,0.27,4.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),72,ng/mL,80,200
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,61,U/L,40,129
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,8,mg/dL,6,23
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.82,mg/dL,0.67,1.17
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,447,U/L,135,225
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,10,U/L,13,60
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mEq/L,136,145
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,39.8,%,40,54
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.5,g/dL,14,18
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.67,K/ul,1,4.8
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.93,K/ul,1.7,7.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,210,K/ul,140,440
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.7,K/ul,4,11
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.45,ng/dL,0.93,1.7
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.88,µIU/mL,0.27,4.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),77,ng/mL,80,200
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),11,U/L,0,41
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,64,U/L,40,129
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),25,U/L,0,40
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,10,mg/dL,6,23
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.82,mg/dL,0.67,1.17
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,503,U/L,135,225
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,9,U/L,13,60
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,138,mEq/L,136,145
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,UN,,NA,NA
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,39.8,%,40,54
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.72,K/ul,1,4.8
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.82,K/ul,1.7,7.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,222,K/ul,140,440
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,5.8,K/ul,4,11
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.47,ng/dL,0.93,1.7
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),1.9,pg/mL,2,4.4
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.38,µIU/mL,0.27,4.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),60,ng/mL,80,200
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Alkaline Phosphatase,62,U/L,40,129
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Aspartate Transferase (SGOT),35,U/L,0,40
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,BUN,9,mg/dL,6,23
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Creatinine,0.80,mg/dL,0.67,1.17
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,LDH,606,U/L,135,225
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Lipase,10,U/L,13,60
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Sodium,135,mEq/L,136,145
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Chemistry,Urea,UN,,NA,NA
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,Hematocrit,40.2,%,40,54
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,Hemoglobin,12.7,g/dL,14,18
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,Lymphocytes abs,0.71,K/ul,1,4.8
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,Neutrophils abs,4.44,K/ul,1.7,7.3
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,Platelet,267,K/ul,140,440
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Hematology,WBC,6.6,K/ul,4,11
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.51,µIU/mL,0.27,4.2
102-0038,037,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,73,Thyroid Function Testing,Triidothyronine (T3),63,ng/mL,80,200
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Thyroxine (FT4),1.50,ng/dL,0.93,1.7
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.48,µIU/mL,0.27,4.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Triidothyronine (T3),109,ng/mL,80,200
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),13,U/L,0,33
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,137,U/L,35,104
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,32
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,6,mg/dL,6,23
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.66,mg/dL,0.51,0.95
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,169,U/L,135,214
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,21,U/L,13,60
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mEq/L,136,145
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,1.0,mg/dL,0,1.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31,%,37,47
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.3,g/dL,12,16
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.31,K/ul,1,4.8
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,1.26,K/ul,1.7,7.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,95,K/ul,140,440
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,1.8,K/ul,4,11
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.77,µIU/mL,0.27,4.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),110,ng/mL,80,200
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),16,U/L,0,33
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,177,U/L,35,104
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,32
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,8,mg/dL,6,23
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.58,mg/dL,0.51,0.95
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.6,mg/dL,0,0.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,176,U/L,135,214
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,24,U/L,13,60
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.4,mEq/L,3.5,5.1
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,135,mEq/L,136,145
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,1.1,mg/dL,0,1.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,32.3,%,37,47
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.5,g/dL,12,16
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.53,K/ul,1,4.8
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.71,K/ul,1.7,7.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,115,K/ul,140,440
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,3.5,K/ul,4,11
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),2.25,ng/dL,0.93,1.7
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.31,µIU/mL,0.27,4.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),126,ng/mL,80,200
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),17,U/L,0,33
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,264,U/L,35,104
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),33,U/L,0,32
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,7,mg/dL,6,23
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.66,mg/dL,0.51,0.95
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,172,U/L,135,214
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,18,U/L,13,60
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,140,mEq/L,136,145
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,UN,,NA,NA
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,29.4,%,37,47
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.5,g/dL,12,16
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.58,K/ul,1,4.8
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,2.45,K/ul,1.7,7.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,127,K/ul,140,440
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,3.5,K/ul,4,11
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.17,ng/dL,0.93,1.7
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),1.4,pg/mL,2,4.4
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.46,µIU/mL,0.27,4.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),53,ng/mL,80,200
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Alanine Transferase (SGPT),12,U/L,0,33
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Alkaline Phosphatase,323,U/L,35,104
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Aspartate Transferase (SGOT),33,U/L,0,32
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,BUN,6,mg/dL,6,23
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Creatinine,0.62,mg/dL,0.51,0.95
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,LDH,190,U/L,135,214
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Lipase,26,U/L,13,60
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Potassium,3.5,mEq/L,3.5,5.1
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Sodium,131,mEq/L,136,145
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Chemistry,Urea,UN,,NA,NA
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,Hematocrit,30.0,%,37,47
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,Hemoglobin,9.7,g/dL,12,16
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,Lymphocytes abs,0.43,K/ul,1,4.8
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,Neutrophils abs,4.10,K/ul,1.7,7.3
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,Platelet,143,K/ul,140,440
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Hematology,WBC,5.0,K/ul,4,11
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Thyroid Function Testing,Free Thyroxine (FT4),0.59,ng/dL,0.93,1.7
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Thyroid Function Testing,Free Triiodothyronine (FT3),1,pg/mL,2,4.4
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),55.80,µIU/mL,0.27,4.2
102-0039,038,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,66,Thyroid Function Testing,Triidothyronine (T3),32,ng/mL,80,200
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,Hematocrit,39.6,%,40,54
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,Hemoglobin,12.4,g/dL,14,18
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,Lymphocytes abs,1.01,K/ul,1,4.8
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,Neutrophils abs,2.47,K/ul,1.7,7.3
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,Platelet,171,K/ul,140,440
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Hematology,WBC,3.9,K/ul,4,11
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Thyroid Function Testing,Free Thyroxine (FT4),1.35,ng/dL,0.93,1.7
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.43,µIU/mL,0.27,4.2
102-0041,074,CD8 HIGH,Nivolumab,SCREENING,-29,Thyroid Function Testing,Triidothyronine (T3),98,ng/mL,80,200
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),20,U/L,0,41
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,70,U/L,40,129
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,40
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,BUN,7,mg/dL,6,23
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.87,mg/dL,0.67,1.17
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,LDH,187,U/L,135,225
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Lipase,22,U/L,13,60
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Sodium,143,mEq/L,136,145
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,20,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.45,µIU/mL,0.27,4.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,20,Thyroid Function Testing,Triidothyronine (T3),101,ng/mL,80,200
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Alanine Transferase (SGPT),,U/L,0,41
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Alkaline Phosphatase,,U/L,40,129
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Aspartate Transferase (SGOT),,U/L,0,40
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,BUN,,mg/dL,6,23
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Creatinine,,mg/dL,0.67,1.17
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,LDH,,U/L,135,225
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Lipase,,U/L,13,60
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Magnesium,,mg/dL,1.6,2.6
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Potassium,,mEq/L,3.5,5.1
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Sodium,,mEq/L,136,145
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Total Bilirubin,,mg/dL,0,1.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Chemistry,Urea,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,Hematocrit,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,Hemoglobin,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,Lymphocytes abs,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,Neutrophils abs,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,Platelet,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Hematology,WBC,,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Thyroid Function Testing,Free Triiodothyronine (FT3),3.00,pg/mL,2,4.4
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.48,µIU/mL,0.27,4.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,53,Thyroid Function Testing,Triidothyronine (T3),115,ng/mL,80,200
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Alanine Transferase (SGPT),29,U/L,0,41
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Alkaline Phosphatase,86,U/L,40,129
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Aspartate Transferase (SGOT),26,U/L,0,40
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,BUN,4,mg/dL,6,23
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Creatinine,0.77,mg/dL,0.67,1.17
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Direct Bilirubin,26,mg/dL,0,0.3
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,LDH,189,U/L,135,225
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Lipase,26,U/L,13,60
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Sodium,136,mEq/L,136,145
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Chemistry,Urea,ND,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,Hematocrit,38.4,%,40,54
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,Hemoglobin,11.8,g/dL,14,18
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,Lymphocytes abs,1.09,K/ul,1,4.8
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,Neutrophils abs,2.98,K/ul,1.7,7.3
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,Platelet,205,K/ul,140,440
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Hematology,WBC,4.6,K/ul,4,11
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Thyroid Function Testing,Free Thyroxine (FT4),1.79,ng/dL,0.93,1.7
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Thyroid Function Testing,Free Triiodothyronine (FT3),3.30,pg/mL,2,4.4
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.63,µIU/mL,0.27,4.2
102-0041,074,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,77,Thyroid Function Testing,Triidothyronine (T3),121,ng/mL,80,200
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Alanine Transferase (SGPT),31,U/L,0,41
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Alkaline Phosphatase,84,U/L,40,129
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,BUN,4,mg/dL,6,23
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Creatinine,0.66,mg/dL,0.67,1.17
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Indirect Bilirubin,2.0,mg/dL,0,0.9
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,LDH,201,U/L,135,225
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Lipase,21,U/L,13,60
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Magnesium,1.7,mg/dL,1.6,2.6
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Sodium,134,mEq/L,136,145
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Chemistry,Urea,NA,,NA,NA
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,Hematocrit,37.6,%,40,54
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,Hemoglobin,11.4,g/dL,14,18
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,Lymphocytes abs,1.02,K/ul,1,4.8
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,Neutrophils abs,6.85,K/ul,1.7,7.3
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,Platelet,169,K/ul,140,440
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Hematology,WBC,8.3,K/ul,4,11
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Thyroid Function Testing,Free Thyroxine (FT4),1.43,ng/dL,0.93,1.7
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Thyroid Function Testing,Free Triiodothyronine (FT3),2.90,pg/mL,2,4.4
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.41,µIU/mL,0.27,4.2
102-0041,074,CD8 HIGH,Nivolumab,END OF TREATMENT,97,Thyroid Function Testing,Triidothyronine (T3),106,ng/mL,80,200
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Free Triiodothyronine (FT3),2.9,pg/mL,2,4.4
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.13,µIU/mL,0.27,4.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Triidothyronine (T3),148,ng/mL,80,200
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),15,U/L,0,33
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,122,U/L,35,104
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,6,mg/dL,6,23
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.74,mg/dL,0.51,0.95
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,178,U/L,135,214
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,17,U/L,13,60
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,142,mEq/L,136,145
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,UN,,NA,NA
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,33.7,%,37,47
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,11.4,g/dL,12,16
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,0.89,K/ul,1,4.8
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,2.28,K/ul,1.7,7.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,357,K/ul,140,440
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,4.1,K/ul,4,11
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),20,U/L,0,33
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,138,U/L,35,104
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,32
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,7,mg/dL,6,23
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.71,mg/dL,0.51,0.95
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,220,U/L,135,214
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,19,U/L,13,60
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mEq/L,3.5,5.1
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,141,mEq/L,136,145
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,UN,,NA,NA
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.3,%,37,47
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.6,g/dL,12,16
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,1.37,K/ul,1.7,7.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,344,K/ul,140,440
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,2.8,K/ul,4,11
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.12,ng/dL,0.93,1.7
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.74,µIU/mL,0.27,4.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),160,ng/mL,80,200
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),32,U/L,0,33
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,182,U/L,35,104
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),30,U/L,0,32
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,11,mg/dL,6,23
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.69,mg/dL,0.51,0.95
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,207,U/L,135,214
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,25,U/L,13,60
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,141,mEq/L,136,145
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,UN,,NA,NA
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,33.5,%,37,47
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.9,g/dL,12,16
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.12,K/ul,1,4.8
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,1.00,K/ul,1.7,7.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,230,K/ul,140,440
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,2.8,K/ul,4,11
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.01,ng/dL,0.93,1.7
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.71,µIU/mL,0.27,4.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),157,ng/mL,80,200
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Alanine Transferase (SGPT),18,U/L,0,33
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Alkaline Phosphatase,144,U/L,35,104
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,BUN,12,mg/dL,6,23
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Creatinine,0.75,mg/dL,0.51,0.95
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Direct Bilirubin,<0.1,mg/dL,0,0.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,LDH,ND,U/L,135,214
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Lipase,ND,U/L,13,60
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Magnesium,2.3,mg/dL,1.6,2.6
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Sodium,141,mEq/L,136,145
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Chemistry,Urea,NA,,NA,NA
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,Hematocrit,39.2,%,37,47
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,Hemoglobin,13.1,g/dL,12,16
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,Lymphocytes abs,1.53,K/ul,1,4.8
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,Neutrophils abs,1.90,K/ul,1.7,7.3
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,Platelet,277,K/ul,140,440
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Hematology,WBC,4.3,K/ul,4,11
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Thyroid Function Testing,Free Thyroxine (FT4),0.88,ng/dL,0.93,1.7
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Thyroid Function Testing,Free Triiodothyronine (FT3),2.30,pg/mL,2,4.4
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.48,µIU/mL,0.27,4.2
102-0042,039,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,113,Thyroid Function Testing,Triidothyronine (T3),117,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Alanine Transferase (SGPT),14,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Alkaline Phosphatase,118,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,BUN,16,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Creatinine,0.68,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,LDH,160,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Lipase,ND,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Magnesium,ND,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Sodium,139,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Chemistry,Urea,NA,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,Hematocrit,36.7,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,Hemoglobin,11.7,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,Lymphocytes abs,1.82,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,Neutrophils abs,2.81,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,Platelet,119,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Hematology,WBC,5.3,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Thyroid Function Testing,Free Thyroxine (FT4),1.40,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.83,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,SCREENING,-25,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,118,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),22,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,BUN,12,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.65,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,LDH,173,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Lipase,19,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Potassium,3.8,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Sodium,139,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Chemistry,Urea,ND,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Thyroid Function Testing,Free Thyroxine (FT4),1.36,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Thyroid Function Testing,Free Triiodothyronine (FT3),3.10,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.87,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 1,1,Thyroid Function Testing,Triidothyronine (T3),131,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,121,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,BUN,14,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.67,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,LDH,158,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Lipase,19,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Sodium,142,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Urea,NA,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hematocrit,39.0,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.6,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.63,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.81,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Platelet,168,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,WBC,6.5,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.48,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.90,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.85,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),121,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,126,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,BUN,12,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.67,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,LDH,156,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Lipase,20,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Sodium,142,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Chemistry,Urea,NA,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,Hematocrit,41.0,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.1,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,2.21,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.32,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,Platelet,179,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Hematology,WBC,7.8,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),2.90,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.63,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),122,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Alkaline Phosphatase,123,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Aspartate Transferase (SGOT),23,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,BUN,15,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Creatinine,0.62,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,LDH,166,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Lipase,22,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Sodium,139,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Urea,ND,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Hematocrit,37.6,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Hemoglobin,12.1,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Lymphocytes abs,0.87,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Neutrophils abs,4.16,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Platelet,155,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,WBC,6.1,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Triiodothyronine (FT3),3.10,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.12,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Triidothyronine (T3),126,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Alanine Transferase (SGPT),13,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Alkaline Phosphatase,116,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Aspartate Transferase (SGOT),18,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,BUN,15,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Creatinine,0.62,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Direct Bilirubin,UN,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Indirect Bilirubin,UN,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,LDH,133,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Lipase,27,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Sodium,140,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Chemistry,Urea,NA,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,Hematocrit,39.2,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,Hemoglobin,12.8,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,Lymphocytes abs,1.19,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,Neutrophils abs,4.43,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,Platelet,161,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Hematology,WBC,6.6,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Thyroid Function Testing,Free Thyroxine (FT4),1.14,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Thyroid Function Testing,Free Triiodothyronine (FT3),2.90,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.63,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,66,Thyroid Function Testing,Triidothyronine (T3),114,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Alkaline Phosphatase,110,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,BUN,20,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Creatinine,0.62,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,LDH,173,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Lipase,29,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Sodium,138,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Chemistry,Urea,NA,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,Hematocrit,42.8,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,Hemoglobin,13.7,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,Lymphocytes abs,1.55,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,Neutrophils abs,3.01,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,Platelet,152,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Hematology,WBC,5.9,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Thyroid Function Testing,Free Thyroxine (FT4),1.34,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Thyroid Function Testing,Free Triiodothyronine (FT3),2.70,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.87,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,87,Thyroid Function Testing,Triidothyronine (T3),119,ng/mL,80,200
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Alanine Transferase (SGPT),18,U/L,0,41
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Alkaline Phosphatase,112,U/L,40,129
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,40
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,BUN,17,mg/dL,6,23
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Creatinine,0.68,mg/dL,0.67,1.17
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,LDH,ND,U/L,135,225
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Lipase,29,U/L,13,60
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Sodium,139,mEq/L,136,145
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Chemistry,Urea,ND,,NA,NA
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,Hematocrit,44.5,%,40,54
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,Hemoglobin,14.2,g/dL,14,18
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,Lymphocytes abs,1.32,K/ul,1,4.8
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,Neutrophils abs,3.39,K/ul,1.7,7.3
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,Platelet,164,K/ul,140,440
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Hematology,WBC,5.8,K/ul,4,11
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Thyroid Function Testing,Free Triiodothyronine (FT3),3.00,pg/mL,2,4.4
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),11.59,µIU/mL,0.27,4.2
102-0044,075,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,115,Thyroid Function Testing,Triidothyronine (T3),112,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Thyroxine (FT4),1.41,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Free Triiodothyronine (FT3),3.10,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.32,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-32,Thyroid Function Testing,Triidothyronine (T3),116,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),13,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,82,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,19,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.19,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,247,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,17,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,141,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,NA,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,28.9,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.5,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,1.87,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,93,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,3.3,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.60,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),3.00,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.13,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,87,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,BUN,19,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Creatinine,1.28,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,LDH,280,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Lipase,18,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Potassium,4.8,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Sodium,140,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Urea,NA,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hematocrit,25.9,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hemoglobin,8.4,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,0.85,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,1.50,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Platelet,67,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,WBC,3.0,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),1.58,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),NA,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.00,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),3.20,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alanine Transferase (SGPT),12,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alkaline Phosphatase,79,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,BUN,17,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Creatinine,1.17,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,LDH,298,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Lipase,19,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Sodium,144,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Urea,ND,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hematocrit,22.7,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hemoglobin,7.6,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Lymphocytes abs,0.55,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Neutrophils abs,1.33,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Platelet,37,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,WBC,2.5,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Thyroxine (FT4),1.80,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Triiodothyronine (FT3),3.90,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Triidothyronine (T3),148,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Alanine Transferase (SGPT),10,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Alkaline Phosphatase,84,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Aspartate Transferase (SGOT),16,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,BUN,17,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Creatinine,1.16,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Indirect Bilirubin,0.2,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,LDH,ND,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Lipase,ND,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Magnesium,ND,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Sodium,139,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Chemistry,Urea,ND,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,Hematocrit,26.6,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,Hemoglobin,9.1,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,Lymphocytes abs,0.67,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,Neutrophils abs,1.15,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,Platelet,41,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,56,Hematology,WBC,2.4,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Alanine Transferase (SGPT),13,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Alkaline Phosphatase,110,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Aspartate Transferase (SGOT),19,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,BUN,16,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Creatinine,1.20,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Direct Bilirubin,<0.1,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Indirect Bilirubin,,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,LDH,307,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Lipase,18,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Magnesium,2.2,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Potassium,4.4,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Sodium,139,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Total Bilirubin,0.4,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Chemistry,Urea,ND,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,Hematocrit,24.7,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,Hemoglobin,8.4,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,Lymphocytes abs,0.60,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,Neutrophils abs,1.43,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,Platelet,41,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,70,Hematology,WBC,2.5,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alanine Transferase (SGPT),14,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alkaline Phosphatase,116,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,BUN,20,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Creatinine,1.13,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Direct Bilirubin,<0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,LDH,307,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Lipase,23,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Magnesium,2.1,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Sodium,143,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Urea,,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hematocrit,23.0,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hemoglobin,7.6,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Lymphocytes abs,0.57,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Neutrophils abs,1.05,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Platelet,39,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,WBC,2.1,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Triiodothyronine (FT3),2.80,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.54,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Triidothyronine (T3),110,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Alanine Transferase (SGPT),15,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Alkaline Phosphatase,105,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,BUN,24,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Creatinine,1.38,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,LDH,349,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Lipase,20,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Potassium,4.7,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Sodium,144,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Urea,ND,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Hematocrit,23.2,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Hemoglobin,7.4,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Lymphocytes abs,0.51,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Neutrophils abs,1.25,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Platelet,28,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,WBC,2.3,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Free Triiodothyronine (FT3),3.10,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.60,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Triidothyronine (T3),118,ng/mL,80,200
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Alanine Transferase (SGPT),10,U/L,0,41
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Alkaline Phosphatase,100,U/L,40,129
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,40
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,BUN,23,mg/dL,6,23
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Creatinine,1.24,mg/dL,0.67,1.17
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,LDH,297,U/L,135,225
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Lipase,21,U/L,13,60
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Potassium,4.8,mEq/L,3.5,5.1
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Sodium,141,mEq/L,136,145
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Chemistry,Urea,,,NA,NA
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,Hematocrit,26.5,%,40,54
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,Hemoglobin,8.7,g/dL,14,18
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,Lymphocytes abs,0.55,K/ul,1,4.8
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,Neutrophils abs,1.50,K/ul,1.7,7.3
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,Platelet,28,K/ul,140,440
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Hematology,WBC,2.3,K/ul,4,11
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Thyroid Function Testing,Free Thyroxine (FT4),1.27,ng/dL,0.93,1.7
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Thyroid Function Testing,Free Triiodothyronine (FT3),3.10,pg/mL,2,4.4
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.34,µIU/mL,0.27,4.2
102-0045,040,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,119,Thyroid Function Testing,Triidothyronine (T3),123,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alanine Transferase (SGPT),10,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Alkaline Phosphatase,61,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,BUN,14,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Creatinine,0.84,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Indirect Bilirubin,0.6,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,LDH,257,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Lipase,19,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Magnesium,2.2,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Sodium,139,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hematocrit,31.8,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Hemoglobin,9.6,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Lymphocytes abs,0.90,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Neutrophils abs,6.27,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,Platelet,305,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Hematology,WBC,8.0,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),11,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,63,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),17,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,10,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.86,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,247,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,22,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.4,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,141,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,NA,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31.4,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.5,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.16,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,7.57,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,336,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,9.7,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),8,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,64,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),19,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,11,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.96,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,251,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,22,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.5,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,140,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,31.7,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,9.5,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.99,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,6.82,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,365,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,8.7,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.26,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),2.80,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.99,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),130,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),18,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,70,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),20,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,9,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.91,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,235,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,19,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,32.5,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.1,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.92,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,6.31,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,337,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,8.1,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.21,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),2.50,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.10,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),119,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Alanine Transferase (SGPT),21,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Alkaline Phosphatase,75,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Aspartate Transferase (SGOT),28,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,BUN,8,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Creatinine,0.81,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Indirect Bilirubin,0.5,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,LDH,240,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Lipase,19,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Potassium,3.9,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Sodium,137,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,Hematocrit,30.7,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,Hemoglobin,9.0,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,Lymphocytes abs,0.90,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,Neutrophils abs,8.26,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,Platelet,421,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Hematology,WBC,10.1,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Thyroid Function Testing,Free Thyroxine (FT4),1.35,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Thyroid Function Testing,Free Triiodothyronine (FT3),2.40,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.23,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,69,Thyroid Function Testing,Triidothyronine (T3),116,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alkaline Phosphatase,69,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Aspartate Transferase (SGOT),27,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,BUN,10,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Creatinine,0.71,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Indirect Bilirubin,0.4,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,LDH,281,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Lipase,40,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Magnesium,1.8,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Potassium,4.3,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Sodium,138,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hematocrit,29.9,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hemoglobin,8.3,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Lymphocytes abs,0.76,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Neutrophils abs,7.28,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Platelet,345,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,WBC,9.1,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Thyroxine (FT4),1.41,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Triiodothyronine (FT3),2.80,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.54,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Triidothyronine (T3),138,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Alanine Transferase (SGPT),14,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Alkaline Phosphatase,65,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Aspartate Transferase (SGOT),21,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,BUN,9,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Creatinine,0.78,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Indirect Bilirubin,0.3,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,LDH,251,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Lipase,37,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Magnesium,1.9,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Sodium,135,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Hematocrit,32.6,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Hemoglobin,9.1,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Lymphocytes abs,0.79,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Neutrophils abs,7.91,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Platelet,344,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,WBC,9.8,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Free Triiodothyronine (FT3),2.30,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.16,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Triidothyronine (T3),117,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Alanine Transferase (SGPT),8,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Alkaline Phosphatase,76,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Aspartate Transferase (SGOT),24,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,BUN,8,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Creatinine,0.79,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,LDH,265,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Lipase,23,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Potassium,4.1,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Sodium,139,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,Hematocrit,29.5,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,Hemoglobin,8.4,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,Lymphocytes abs,0.85,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,Neutrophils abs,9.64,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,Platelet,444,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Hematology,WBC,11.7,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Thyroid Function Testing,Free Thyroxine (FT4),1.23,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.87,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,148,Thyroid Function Testing,Triidothyronine (T3),210,ng/mL,80,200
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Alanine Transferase (SGPT),8,U/L,0,33
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Alkaline Phosphatase,70,U/L,35,104
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Aspartate Transferase (SGOT),15,U/L,0,32
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,BUN,9,mg/dL,6,23
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Creatinine,0.72,mg/dL,0.51,0.95
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Indirect Bilirubin,,mg/dL,0,0.9
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,LDH,218,U/L,135,214
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Lipase,25,U/L,13,60
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Potassium,3.7,mEq/L,3.5,5.1
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Sodium,135,mEq/L,136,145
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Chemistry,Urea,ND,,NA,NA
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,Hematocrit,28.4,%,37,47
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,Hemoglobin,7.8,g/dL,12,16
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,Lymphocytes abs,0.82,K/ul,1,4.8
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,Neutrophils abs,7.44,K/ul,1.7,7.3
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,Platelet,406,K/ul,140,440
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Hematology,WBC,9.2,K/ul,4,11
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Thyroid Function Testing,Free Thyroxine (FT4),1.22,ng/dL,0.93,1.7
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.27,µIU/mL,0.27,4.2
102-0046,041,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,176,Thyroid Function Testing,Triidothyronine (T3),115,ng/mL,80,200
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hematocrit,31.0,%,40,54
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hemoglobin,10.0,g/dL,14,18
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Lymphocytes abs,4.20,K/ul,1,4.8
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Neutrophils abs,5.25,K/ul,1.7,7.3
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Platelet,193,K/ul,140,440
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,WBC,10.8,K/ul,4,11
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Alanine Transferase (SGPT),25,U/L,0,41
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Alkaline Phosphatase,185,U/L,40,129
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Aspartate Transferase (SGOT),31,U/L,0,40
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,BUN,23,mg/dL,6,23
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Creatinine,0.72,mg/dL,0.67,1.17
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Indirect Bilirubin,0.1,mg/dL,0,0.9
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,LDH,ND,U/L,135,225
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Lipase,ND,U/L,13,60
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Magnesium,2.0,mg/dL,1.6,2.6
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Potassium,4.2,mEq/L,3.5,5.1
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Sodium,138,mEq/L,136,145
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.2
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Chemistry,Urea,ND,,NA,NA
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,Hematocrit,30.0,%,40,54
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,Hemoglobin,9.5,g/dL,14,18
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,Lymphocytes abs,5.44,K/ul,1,4.8
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,Neutrophils abs,6.27,K/ul,1.7,7.3
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,Platelet,211,K/ul,140,440
102-0048,042,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,8,Hematology,WBC,12.9,K/ul,4,11
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alanine Transferase (SGPT),51,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alkaline Phosphatase,96,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Aspartate Transferase (SGOT),35,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,BUN,12,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Creatinine,0.81,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,LDH,215,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Lipase,30,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Sodium,137,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hematocrit,44.6,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hemoglobin,15.3,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Lymphocytes abs,1.60,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Neutrophils abs,1.99,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Platelet,153,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,WBC,4.2,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),12,pmol/L,10,18
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),5.5,pmol/L,2.6,5.7
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.08,mcU/mL,0.45,4.12
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),1.7,nmol/L,0.9,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alanine Transferase (SGPT),28,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Alkaline Phosphatase,89,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Aspartate Transferase (SGOT),25,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,BUN,10,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Creatinine,0.70,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,LDH,160,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Lipase,38,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Potassium,3.8,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Sodium,139,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hematocrit,36.0,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Hemoglobin,12.2,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Lymphocytes abs,1.03,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Neutrophils abs,2.25,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,Platelet,153,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Hematology,WBC,3.7,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Free Triiodothyronine (FT3),5.2,pmol/L,2.6,5.7
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.43,mcU/mL,0.45,4.12
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,10,Thyroid Function Testing,Triidothyronine (T3),1.7,nmol/L,0.9,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Alanine Transferase (SGPT),62,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Alkaline Phosphatase,121,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Aspartate Transferase (SGOT),54,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,BUN,8,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Creatinine,0.66,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,LDH,175,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Lipase,37,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Potassium,4,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Sodium,136,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,Hematocrit,35,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,Hemoglobin,11.7,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,Lymphocytes abs,1.17,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,Neutrophils abs,3.3,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,Platelet,170,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,22,Hematology,WBC,4.9,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alanine Transferase (SGPT),54,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Alkaline Phosphatase,103,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,BUN,7,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Creatinine,0.64,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,LDH,151,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Lipase,36,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Sodium,136,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hematocrit,32.6,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Hemoglobin,10.7,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Lymphocytes abs,1.18,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Neutrophils abs,2.47,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,Platelet,161,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Hematology,WBC,4.2,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Thyroxine (FT4),15,pmol/L,10,18
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Triiodothyronine (FT3),5.7,pmol/L,2.6,5.7
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.59,mcU/mL,0.45,4.12
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,29,Thyroid Function Testing,Triidothyronine (T3),2,nmol/L,0.9,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alanine Transferase (SGPT),57,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alkaline Phosphatase,157,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Aspartate Transferase (SGOT),42,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,BUN,13,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Creatinine,0.63,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,LDH,222,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Lipase,44,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Potassium,3.6,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Sodium,137,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hematocrit,30.3,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hemoglobin,9.9,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Lymphocytes abs,1.38,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Neutrophils abs,2.58,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Platelet,207,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,WBC,4.7,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Thyroxine (FT4),33,pmol/L,10,18
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Triiodothyronine (FT3),17.1,pmol/L,2.6,5.7
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.01,mcU/mL,0.45,4.12
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Triidothyronine (T3),4.4,nmol/L,0.9,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Alanine Transferase (SGPT),59,U/L,12,60
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Alkaline Phosphatase,124,U/L,31,95
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Aspartate Transferase (SGOT),48,U/L,17,42
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,BUN,7,mg/dL,6,22
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Creatinine,0.65,mg/dL,0.61,1.24
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Indirect Bilirubin,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,LDH,188,U/L,102,199
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Lipase,42,U/L,19,56
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Potassium,3.8,mmol/L,3.5,5.1
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Sodium,135,mmol/L,135,145
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Chemistry,Urea,,,NA,NA
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,Hematocrit,33,%,41,53
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,Hemoglobin,10.6,g/dL,13.6,17.5
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,Lymphocytes abs,1.53,x10E9/L,1,3.4
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,Neutrophils abs,3.25,x10E9/L,1.8,6.8
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,Platelet,223,x10E9/L,140,450
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Hematology,WBC,5.5,x10E9/L,3.4,10
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Thyroid Function Testing,Free Thyroxine (FT4),16,pmol/L,10,18
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Thyroid Function Testing,Free Triiodothyronine (FT3),4.8,pmol/L,2.6,5.7
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.01,mcU/mL,0.45,4.12
103-0001,043,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,67,Thyroid Function Testing,Triidothyronine (T3),1.5,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Alanine Transferase (SGPT),44,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Alkaline Phosphatase,75,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Aspartate Transferase (SGOT),57,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Creatinine,0.98,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,LDH,237,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Lipase,75,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Potassium,4.2,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Sodium,136,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,Hematocrit,42.8,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,Hemoglobin,14.5,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,Lymphocytes abs,2.26,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,Neutrophils abs,2.12,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,Platelet,239,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Hematology,WBC,5.6,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Thyroid Function Testing,Free Thyroxine (FT4),10,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Thyroid Function Testing,Free Triiodothyronine (FT3),5.1,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.00,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,SCREENING,-14,Thyroid Function Testing,Triidothyronine (T3),1.7,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),46,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,72,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),70,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.03,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,LDH,249,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Lipase,60,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Sodium,137,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,Hematocrit,41.3,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,Hemoglobin,13.8,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,1.39,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,1.54,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,Platelet,222,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Hematology,WBC,3.8,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),10,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),5.3,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.6,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),1.7,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),48,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,67,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),59,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Creatinine,0.99,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,LDH,225,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Lipase,51,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Sodium,137,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Hematocrit,42.5,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Hemoglobin,14.4,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,1.52,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,2.55,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Platelet,241,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,WBC,5.2,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),12,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),5.5,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.49,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),1.8,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Alanine Transferase (SGPT),41,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Alkaline Phosphatase,70,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Aspartate Transferase (SGOT),46,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Creatinine,0.91,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,LDH,198,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Lipase,45,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Potassium,4.7,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Hematocrit,42.0,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Hemoglobin,13.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Lymphocytes abs,1.59,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Neutrophils abs,2.21,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Platelet,224,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,WBC,4.8,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Thyroxine (FT4),20,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Triiodothyronine (FT3),6.8,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Triidothyronine (T3),2.1,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Alanine Transferase (SGPT),41,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Alkaline Phosphatase,64,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Aspartate Transferase (SGOT),54,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,BUN,22,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Creatinine,0.97,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,LDH,187,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Lipase,46,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Sodium,136,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Total Bilirubin,1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,Hematocrit,44,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,Hemoglobin,15.1,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,Lymphocytes abs,1.71,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,Neutrophils abs,2.68,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,Platelet,209,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Hematology,WBC,5.2,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Thyroxine (FT4),8,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Thyroid Function Testing,Free Triiodothyronine (FT3),3.7,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.15,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,63,Thyroid Function Testing,Triidothyronine (T3),1.1,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Alanine Transferase (SGPT),40,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Alkaline Phosphatase,72,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Aspartate Transferase (SGOT),45,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,BUN,24,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Creatinine,1.06,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,LDH,293,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Lipase,54,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Total Bilirubin,1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,Hematocrit,44.1,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,Hemoglobin,14.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,Lymphocytes abs,1.52,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,Neutrophils abs,2.36,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,Platelet,197,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Hematology,WBC,4.7,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Thyroid Function Testing,Free Thyroxine (FT4),8,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Thyroid Function Testing,Free Triiodothyronine (FT3),3.9,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.9,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,91,Thyroid Function Testing,Triidothyronine (T3),1,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Alanine Transferase (SGPT),36,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Alkaline Phosphatase,82,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Aspartate Transferase (SGOT),50,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,BUN,13,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Creatinine,1.07,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,LDH,272,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Lipase,ND,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Sodium,135,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Total Bilirubin,1.5,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,Hematocrit,44.9,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,Hemoglobin,15.6,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,Lymphocytes abs,2.1,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,Neutrophils abs,2.62,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,Platelet,185,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,UNSCHEDULED,104,Hematology,WBC,5.9,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Alanine Transferase (SGPT),27,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Alkaline Phosphatase,80,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Aspartate Transferase (SGOT),28,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,BUN,20,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Creatinine,1.09,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,LDH,208,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Lipase,53,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Potassium,5.4,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,Hematocrit,39.5,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,Hemoglobin,13.5,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,Lymphocytes abs,1.27,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,Neutrophils abs,6.66,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,Platelet,213,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Hematology,WBC,9.4,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Thyroid Function Testing,Free Triiodothyronine (FT3),4.1,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.91,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,119,Thyroid Function Testing,Triidothyronine (T3),1.2,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Alanine Transferase (SGPT),33,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Alkaline Phosphatase,72,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Aspartate Transferase (SGOT),37,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,BUN,21,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Creatinine,1.09,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,LDH,263,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Lipase,45,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,Hematocrit,39.5,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,Hemoglobin,13.4,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,Lymphocytes abs,1.96,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,Neutrophils abs,2.28,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,Platelet,184,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Hematology,WBC,5.3,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Thyroid Function Testing,Free Triiodothyronine (FT3),6,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.14,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 3,147,Thyroid Function Testing,Triidothyronine (T3),1.5,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Alanine Transferase (SGPT),20,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Alkaline Phosphatase,68,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Aspartate Transferase (SGOT),25,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Creatinine,1.06,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Direct Bilirubin,0.9,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,LDH,224,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Lipase,43,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Potassium,4.7,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,Hematocrit,41.6,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,Hemoglobin,13.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,Lymphocytes abs,1.65,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,Neutrophils abs,3.69,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,Platelet,245,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Hematology,WBC,6.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Thyroid Function Testing,Free Thyroxine (FT4),17,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Thyroid Function Testing,Free Triiodothyronine (FT3),4.6,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.21,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 5,203,Thyroid Function Testing,Triidothyronine (T3),1.6,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Alanine Transferase (SGPT),20,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Alkaline Phosphatase,62,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,BUN,20,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Creatinine,1.04,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,LDH,215,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Lipase,47,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,Hematocrit,41.1,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,Hemoglobin,13.7,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,Lymphocytes abs,2.06,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,Neutrophils abs,2.42,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,Platelet,206,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Hematology,WBC,5.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Thyroid Function Testing,Free Thyroxine (FT4),18,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Thyroid Function Testing,Free Triiodothyronine (FT3),3.7,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.49,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 6,231,Thyroid Function Testing,Triidothyronine (T3),1.3,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Alanine Transferase (SGPT),22,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Alkaline Phosphatase,65,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,BUN,20,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Creatinine,1.1,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,LDH,238,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Lipase,41,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,Hematocrit,43.4,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,Hemoglobin,14.3,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,Lymphocytes abs,1.62,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,Neutrophils abs,2.84,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,Platelet,207,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Hematology,WBC,5.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Thyroid Function Testing,Free Thyroxine (FT4),17,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Thyroid Function Testing,Free Triiodothyronine (FT3),4.5,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.3,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 7,259,Thyroid Function Testing,Triidothyronine (T3),1.1,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Alanine Transferase (SGPT),23,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Alkaline Phosphatase,62,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,BUN,22,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Creatinine,1.06,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,LDH,228,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Lipase,46,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Total Bilirubin,0.9,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,Hematocrit,41.3,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,Hemoglobin,13.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,Lymphocytes abs,1.29,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,Neutrophils abs,3.07,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,Platelet,210,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Hematology,WBC,5.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Thyroid Function Testing,Free Triiodothyronine (FT3),4.9,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.57,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 8,287,Thyroid Function Testing,Triidothyronine (T3),1.7,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Alanine Transferase (SGPT),17,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Alkaline Phosphatase,84,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Aspartate Transferase (SGOT),20,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,BUN,20,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Creatinine,1.1,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,LDH,255,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Lipase,52,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Sodium,137,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,Hematocrit,38,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,Hemoglobin,12.8,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,Lymphocytes abs,1.53,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,Neutrophils abs,5.91,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,Platelet,446,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Hematology,WBC,8.7,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.16,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 9,315,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Alanine Transferase (SGPT),16,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Alkaline Phosphatase,76,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,BUN,17,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Creatinine,1,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,LDH,172,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Lipase,62,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,Hematocrit,39.6,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,Hemoglobin,12.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,Lymphocytes abs,1.43,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,Neutrophils abs,3.97,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,Platelet,266,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Hematology,WBC,6.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.08,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 10,343,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Alanine Transferase (SGPT),16,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Alkaline Phosphatase,72,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,BUN,14,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Creatinine,0.92,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,LDH,214,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Lipase,57,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,Hematocrit,38.8,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,Hemoglobin,12.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,Lymphocytes abs,1.16,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,Neutrophils abs,3.82,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,Platelet,235,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Hematology,WBC,6.1,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.8,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 11,371,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Alanine Transferase (SGPT),18,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Alkaline Phosphatase,66,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Aspartate Transferase (SGOT),26,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Creatinine,0.97,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,LDH,251,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Lipase,60,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Potassium,4,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Total Bilirubin,1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,Hematocrit,38.7,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,Hemoglobin,13.2,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,Lymphocytes abs,1.29,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,Neutrophils abs,5.14,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,Platelet,235,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Hematology,WBC,7.6,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Thyroid Function Testing,Free Triiodothyronine (FT3),5.1,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.58,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 12,399,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Alanine Transferase (SGPT),18,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Alkaline Phosphatase,73,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,BUN,16,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Creatinine,0.92,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,LDH,206,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Lipase,49,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Total Bilirubin,0.9,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,Hematocrit,40,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,Hemoglobin,13.1,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,Lymphocytes abs,1.43,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,Neutrophils abs,3.01,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,Platelet,225,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Hematology,WBC,5.4,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.12,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 13,427,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Alanine Transferase (SGPT),19,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Alkaline Phosphatase,69,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Aspartate Transferase (SGOT),25,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,BUN,15,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Creatinine,1.02,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,LDH,229,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Lipase,51,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Magnesium,2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Potassium,3.8,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Total Bilirubin,1.3,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,Hematocrit,42.1,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,Hemoglobin,13.9,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,Lymphocytes abs,1.17,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,Neutrophils abs,3.76,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,Platelet,212,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Hematology,WBC,6,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.24,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 14,455,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Alanine Transferase (SGPT),18,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Alkaline Phosphatase,69,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Creatinine,0.97,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Direct Bilirubin,0.5,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,LDH,216,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Lipase,57,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Potassium,4.0,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Total Bilirubin,1.3,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,Hematocrit,39.8,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,Hemoglobin,13.3,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,Lymphocytes abs,1.08,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,Neutrophils abs,3.40,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,Platelet,197,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Hematology,WBC,5.4,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.71,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 15,483,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Alanine Transferase (SGPT),16,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Alkaline Phosphatase,67,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,BUN,16,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Creatinine,1.03,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,LDH,213,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Lipase,47,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Total Bilirubin,1.3,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,Hematocrit,40.3,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,Hemoglobin,13.4,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,Lymphocytes abs,1.28,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,Neutrophils abs,4.05,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,Platelet,221,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Hematology,WBC,6.3,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Thyroid Function Testing,Free Thyroxine (FT4),15,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.49,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 16,511,Thyroid Function Testing,Triidothyronine (T3),1.4,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Alanine Transferase (SGPT),20,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Alkaline Phosphatase,67,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Aspartate Transferase (SGOT),28,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Creatinine,1.01,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,LDH,263,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Lipase,62,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,Hematocrit,42.2,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,Hemoglobin,14.3,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,Lymphocytes abs,1.42,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,Neutrophils abs,5.81,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,Platelet,218,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Hematology,WBC,8.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.16,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 17,539,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Alanine Transferase (SGPT),18,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Alkaline Phosphatase,67,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Creatinine,0.97,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,LDH,271,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Lipase,72,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,Hematocrit,41.9,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,Hemoglobin,14.2,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,Lymphocytes abs,1.45,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,Neutrophils abs,3.64,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,Platelet,215,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Hematology,WBC,6.3,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.85,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 18,567,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Alanine Transferase (SGPT),16,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Alkaline Phosphatase,67,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Aspartate Transferase (SGOT),21,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,BUN,14,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Creatinine,0.96,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,LDH,208,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Lipase,51,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Total Bilirubin,0.9,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,Hematocrit,41.0,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,Hemoglobin,13.8,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,Lymphocytes abs,1.00,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,Neutrophils abs,4.28,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,Platelet,221,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Hematology,WBC,6.0,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.32,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 19,595,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Alanine Transferase (SGPT),21,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Alkaline Phosphatase,59,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Aspartate Transferase (SGOT),25,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Creatinine,0.96,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,LDH,221,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Lipase,47,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Potassium,3.7,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Total Bilirubin,1.0,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,Hematocrit,41.4,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,Hemoglobin,14.2,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,Lymphocytes abs,0.99,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,Neutrophils abs,3.97,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,Platelet,224,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Hematology,WBC,5.7,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.30,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 20,630,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Alanine Transferase (SGPT),19,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Alkaline Phosphatase,66,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,BUN,21,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Creatinine,1.05,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Indirect Bilirubin,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,LDH,227,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Lipase,45,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Potassium,4.9,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Total Bilirubin,1.3,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,Hematocrit,41.9,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,Hemoglobin,14.0,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,Lymphocytes abs,1.28,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,Neutrophils abs,5.47,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,Platelet,230,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Hematology,WBC,8.0,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.69,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 21,658,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Alanine Transferase (SGPT),83,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Alkaline Phosphatase,64,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Aspartate Transferase (SGOT),49,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,BUN,19,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Creatinine,0.96,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Indirect Bilirubin,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,LDH,ND,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Lipase,54,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Sodium,138,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Total Bilirubin,0.9,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Chemistry,Urea,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,Hematocrit,ND,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,Hemoglobin,13.0,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,Lymphocytes abs,1.53,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,Neutrophils abs,4.97,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,Platelet,238,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Hematology,WBC,7.6,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Thyroid Function Testing,Free Thyroxine (FT4),17,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.24,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 22,686,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Alanine Transferase (SGPT),24,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Alkaline Phosphatase,62,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Aspartate Transferase (SGOT),31,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,BUN,15,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Creatinine,0.94,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Indirect Bilirubin,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,LDH,216,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Lipase,38,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Sodium,141,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Total Bilirubin,1.2,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Chemistry,Urea,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,Hematocrit,41.9,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,Hemoglobin,14.0,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,Lymphocytes abs,1.83,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,Neutrophils abs,3.29,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,Platelet,209,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Hematology,WBC,6.3,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.70,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 23,714,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Alanine Transferase (SGPT),17,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Alkaline Phosphatase,65,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Aspartate Transferase (SGOT),24,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,BUN,16,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Creatinine,1.06,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,LDH,193,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Lipase,37,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,Hematocrit,43,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,Hemoglobin,14.1,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,Lymphocytes abs,1.46,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,Neutrophils abs,4.92,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,Platelet,243,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Hematology,WBC,7.6,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.89,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 24,742,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Alanine Transferase (SGPT),21,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Alkaline Phosphatase,63,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Creatinine,0.98,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,LDH,236,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Lipase,43,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Sodium,140,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,Hematocrit,42.3,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,Hemoglobin,14.2,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,Lymphocytes abs,2.44,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,Neutrophils abs,3.08,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,Platelet,222,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Hematology,WBC,6.7,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Thyroid Function Testing,Free Thyroxine (FT4),13,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.07,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 25,770,Thyroid Function Testing,Triidothyronine (T3),1.3,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Alanine Transferase (SGPT),17,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Alkaline Phosphatase,56,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Aspartate Transferase (SGOT),27,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,BUN,18,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Creatinine,0.97,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Direct Bilirubin,0.3,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,LDH,229,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Lipase,42,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Sodium,139,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,Hematocrit,40.7,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,Hemoglobin,13.7,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,Lymphocytes abs,1.78,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,Neutrophils abs,3.95,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,Platelet,248,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Hematology,WBC,7.0,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.63,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 26,798,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Alanine Transferase (SGPT),16,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Alkaline Phosphatase,63,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Aspartate Transferase (SGOT),23,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,BUN,15,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Creatinine,1.03,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Direct Bilirubin,0.4,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Indirect Bilirubin,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,LDH,216,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Lipase,37,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Sodium,135,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Total Bilirubin,1.1,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,Hematocrit,39.2,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,Hemoglobin,13.2,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,Lymphocytes abs,1.00,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,Neutrophils abs,5.40,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,Platelet,213,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Hematology,WBC,7.5,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Thyroid Function Testing,Free Thyroxine (FT4),ND,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.88,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,END OF TREATMENT,826,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Alanine Transferase (SGPT),15,U/L,12,60
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Alkaline Phosphatase,62,U/L,31,95
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Aspartate Transferase (SGOT),21,U/L,17,42
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,BUN,15,mg/dL,6,22
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Creatinine,0.98,mg/dL,0.61,1.24
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.29
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Indirect Bilirubin,ND,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,LDH,ND,U/L,102,199
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Lipase,ND,U/L,19,56
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Magnesium,ND,mg/dL,1.8,2.4
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Sodium,142,mmol/L,135,145
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.3
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Chemistry,Urea,,,NA,NA
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,Hematocrit,38.4,%,41,53
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,Hemoglobin,13.0,g/dL,13.6,17.5
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,Lymphocytes abs,1.48,x10E9/L,1,3.4
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,Neutrophils abs,4.05,x10E9/L,1.8,6.8
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,Platelet,236,x10E9/L,140,450
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Hematology,WBC,6.8,x10E9/L,3.4,10
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Thyroid Function Testing,Free Thyroxine (FT4),14,pmol/L,10,18
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Thyroid Function Testing,Free Triiodothyronine (FT3),3.7,pmol/L,2.6,5.7
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.18,mcU/mL,0.45,4.12
103-0003,076,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,917,Thyroid Function Testing,Triidothyronine (T3),ND,nmol/L,0.9,2.4
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alkaline Phosphatase,219,U/L,34,104
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Aspartate Transferase (SGOT),39,U/L,13,39
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,BUN,16,mg/dL,7,25
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Creatinine,0.73,mg/dL,0.6,1.3
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,LDH,460,U/L,140,271
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Lipase,ND,U/L,11,82
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Potassium,5.3,mmol/L,3.5,5.1
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Sodium,134,mmol/L,136,145
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Urea,16,,NA,NA
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hematocrit,31.4,%,40.1,51
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hemoglobin,9.1,g/dL,13.7,17.5
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Lymphocytes abs,0.70,x10E3/µL,1.18,3.74
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Neutrophils abs,4.10,x10E3/µL,1.56,6.13
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Platelet,437,x10E3/µL,163,369
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,WBC,5.48,x10E3/µL,4,10
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.8,1.7
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.29,µIU/mL,0.5,6
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),96,ng/dL,85,185
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Alanine Transferase (SGPT),19,U/L,7,52
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Alkaline Phosphatase,682,U/L,34,104
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Aspartate Transferase (SGOT),54,U/L,13,39
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,BUN,21,mg/dL,7,25
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Creatinine,0.6,mg/dL,0.6,1.3
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,LDH,1174.0,U/L,140,271
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Lipase,ND,U/L,11,82
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Potassium,4.83,mmol/L,3.5,5.1
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Sodium,129,mmol/L,136,145
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Total Bilirubin,0.90,mg/dL,0.3,1
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Chemistry,Urea,21,,NA,NA
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,Hematocrit,26.8,%,40.1,51
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,Hemoglobin,7.7,g/dL,13.7,17.5
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,Lymphocytes abs,0.51,x10E3/µL,1.18,3.74
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,Neutrophils abs,6.31,x10E3/µL,1.56,6.13
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,Platelet,212,x10E3/µL,163,369
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Hematology,WBC,7.8,x10E3/µL,4,10
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.49,µIU/mL,0.5,6
104-0001,044,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,37,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-28,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-28,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-28,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.7,µIU/mL,0.5,6
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-28,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,54,U/L,34,104
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),30,U/L,13,39
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,12,mg/dL,7,25
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.44,mg/dL,0.6,1.3
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,ND,U/L,140,271
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,11,82
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.2,mmol/L,3.5,5.1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mmol/L,136,145
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,29.5,%,40.1,51
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.5,g/dL,13.7,17.5
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.55,x10E3/µL,1.18,3.74
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.86,x10E3/µL,1.56,6.13
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,262,x10E3/µL,163,369
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.2,x10E3/µL,4,10
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,50,U/L,34,104
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),37,U/L,13,39
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,11,mg/dL,7,25
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.41,mg/dL,0.6,1.3
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,324,U/L,140,271
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,5,U/L,11,82
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.2,mmol/L,3.5,5.1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mmol/L,136,145
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,29.1,%,40.1,51
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,9.3,g/dL,13.7,17.5
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.46,x10E3/µL,1.18,3.74
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.76,x10E3/µL,1.56,6.13
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,271,x10E3/µL,163,369
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5,x10E3/µL,4,10
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.7,µIU/mL,0.5,6
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),30,U/L,13,39
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),30,U/L,13,39
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,21,mg/dL,7,25
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,21,mg/dL,7,25
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.33,mg/dL,0.6,1.3
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.33,mg/dL,0.6,1.3
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,259,U/L,140,271
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,259,U/L,140,271
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,11,U/L,11,82
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,11,U/L,11,82
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.5,mg/dL,1.9,2.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.5,mg/dL,1.9,2.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.7,mmol/L,3.5,5.1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.7,mmol/L,3.5,5.1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mmol/L,136,145
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,137,mmol/L,136,145
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,21,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,29.3,%,40.1,51
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,29.3,%,40.1,51
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.3,g/dL,13.7,17.5
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.3,g/dL,13.7,17.5
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.3,x10E3/µL,1.18,3.74
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.30,x10E3/µL,1.18,3.74
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,0.4,x10E3/µL,1.56,6.13
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,0.40,x10E3/µL,1.56,6.13
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,144,x10E3/µL,163,369
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,144,x10E3/µL,163,369
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,0.8,x10E3/µL,4,10
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,0.8,x10E3/µL,4,10
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.3,µIU/mL,0.5,6
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.3,µIU/mL,0.5,6
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0002,045,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Alkaline Phosphatase,72,U/L,34,104
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Aspartate Transferase (SGOT),11,U/L,13,39
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,BUN,31,mg/dL,7,25
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Creatinine,1.34,mg/dL,0.6,1.3
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,LDH,178,U/L,140,271
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Lipase,30,U/L,11,82
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Sodium,145,mmol/L,136,145
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Chemistry,Urea,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,Hematocrit,40.5,%,34.1,44.9
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,Hemoglobin,13.3,g/dL,11.2,15.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,Lymphocytes abs,0.59,x10E3/µL,1.18,3.74
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,Neutrophils abs,8.29,x10E3/µL,1.56,6.13
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,Platelet,346,x10E3/µL,163,369
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Hematology,WBC,9.02,x10E3/µL,4,10
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Free Thyroxine (FT4),1.9,ng/dL,0.8,1.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.18,µIU/mL,0.5,6
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-23,Thyroid Function Testing,Triidothyronine (T3),86,ng/dL,85,185
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),4,U/L,7,52
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,62,U/L,34,104
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),7,U/L,13,39
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,46,mg/dL,7,25
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,105,U/L,140,271
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,35,U/L,11,82
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.20,mmol/L,3.5,5.1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mmol/L,136,145
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.20,mg/dL,0.3,1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,26.6,%,34.1,44.9
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,8.9,g/dL,11.2,15.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.75,x10E3/µL,1.18,3.74
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,8,x10E3/µL,1.56,6.13
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,401,x10E3/µL,163,369
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,11.1,x10E3/µL,4,10
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.81,µIU/mL,0.5,6
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),6,U/L,7,52
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,66,U/L,34,104
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),9,U/L,13,39
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,18,mg/dL,7,25
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,151,U/L,140,271
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,29,U/L,11,82
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,5.15,mmol/L,3.5,5.1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,144,mmol/L,136,145
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.20,mg/dL,0.3,1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,27.4,%,34.1,44.9
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,8.8,g/dL,11.2,15.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,2.03,x10E3/µL,1.18,3.74
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,5.51,x10E3/µL,1.56,6.13
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,448,x10E3/µL,163,369
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,9,x10E3/µL,4,10
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.34,µIU/mL,0.5,6
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Alkaline Phosphatase,56,U/L,34,104
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,BUN,23,mg/dL,7,25
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Direct Bilirubin,0.03,mg/dL,0.03,0.18
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,LDH,141,U/L,140,271
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Lipase,60,U/L,11,82
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Potassium,3.08,mmol/L,3.5,5.1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Sodium,139,mmol/L,136,145
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Chemistry,Urea,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Hematocrit,28.4,%,34.1,44.9
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Hemoglobin,9.1,g/dL,11.2,15.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Lymphocytes abs,1.87,x10E3/µL,1.18,3.74
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Neutrophils abs,3.01,x10E3/µL,1.56,6.13
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,Platelet,345,x10E3/µL,163,369
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Hematology,WBC,6.1,x10E3/µL,4,10
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Free Thyroxine (FT4),2.0,ng/dL,0.8,1.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.19,µIU/mL,0.5,6
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,57,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Alkaline Phosphatase,63,U/L,34,104
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,BUN,20.0,mg/dL,7,25
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,LDH,ND,U/L,140,271
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Lipase,ND,U/L,11,82
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Magnesium,ND,mg/dL,1.9,2.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Potassium,3.82,mmol/L,3.5,5.1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Sodium,139,mmol/L,136,145
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Chemistry,Urea,,,NA,NA
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,Hematocrit,38.4,%,34.1,44.9
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,Hemoglobin,12.5,g/dL,11.2,15.7
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,Lymphocytes abs,1.57,x10E3/µL,1.18,3.74
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,Neutrophils abs,5.72,x10E3/µL,1.56,6.13
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,Platelet,321,x10E3/µL,163,369
104-0005,046,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,141,Hematology,WBC,8.7,x10E3/µL,4,10
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alanine Transferase (SGPT),33,U/L,7,52
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alkaline Phosphatase,219,U/L,34,104
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Aspartate Transferase (SGOT),37,U/L,13,39
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,BUN,15.0,mg/dL,7,25
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,LDH,183.0,U/L,140,271
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Lipase,74.0,U/L,11,82
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Potassium,4.08,mmol/L,3.5,5.1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Sodium,138,mmol/L,136,145
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Urea,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hematocrit,35.5,%,34.1,44.9
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hemoglobin,11.2,g/dL,11.2,15.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Lymphocytes abs,1.16,x10E3/µL,1.18,3.74
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Neutrophils abs,2.67,x10E3/µL,1.56,6.13
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Platelet,184,x10E3/µL,163,369
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,WBC,4.5,x10E3/µL,4,10
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.7,µIU/mL,0.5,6
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),27,U/L,7,52
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,137,U/L,34,104
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),32,U/L,13,39
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,20,mg/dL,7,25
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.6,mg/dL,0.6,1.3
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,178,U/L,140,271
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,61,U/L,11,82
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.72,mmol/L,3.5,5.1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,141,mmol/L,136,145
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,32.3,%,34.1,44.9
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.9,g/dL,11.2,15.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.99,x10E3/µL,1.18,3.74
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.32,x10E3/µL,1.56,6.13
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,140,x10E3/µL,163,369
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,5.0,x10E3/µL,4,10
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.6,µIU/mL,0.5,6
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),76,U/L,7,52
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,296,U/L,34,104
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),52,U/L,13,39
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,21,mg/dL,7,25
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,225,U/L,140,271
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,174,U/L,11,82
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.34,mmol/L,3.5,5.1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,135,mmol/L,136,145
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,32,%,34.1,44.9
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10,g/dL,11.2,15.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.85,x10E3/µL,1.18,3.74
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.18,x10E3/µL,1.56,6.13
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,171,x10E3/µL,163,369
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,4.8,x10E3/µL,4,10
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.6,µIU/mL,0.5,6
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Alanine Transferase (SGPT),94,U/L,7,52
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Alkaline Phosphatase,173,U/L,34,104
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Aspartate Transferase (SGOT),42,U/L,13,39
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,BUN,27,mg/dL,7,25
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Creatinine,0.58,mg/dL,0.6,1.3
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,LDH,276,U/L,140,271
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Lipase,300,U/L,11,82
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Potassium,4.0,mmol/L,3.5,5.1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Sodium,141,mmol/L,136,145
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Chemistry,Urea,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,Hematocrit,38.2,%,34.1,44.9
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,Hemoglobin,11.7,g/dL,11.2,15.7
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,Lymphocytes abs,1.40,x10E3/µL,1.18,3.74
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,Neutrophils abs,6.23,x10E3/µL,1.56,6.13
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,Platelet,164,x10E3/µL,163,369
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Hematology,WBC,4.32,x10E3/µL,4,10
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Thyroid Function Testing,Free Thyroxine (FT4),,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,61,Thyroid Function Testing,Triidothyronine (T3),,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,Hematocrit,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,Hemoglobin,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,Lymphocytes abs,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,Neutrophils abs,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,Platelet,,,NA,NA
104-0006,047,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,105,Hematology,WBC,,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alanine Transferase (SGPT),21,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alkaline Phosphatase,95,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,BUN,19,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Creatinine,1.05,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,LDH,157,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Lipase,30,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Sodium,139,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Total Bilirubin,1.2,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Urea,19,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hematocrit,46.4,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hemoglobin,14.6,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Lymphocytes abs,1.99,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Neutrophils abs,6.21,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Platelet,333,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,WBC,9.20,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.48,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),16,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,84,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,21,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.90,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,182,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,38,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.9,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,21,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,44.8,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,14.6,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.64,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,6.44,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,300,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,9.53,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),2.2,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.06,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,87,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),23,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,20,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.86,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,352,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,29,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,5.8,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,144,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.8,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,20,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,48.6,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,15.4,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.44,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,8.44,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,457,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,11.55,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.80,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),58,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,81,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,18,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.80,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,256,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,32,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,141,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,18,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,42.4,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,13.5,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.43,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,7.65,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,446,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,10.43,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.17,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),79,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,95,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,19,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.08,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,230,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,34,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,139,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,19,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,44.7,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,14.4,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.51,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,10.41,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,357,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,13.3,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.89,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,86,U/L,34,104
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),23,U/L,13,39
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,28,mg/dL,7,25
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.72,mg/dL,0.6,1.3
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,289,U/L,140,271
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,35,U/L,11,82
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,136,mmol/L,136,145
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.7,mg/dL,0.3,1
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,28,,NA,NA
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,44.7,%,40.1,51
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,14.7,g/dL,13.7,17.5
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.82,x10E3/µL,1.18,3.74
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,7.71,x10E3/µL,1.56,6.13
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,337,x10E3/µL,163,369
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,11.4,x10E3/µL,4,10
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.9,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.18,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,102,Thyroid Function Testing,Free Thyroxine (FT4),2.5,ng/dL,0.8,1.7
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,102,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,102,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.27,µIU/mL,0.5,6
104-0007,048,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,102,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),30,U/L,7,52
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,43,U/L,34,104
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),29,U/L,13,39
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,BUN,26,mg/dL,7,25
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,LDH,154,U/L,140,271
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Lipase,41,U/L,11,82
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Potassium,3.85,mmol/L,3.5,5.1
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Sodium,136,mmol/L,136,145
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Chemistry,Urea,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,Hematocrit,41.2,%,40.1,51
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,Hemoglobin,14,g/dL,13.7,17.5
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,Lymphocytes abs,1.36,x10E3/µL,1.18,3.74
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,Neutrophils abs,1.76,x10E3/µL,1.56,6.13
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,Platelet,195,x10E3/µL,163,369
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Hematology,WBC,3.6,x10E3/µL,4,10
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.9,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),21,U/L,7,52
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,50,U/L,34,104
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),27,U/L,13,39
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,BUN,27,mg/dL,7,25
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.5,mg/dL,0.6,1.3
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,LDH,222,U/L,140,271
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Lipase,27,U/L,11,82
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Potassium,3.76,mmol/L,3.5,5.1
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Sodium,135,mmol/L,136,145
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.6,%,40.1,51
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.8,g/dL,13.7,17.5
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.94,x10E3/µL,1.18,3.74
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.45,x10E3/µL,1.56,6.13
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Platelet,280,x10E3/µL,163,369
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,WBC,4.0,x10E3/µL,4,10
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,29,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,29,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),7.0,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.3,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,72,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,72,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,72,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 4 DAY 1,72,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,92,Thyroid Function Testing,Free Thyroxine (FT4),7.2,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,92,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,92,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 1,92,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Alanine Transferase (SGPT),93,U/L,7,52
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Alkaline Phosphatase,132,U/L,34,104
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Aspartate Transferase (SGOT),94,U/L,13,39
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,BUN,23,mg/dL,7,25
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Creatinine,1.08,mg/dL,0.6,1.3
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,LDH,447,U/L,140,271
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Lipase,44,U/L,11,82
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Potassium,4.7,mmol/L,3.5,5.1
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Sodium,140,mmol/L,136,145
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Chemistry,Urea,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,Hematocrit,40.7,%,40.1,51
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,Hemoglobin,13.2,g/dL,13.7,17.5
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,Lymphocytes abs,0.84,x10E3/µL,1.18,3.74
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,Neutrophils abs,3.33,x10E3/µL,1.56,6.13
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,Platelet,258,x10E3/µL,163,369
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Hematology,WBC,5.01,x10E3/µL,4,10
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.0,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,NIVO MAINTENANCE CYCLE 2,120,Thyroid Function Testing,Triidothyronine (T3),94,ng/dL,85,185
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Alanine Transferase (SGPT),119,U/L,7,52
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Alkaline Phosphatase,159,U/L,34,104
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Aspartate Transferase (SGOT),103,U/L,13,39
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,BUN,23,mg/dL,7,25
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,LDH,415,U/L,140,271
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Lipase,58,U/L,11,82
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Potassium,4.01,mmol/L,3.5,5.1
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Sodium,136,mmol/L,136,145
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Chemistry,Urea,,,NA,NA
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,Hematocrit,40.1,%,40.1,51
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,Hemoglobin,13.4,g/dL,13.7,17.5
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,Lymphocytes abs,0.89,x10E3/µL,1.18,3.74
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,Neutrophils abs,3.36,x10E3/µL,1.56,6.13
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,Platelet,306,x10E3/µL,163,369
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Hematology,WBC,5,x10E3/µL,4,10
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0008,077,CD8 HIGH,Nivolumab,END OF TREATMENT,141,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alanine Transferase (SGPT),16,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alkaline Phosphatase,50,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,BUN,18.0,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,LDH,147,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Lipase,62.0,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Potassium,4.04,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Sodium,136,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hematocrit,43.2,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hemoglobin,15.1,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Lymphocytes abs,1.67,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Neutrophils abs,4.85,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Platelet,310,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,WBC,6.9,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),20,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,51,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),19,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,14.0,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,155.0,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,58.0,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,4.07,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,43.0,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,14.7,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,1.86,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,3.82,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,253,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,6.4,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.7,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),104,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,54,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,BUN,23,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,LDH,176,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Lipase,52,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Potassium,4.33,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hematocrit,41.7,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Hemoglobin,14.5,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,1.43,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,3.99,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,Platelet,247,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Hematology,WBC,6.6,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.1,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alanine Transferase (SGPT),15,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Alkaline Phosphatase,66,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Aspartate Transferase (SGOT),11,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,BUN,17,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,LDH,165,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Lipase,52,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Potassium,4,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hematocrit,36.7,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Hemoglobin,12.6,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Lymphocytes abs,0.94,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Neutrophils abs,2.73,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,Platelet,230,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Hematology,WBC,4.6,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Thyroxine (FT4),3.6,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Free Triiodothyronine (FT3),698,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,49,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,BUN,15.0,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,LDH,173.0,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Lipase,47.0,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Potassium,3.98,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Sodium,136,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hematocrit,41.7,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hemoglobin,14.1,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Lymphocytes abs,0.88,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Neutrophils abs,4.00,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Platelet,235,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,WBC,5.7,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Thyroxine (FT4),0.5,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),21.1,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Triidothyronine (T3),54,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Alkaline Phosphatase,55,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,BUN,16,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,LDH,144,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Lipase,45,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Potassium,4.05,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Hematocrit,41.8,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Hemoglobin,14,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Lymphocytes abs,1.18,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Neutrophils abs,4.04,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,Platelet,255,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Hematology,WBC,6.4,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.1,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,98,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Alkaline Phosphatase,45,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,BUN,13,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,LDH,166,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Lipase,39,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Potassium,4.12,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Sodium,140,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,Hematocrit,40.8,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,Hemoglobin,13.8,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,Lymphocytes abs,1.43,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,Neutrophils abs,3.57,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,Platelet,229,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Hematology,WBC,6.3,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.4,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,119,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Alkaline Phosphatase,56,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,BUN,12,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,LDH,164,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Lipase,55,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Potassium,4.06,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Hematocrit,41.9,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Hemoglobin,14.1,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Lymphocytes abs,1.32,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Neutrophils abs,3.48,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Platelet,236,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,WBC,6.1,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Free Thyroxine (FT4),1.1,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),13.3,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Alkaline Phosphatase,50,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,BUN,15,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Creatinine,1,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,LDH,166,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Lipase,51,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Potassium,3.84,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Sodium,137,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,Hematocrit,40.9,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,Hemoglobin,14,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,Lymphocytes abs,1,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,Neutrophils abs,3.43,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,Platelet,219,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Hematology,WBC,5.3,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),17.3,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,168,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Alkaline Phosphatase,40,U/L,34,104
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,BUN,26,mg/dL,7,25
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Creatinine,1,mg/dL,0.6,1.3
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Indirect Bilirubin,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,LDH,181,U/L,140,271
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Lipase,321,U/L,11,82
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Potassium,3.92,mmol/L,3.5,5.1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Sodium,133,mmol/L,136,145
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Chemistry,Urea,,,NA,NA
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,Hematocrit,41.2,%,40.1,51
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,Hemoglobin,14.1,g/dL,13.7,17.5
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,Lymphocytes abs,0.89,x10E3/µL,1.18,3.74
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,Neutrophils abs,8.66,x10E3/µL,1.56,6.13
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,Platelet,267,x10E3/µL,163,369
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Hematology,WBC,10.1,x10E3/µL,4,10
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.8,1.7
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),10,µIU/mL,0.5,6
104-0009,049,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,190,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Alkaline Phosphatase,98,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,BUN,25,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Creatinine,1.25,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,LDH,145,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Lipase,21,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Sodium,142,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,Hematocrit,38.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,Lymphocytes abs,2.11,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,Neutrophils abs,4.26,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,Platelet,320,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Hematology,WBC,7.14,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.97,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,80,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,143.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.19,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,35.4,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.59,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.88,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,357,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,7.2,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,86,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),11,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,140.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,15.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.85,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,135,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,35.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.92,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,5.52,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,391,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,8.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.65,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,18.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,114.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,16.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,3.73,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,136,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,36.8,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,2.34,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,4.93,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,364,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,8.2,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,77,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,15.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,123.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,26.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.12,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,35.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,11.3,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,2.07,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,4.68,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,324,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,7.9,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,BUN,21.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,LDH,152,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Lipase,17,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Potassium,4.26,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Sodium,140,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,Hematocrit,36.2,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,Hemoglobin,11.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,Lymphocytes abs,2.14,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,Neutrophils abs,4.59,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,Platelet,330,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Hematology,WBC,7.7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,107,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,86,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,31.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,111,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,23,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,4.12,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,132,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,31.0,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,37.0,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,1.97,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,5.02,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,340,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,7.9,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.84,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Alkaline Phosphatase,83,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,BUN,24,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,LDH,124,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Lipase,21.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Potassium,3.86,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,Hematocrit,37.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,Lymphocytes abs,1.86,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,Neutrophils abs,4.95,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,Platelet,325,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Hematology,WBC,7.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,156,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alkaline Phosphatase,102,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,BUN,20,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,LDH,162,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Lipase,19,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Potassium,4.26,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hematocrit,39.9,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hemoglobin,12.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Lymphocytes abs,1.90,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Neutrophils abs,4.57,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Platelet,335,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,WBC,7.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.7,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Alkaline Phosphatase,87,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,LDH,131.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Potassium,4.24,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Sodium,136,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Total Bilirubin,ND,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Hematocrit,37.9,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Hemoglobin,12.0,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Lymphocytes abs,1.77,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Neutrophils abs,5.09,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,Platelet,325,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Hematology,WBC,7.8,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,211,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Alkaline Phosphatase,80,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,BUN,16,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Creatinine,1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Direct Bilirubin,0.02,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Indirect Bilirubin,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,LDH,121,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Lipase,17,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Potassium,4.24,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Sodium,136,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Hematocrit,37.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Hemoglobin,11.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Lymphocytes abs,1.86,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Neutrophils abs,4.67,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,Platelet,318,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Hematology,WBC,7.4,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,239,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alkaline Phosphatase,91,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,BUN,16,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Creatinine,1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,LDH,137,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Lipase,14,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Potassium,4.20,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Sodium,135,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hematocrit,37.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Lymphocytes abs,1.94,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Neutrophils abs,4.24,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Platelet,330,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,WBC,7.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alkaline Phosphatase,91,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,BUN,19,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Direct Bilirubin,0.02,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,LDH,128,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Lipase,19,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Potassium,4.36,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Urea,,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hematocrit,36.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hemoglobin,11.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Lymphocytes abs,1.75,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Neutrophils abs,4.06,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Platelet,352,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Alkaline Phosphatase,89,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,BUN,24,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,LDH,124,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Lipase,20,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Potassium,3.92,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Hematocrit,37.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Hemoglobin,12,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Lymphocytes abs,1.35,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Neutrophils abs,4.22,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Platelet,303,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,WBC,6.4,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Alkaline Phosphatase,94,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,BUN,18,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,LDH,133,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Lipase,17,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Potassium,3.98,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Hematocrit,39.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Hemoglobin,12.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Lymphocytes abs,1.67,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Neutrophils abs,4.58,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Platelet,295,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,WBC,7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Alkaline Phosphatase,87,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,BUN,18.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,LDH,121.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Potassium,4.66,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Sodium,141,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Hematocrit,37.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Lymphocytes abs,1.99,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Neutrophils abs,5.14,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Platelet,315,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,WBC,8.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Alkaline Phosphatase,83,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,BUN,23,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,LDH,142.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Lipase,20.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Potassium,4.24,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Hematocrit,39.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Lymphocytes abs,2.06,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Neutrophils abs,5.27,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Platelet,324,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,WBC,8.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.79,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Alkaline Phosphatase,88,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,LDH,121.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Lipase,23.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Potassium,4.17,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Hematocrit,38.9,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Hemoglobin,12.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Lymphocytes abs,1.93,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Neutrophils abs,5.02,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Platelet,351,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,WBC,7.7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.83,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Alkaline Phosphatase,102,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,LDH,113.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Potassium,4.01,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,Hematocrit,36.2,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,Hemoglobin,11.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,Lymphocytes abs,2.17,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,Neutrophils abs,4.09,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,Platelet,374,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Hematology,WBC,7.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.81,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,464,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Alkaline Phosphatase,97,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,LDH,131.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Potassium,4.08,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Hematocrit,37.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Hemoglobin,11.7,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Lymphocytes abs,1.85,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Neutrophils abs,4.12,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Platelet,360,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,WBC,6.8,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Alkaline Phosphatase,97,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,LDH,152.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Potassium,4.28,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,Hematocrit,40.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,Hemoglobin,12.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,Lymphocytes abs,1.92,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,Neutrophils abs,4.21,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,Platelet,352,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Hematology,WBC,6.9,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,520,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Alkaline Phosphatase,82,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,LDH,119.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Lipase,20.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Potassium,4.12,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Sodium,141,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,Hematocrit,36.8,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,Hemoglobin,11.7,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,Lymphocytes abs,1.75,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,Neutrophils abs,4.14,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,Platelet,311,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Hematology,WBC,6.7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 16,547,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Alkaline Phosphatase,84,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,BUN,21.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,LDH,117.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Potassium,2.07,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Chemistry,Urea,21.0,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,Hematocrit,36.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,Lymphocytes abs,1.74,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,Neutrophils abs,4.18,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,Platelet,343,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.72,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 17,575,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,BUN,18,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,LDH,143,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Lipase,16,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Potassium,4.24,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,Hematocrit,36.8,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,Lymphocytes abs,1.96,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,Neutrophils abs,6.45,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,Platelet,332,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 18,603,Hematology,WBC,9.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Alkaline Phosphatase,70,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,LDH,135.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Lipase,21.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Potassium,4.17,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,Hematocrit,36.5,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,Hemoglobin,11.5,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,Lymphocytes abs,1.61,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,Neutrophils abs,4.69,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,Platelet,345,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Hematology,WBC,7.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 19,631,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Alkaline Phosphatase,69,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,BUN,18.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,LDH,129.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Potassium,3.95,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,Hematocrit,37.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,Hemoglobin,11.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,Lymphocytes abs,1.66,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,Neutrophils abs,3.90,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,Platelet,325,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Hematology,WBC,6.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 20,659,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,Hematocrit,40.4,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,Lymphocytes abs,1.67,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,Neutrophils abs,4.49,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,Platelet,321,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Hematology,WBC,7.0,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.6,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 21,687,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Alkaline Phosphatase,77,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,BUN,17.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,LDH,128.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Potassium,4.32,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,Hematocrit,37.5,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,Hemoglobin,11.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,Lymphocytes abs,1.68,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,Neutrophils abs,4.12,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,Platelet,304,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Hematology,WBC,6.5,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 22,715,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Alkaline Phosphatase,93,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,LDH,128.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Potassium,4.06,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,Hematocrit,41.0,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,Hemoglobin,12.7,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,Lymphocytes abs,1.78,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,Neutrophils abs,4.64,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,Platelet,324,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Hematology,WBC,7.2,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.87,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 23,743,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Alkaline Phosphatase,90,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,LDH,136.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Lipase,16.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Potassium,4.33,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,Hematocrit,40.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,Lymphocytes abs,1.92,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,Neutrophils abs,4.89,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,Platelet,346,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Hematology,WBC,7.5,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 24,771,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,BUN,25.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Direct Bilirubin,0.18,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,LDH,144.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Lipase,21.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Potassium,4.48,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,Hematocrit,39.0,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,Hemoglobin,12.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,Lymphocytes abs,1.49,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,Neutrophils abs,5.02,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,Platelet,317,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Hematology,WBC,7.4,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 25,799,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Alkaline Phosphatase,82,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,LDH,139.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Potassium,4.0,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,Hematocrit,40.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,Lymphocytes abs,1.83,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,Neutrophils abs,4.27,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,Platelet,308,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Hematology,WBC,6.9,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 26,827,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,BUN,22.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,LDH,137.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Potassium,4.31,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,Hematocrit,39.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,Hemoglobin,12.5,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,Lymphocytes abs,1.74,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,Neutrophils abs,4.59,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,Platelet,313,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Hematology,WBC,7.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 27,855,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Alkaline Phosphatase,90,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,BUN,20,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,LDH,154.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Lipase,16,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Potassium,4.63,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,Hematocrit,39.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,Lymphocytes abs,1.69,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,Neutrophils abs,5.73,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,Platelet,374,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Hematology,WBC,8.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 28,883,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Alkaline Phosphatase,83,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Aspartate Transferase (SGOT),11,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,BUN,21.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,LDH,123.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Potassium,4.14,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Sodium,140,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,Hematocrit,38.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,Hemoglobin,12.3,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,Lymphocytes abs,1.49,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,Neutrophils abs,8.12,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,Platelet,382,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Hematology,WBC,10.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 29,911,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,BUN,23.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,LDH,135.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Lipase,21.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Potassium,4.07,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,Hematocrit,38.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,Lymphocytes abs,1.71,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,Neutrophils abs,5.15,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,Platelet,309,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Hematology,WBC,7.5,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 30,939,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Alkaline Phosphatase,80,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,LDH,135.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Lipase,20.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Potassium,4.28,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,Hematocrit,40.9,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,Hemoglobin,12.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,Lymphocytes abs,1.51,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,Neutrophils abs,4.46,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,Platelet,325,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Hematology,WBC,6.7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.91,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 31,968,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,LDH,136.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Lipase,26.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Potassium,3.78,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,Hematocrit,39.0,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,Lymphocytes abs,1.64,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,Neutrophils abs,5.77,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,Platelet,327,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Hematology,WBC,8.3,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.94,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 32,995,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,BUN,15.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,LDH,115.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Lipase,14.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Potassium,3.98,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,Hematocrit,39.6,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,Hemoglobin,12.3,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,Lymphocytes abs,1.70,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,Neutrophils abs,5.65,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,Platelet,317,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Hematology,WBC,8.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 33,1023,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,LDH,134.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Lipase,13.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Potassium,4.11,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,Hematocrit,40.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,Hemoglobin,12.7,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,Lymphocytes abs,1.47,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,Neutrophils abs,4.46,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,Platelet,341,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 34,1051,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,BUN,17.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,LDH,126.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Lipase,19.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Potassium,4.14,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,Hematocrit,40.5,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,Hemoglobin,12.6,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,Lymphocytes abs,1.50,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,Neutrophils abs,5.12,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,Platelet,330,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Hematology,WBC,7.4,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 35,1079,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Alkaline Phosphatase,79,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,BUN,16.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,LDH,144,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Lipase,16.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Potassium,3.95,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,Hematocrit,39.3,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,Hemoglobin,12.3,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,Lymphocytes abs,1.78,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,Neutrophils abs,5.26,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,Platelet,375,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Hematology,WBC,8.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.72,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 36,1107,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Alkaline Phosphatase,72,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,BUN,18.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,LDH,130.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Lipase,12.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Potassium,4.06,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Sodium,136,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Chemistry,Urea,18.0,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,Hematocrit,38.8,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,Hemoglobin,12.2,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,Lymphocytes abs,1.46,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,Neutrophils abs,4.01,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,Platelet,337,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 37,1135,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Alkaline Phosphatase,76,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,BUN,22,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,LDH,133,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Potassium,4.04,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Sodium,139,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,Hematocrit,38.7,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,Hemoglobin,11.9,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,Lymphocytes abs,1.72,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,Neutrophils abs,4.43,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,Platelet,327,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Hematology,WBC,6.9,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.88,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 38,1163,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Alkaline Phosphatase,77,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,LDH,148.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Potassium,4.26,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,Hematocrit,40.5,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,Hemoglobin,12.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,Lymphocytes abs,1.75,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,Neutrophils abs,5.06,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,Platelet,313,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Hematology,WBC,7.7,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 39,1191,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Alkaline Phosphatase,73,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,BUN,20.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,LDH,117.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Lipase,25.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Potassium,4.55,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Sodium,137,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,Hematocrit,39.1,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,Hemoglobin,12.4,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,Lymphocytes abs,1.89,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,Neutrophils abs,4.40,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,Platelet,310,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Hematology,WBC,7.1,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 40,1219,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Alkaline Phosphatase,80,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,BUN,18.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,LDH,139.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Potassium,4.42,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Sodium,140,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,Hematocrit,39.8,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,Hemoglobin,12.7,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,Lymphocytes abs,1.87,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,Neutrophils abs,4.79,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,Platelet,309,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Hematology,WBC,7.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 41,1247,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Alkaline Phosphatase,72,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,BUN,19.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Direct Bilirubin,0.18,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,LDH,143,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Lipase,18.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Potassium,3.98,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Sodium,141,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,Hematocrit,39.0,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,Hemoglobin,12.5,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,Lymphocytes abs,1.71,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,Neutrophils abs,4.52,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,Platelet,291,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Hematology,WBC,7.0,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.60,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 42,1275,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,BUN,23.0,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,BUN,23,mg/dL,7,25
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,LDH,129.0,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,LDH,129,U/L,140,271
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Lipase,17.0,U/L,11,82
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Potassium,4.38,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Potassium,4.38,mmol/L,3.5,5.1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Sodium,138,mmol/L,136,145
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Chemistry,Urea,ND,,NA,NA
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Hematocrit,40.2,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Hematocrit,40.2,%,34.1,44.9
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Hemoglobin,12.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Hemoglobin,12.8,g/dL,11.2,15.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Lymphocytes abs,1.74,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Lymphocytes abs,1.74,x10E3/µL,1.18,3.74
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Neutrophils abs,4.15,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Neutrophils abs,4.15,x10E3/µL,1.56,6.13
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Platelet,357,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,Platelet,357,x10E3/µL,163,369
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Hematology,WBC,6.6,x10E3/µL,4,10
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0010,050,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,1303,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alkaline Phosphatase,112,U/L,34,104
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,BUN,16,mg/dL,7,25
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Creatinine,0.63,mg/dL,0.6,1.3
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,LDH,184,U/L,140,271
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Lipase,51,U/L,11,82
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Sodium,143,mmol/L,136,145
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Urea,16,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hematocrit,41.0,%,34.1,44.9
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hemoglobin,13.3,g/dL,11.2,15.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Lymphocytes abs,2.05,x10E3/µL,1.18,3.74
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Neutrophils abs,7.17,x10E3/µL,1.56,6.13
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Platelet,279,x10E3/µL,163,369
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,WBC,10.0,x10E3/µL,4,10
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.1,µIU/mL,0.5,6
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,108,U/L,34,104
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,9,mg/dL,7,25
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.59,mg/dL,0.6,1.3
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,169,U/L,140,271
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,38,U/L,11,82
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,5.1,mmol/L,3.5,5.1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,142,mmol/L,136,145
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,9,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,43.4,%,34.1,44.9
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.3,g/dL,11.2,15.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,24.4,x10E3/µL,1.18,3.74
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,5.60,x10E3/µL,1.56,6.13
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,327,x10E3/µL,163,369
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,8.64,x10E3/µL,4,10
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.8,1.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.2,µIU/mL,0.5,6
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,95,U/L,34,104
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,11,mg/dL,7,25
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.56,mg/dL,0.6,1.3
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,171,U/L,140,271
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,36,U/L,11,82
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.6,mmol/L,3.5,5.1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mmol/L,136,145
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,11,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,37.4,%,34.1,44.9
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,2.09,x10E3/µL,1.18,3.74
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,6.70,x10E3/µL,1.56,6.13
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,326,x10E3/µL,163,369
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,9.8,x10E3/µL,4,10
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.8,1.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.9,µIU/mL,0.5,6
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,100,U/L,34,104
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,9,mg/dL,7,25
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.52,mg/dL,0.6,1.3
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,208,U/L,140,271
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,32,U/L,11,82
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,139,mmol/L,136,145
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,9,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,40.5,%,34.1,44.9
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,13.0,g/dL,11.2,15.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,3.02,x10E3/µL,1.18,3.74
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,6.59,x10E3/µL,1.56,6.13
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,322,x10E3/µL,163,369
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,10.8,x10E3/µL,4,10
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.1,ng/dL,0.8,1.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),13.8,µIU/mL,0.5,6
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),82,ng/dL,85,185
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,Hematocrit,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,Hemoglobin,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,Lymphocytes abs,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,Neutrophils abs,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,Platelet,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,85,Hematology,WBC,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Alkaline Phosphatase,93,U/L,34,104
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,BUN,11,mg/dL,7,25
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Creatinine,0.43,mg/dL,0.6,1.3
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Direct Bilirubin,<0.2,mg/dL,0.03,0.18
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,LDH,156,U/L,140,271
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Lipase,36,U/L,11,82
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Magnesium,1.5,mg/dL,1.9,2.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Potassium,3.8,mmol/L,3.5,5.1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Sodium,138,mmol/L,136,145
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Chemistry,Urea,,,NA,NA
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,Hematocrit,37,%,34.1,44.9
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,Hemoglobin,11.2,g/dL,11.2,15.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,Lymphocytes abs,2.46,x10E3/µL,1.18,3.74
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,Neutrophils abs,9.68,x10E3/µL,1.56,6.13
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,Platelet,472,x10E3/µL,163,369
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Hematology,WBC,13.16,x10E3/µL,4,10
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.59,µIU/mL,0.5,6
104-0014,051,CD8 LOW,Nivolumab + Ipilimumab,90 DAY FOLLOW-UP,126,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),19,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,81,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,BUN,11,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Creatinine,0.86,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Direct Bilirubin,<0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,LDH,207,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Lipase,37,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Sodium,142,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),2.4,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,143,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,13,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.86,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,238,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,29,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,143,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,13,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.2,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.8,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.71,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,5.80,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,238,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,7.2,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.9,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,108,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,14,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.89,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,192,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,29,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,141,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,14,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,35.7,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.3,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.75,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,4.67,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,295,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,6.15,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),1.9,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.02,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,94,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,9,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.91,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,204,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,33,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,142,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,9,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,38.1,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.5,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,0.61,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,4.93,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,291,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,6.31,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.7,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.13,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,169,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,10,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.76,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,211,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,29,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,135,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,34.6,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,11.1,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,0.54,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,4.23,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,345,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,5.45,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),1.7,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),233,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.05,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),93,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,131,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),21,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,10,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.73,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,206,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,27,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,139,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,36.2,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,11.3,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,0.54,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,4.36,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,315,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,5.73,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),1.6,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),229,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.07,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,130,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),19,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,14,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.78,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,210,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,29,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,139,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,34.1,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,11.0,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,0.56,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,4.38,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,297,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,5.68,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),1.7,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),262,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.04,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),22,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,208,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,11,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,0.85,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,225,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,31,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,4.9,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,138,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,33.6,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,10.5,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,0.58,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,5.19,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,292,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,6.70,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),2.1,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.03,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alkaline Phosphatase,135,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,BUN,13,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Creatinine,0.84,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Direct Bilirubin,<0.2,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,LDH,225,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Lipase,28,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Potassium,4.6,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Sodium,140,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hematocrit,32.6,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hemoglobin,10.1,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Lymphocytes abs,0.48,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Neutrophils abs,5.09,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Platelet,306,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,WBC,6.26,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Thyroxine (FT4),2.0,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),<0.02,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Alkaline Phosphatase,141,U/L,34,104
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Aspartate Transferase (SGOT),25,U/L,13,39
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,BUN,12,mg/dL,7,25
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Creatinine,0.83,mg/dL,0.6,1.3
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,LDH,335,U/L,140,271
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Lipase,9,U/L,11,82
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Magnesium,1.5,mg/dL,1.9,2.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Sodium,139,mmol/L,136,145
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Chemistry,Urea,,,NA,NA
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,Hematocrit,29.1,%,34.1,44.9
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,Hemoglobin,8.7,g/dL,11.2,15.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,Lymphocytes abs,0.58,x10E3/µL,1.18,3.74
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,Neutrophils abs,6.33,x10E3/µL,1.56,6.13
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,Platelet,334,x10E3/µL,163,369
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Hematology,WBC,7.7,x10E3/µL,4,10
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.8,1.7
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.4,µIU/mL,0.5,6
104-0015,052,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,203,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.6,µIU/mL,0.5,6
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-25,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,111,U/L,34,104
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),28,U/L,13,39
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,22,mg/dL,7,25
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.57,mg/dL,0.6,1.3
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,548,U/L,140,271
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,7,U/L,11,82
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.4,mg/dL,1.9,2.7
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.1,mmol/L,3.5,5.1
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,135,mmol/L,136,145
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.3,%,34.1,44.9
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,12.1,g/dL,11.2,15.7
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.27,x10E3/µL,1.18,3.74
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.9,x10E3/µL,1.56,6.13
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,201,x10E3/µL,163,369
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.1,x10E3/µL,4,10
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.8,µIU/mL,0.5,6
104-0016,053,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alanine Transferase (SGPT),25,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Alkaline Phosphatase,105,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Aspartate Transferase (SGOT),32,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,BUN,26,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Creatinine,1.37,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,LDH,348,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Lipase,35,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Magnesium,1.5,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Potassium,5.1,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Sodium,143,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hematocrit,41.8,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Hemoglobin,13.4,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Lymphocytes abs,1.32,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Neutrophils abs,5.19,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,Platelet,217,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Hematology,WBC,7.47,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.9,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,12,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),40,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),37,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,37,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,227,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,33,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.97,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,135,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,37.5,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.2,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.42,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.83,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,183,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,6.4,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.1,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),44,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,135,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),44,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,36.0,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,204,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,23.0,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.24,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,140,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,38.4,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,12.6,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.84,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,3.45,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,192,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,6.5,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.1,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),41,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,151,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),36,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,41.0,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,193.0,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,29.0,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.27,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,140,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,40.4,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,13.1,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.89,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,4.37,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,171,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,7.4,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.66,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),25,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,126,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),29,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,31,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,186,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,30,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.27,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,140,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,40.6,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,13.1,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.68,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,4.43,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,176,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,7.3,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.57,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),19,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),26,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,33,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,1.3,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,178,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,40,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,4.36,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,139,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,42.7,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,13.9,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.72,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,3.83,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,179,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,6.8,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.3,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Alkaline Phosphatase,75,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Aspartate Transferase (SGOT),26,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,BUN,28,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Creatinine,1.3,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,LDH,218,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Lipase,34,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Potassium,4.09,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Sodium,142,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,Hematocrit,42.3,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,Hemoglobin,13.4,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,Lymphocytes abs,1.97,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,Neutrophils abs,4.10,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,Platelet,203,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Hematology,WBC,7.3,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,142,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Alanine Transferase (SGPT),29,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Alkaline Phosphatase,106,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Aspartate Transferase (SGOT),34,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,BUN,34,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Creatinine,1.3,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Direct Bilirubin,0.02,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Indirect Bilirubin,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,LDH,208,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Lipase,35,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Potassium,4.31,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Sodium,138,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Hematocrit,43.3,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Hemoglobin,14.1,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Lymphocytes abs,1.61,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Neutrophils abs,4.66,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,Platelet,170,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Hematology,WBC,7.9,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.5,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,169,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Alanine Transferase (SGPT),25,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Aspartate Transferase (SGOT),29,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,BUN,31,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Direct Bilirubin,0.14,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,LDH,204,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Lipase,29,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Potassium,4.12,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Sodium,138,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Hematocrit,44.1,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Hemoglobin,14.2,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Lymphocytes abs,1.64,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Neutrophils abs,3.86,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,Platelet,187,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Hematology,WBC,6.7,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.1,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,197,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Alanine Transferase (SGPT),23,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Aspartate Transferase (SGOT),28,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,BUN,27,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Creatinine,1.3,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Direct Bilirubin,0.14,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,LDH,209,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Lipase,29,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Potassium,4.31,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Sodium,138,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,Hematocrit,42.9,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,Hemoglobin,14,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,Lymphocytes abs,1.59,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,Neutrophils abs,4.09,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,Platelet,194,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Hematology,WBC,6.6,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.7,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,226,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Alanine Transferase (SGPT),35,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Alkaline Phosphatase,68,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Aspartate Transferase (SGOT),29,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,BUN,42,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Direct Bilirubin,0.14,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,LDH,243,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Lipase,40,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Potassium,3.96,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Sodium,139,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Chemistry,Urea,,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,Hematocrit,44.6,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,Hemoglobin,14.5,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,Lymphocytes abs,1.89,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,Neutrophils abs,7.97,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,Platelet,164,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,239,Hematology,WBC,10.9,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Alanine Transferase (SGPT),20,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Alkaline Phosphatase,87,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Aspartate Transferase (SGOT),29,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,BUN,41,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Creatinine,1.7,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,LDH,228,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Lipase,40,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Potassium,4.08,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Sodium,138,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,Hematocrit,44.6,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,Hemoglobin,14.7,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,Lymphocytes abs,1.99,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,Neutrophils abs,6.2,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,Platelet,195,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Hematology,WBC,9.4,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.8,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,267,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Alanine Transferase (SGPT),22,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Alkaline Phosphatase,80,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Aspartate Transferase (SGOT),26,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,BUN,31,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,LDH,195,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Lipase,32,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Potassium,4.36,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Sodium,140,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,Hematocrit,41.5,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,Hemoglobin,13.5,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,Lymphocytes abs,1.39,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,Neutrophils abs,4.25,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,Platelet,164,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Hematology,WBC,6.8,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,294,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Alanine Transferase (SGPT),21,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Alkaline Phosphatase,90,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Aspartate Transferase (SGOT),27,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,BUN,35,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Creatinine,1.5,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,LDH,230,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Lipase,26,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Potassium,4.34,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Sodium,137,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Chemistry,Urea,35,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,Hematocrit,41.5,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,Hemoglobin,13.7,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,Lymphocytes abs,1.46,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,Neutrophils abs,3.63,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,Platelet,198,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Hematology,WBC,6.3,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.8,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,323,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Alanine Transferase (SGPT),30,U/L,7,52
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Alkaline Phosphatase,102,U/L,34,104
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Aspartate Transferase (SGOT),36,U/L,13,39
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,BUN,35,mg/dL,7,25
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Creatinine,1.4,mg/dL,0.6,1.3
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,LDH,244,U/L,140,271
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Lipase,35,U/L,11,82
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Potassium,4.2,mmol/L,3.5,5.1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Sodium,139,mmol/L,136,145
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Chemistry,Urea,ND,,NA,NA
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,Hematocrit,42.1,%,40.1,51
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,Hemoglobin,13.5,g/dL,13.7,17.5
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,Lymphocytes abs,1.59,x10E3/µL,1.18,3.74
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,Neutrophils abs,4.72,x10E3/µL,1.56,6.13
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,Platelet,182,x10E3/µL,163,369
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Hematology,WBC,7.2,x10E3/µL,4,10
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.3,µIU/mL,0.5,6
104-0018,054,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,351,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),22,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,39,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,BUN,18.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,LDH,121.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Lipase,32.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Potassium,4.29,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Sodium,140,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hematocrit,36.2,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hemoglobin,11.6,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Lymphocytes abs,1.20,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Neutrophils abs,2.23,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Platelet,222,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.7,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,40,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,12.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.14,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,160.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,25.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.10,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,136,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,33.5,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.9,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.93,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.59,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,169,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.4,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.9,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),14,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,36,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,21.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,109.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,31.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.79,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,34.3,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.2,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.16,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.35,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,161,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,4.3,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),15,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,38,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,14.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.13,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,116.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,40.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.4,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.42,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,138,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,34.4,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.2,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.24,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,2.19,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,174,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.4,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Alanine Transferase (SGPT),20,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Alkaline Phosphatase,38,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Aspartate Transferase (SGOT),21,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,BUN,16.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,LDH,118.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Lipase,31.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Potassium,4.04,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Sodium,138,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,Hematocrit,35.0,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,Hemoglobin,11.3,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,Lymphocytes abs,1.17,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,Neutrophils abs,2.30,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,Platelet,159,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Hematology,WBC,4.2,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.0,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,65,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,39,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,20,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,0.16,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,97,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,32,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,3.98,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,133,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.90,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,35.4,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,11.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.23,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,2.28,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,157,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,4.3,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,42,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,15,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,0.14,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,109,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,36,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,2.4,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,4.26,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,138,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,35.8,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,11.4,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.26,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,2.52,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,160,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,4.4,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.5,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,34,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),19,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,13,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,115,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,28,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,4.10,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,133,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.90,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,35.1,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,11.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,1.11,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,2.51,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,166,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,4.3,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),0.8,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.16,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alkaline Phosphatase,42,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,BUN,13,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Direct Bilirubin,0.16,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,LDH,111,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Lipase,43,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Potassium,4.32,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Sodium,122,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Total Bilirubin,1.10,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hematocrit,31.6,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hemoglobin,10.6,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Lymphocytes abs,1.03,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Neutrophils abs,2.48,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Platelet,167,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alkaline Phosphatase,38,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,BUN,24,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Direct Bilirubin,0.23,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,LDH,115,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Lipase,35,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Potassium,4.05,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Sodium,137,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Total Bilirubin,1.10,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hematocrit,35.8,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hemoglobin,11.7,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Lymphocytes abs,1.13,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Neutrophils abs,3.08,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Platelet,183,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,WBC,4.7,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Alkaline Phosphatase,38,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,BUN,27,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Indirect Bilirubin,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,LDH,120,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Lipase,46,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Potassium,3.83,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Sodium,139,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Hematocrit,33.4,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Hemoglobin,10.7,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Lymphocytes abs,1.13,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Neutrophils abs,2.42,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,Platelet,193,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,210,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Alkaline Phosphatase,38,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,BUN,21,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Direct Bilirubin,0.15,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,LDH,104,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Lipase,31,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Potassium,3.53,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Sodium,140,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Chemistry,Urea,,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,Hematocrit,32.7,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,Hemoglobin,10.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,Lymphocytes abs,0.99,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,Neutrophils abs,2.19,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,Platelet,166,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Hematology,WBC,3.6,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.75,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,240,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Alkaline Phosphatase,37,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,BUN,23,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Direct Bilirubin,0.22,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,LDH,106,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Lipase,41,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Potassium,3.69,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Sodium,138,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Total Bilirubin,0.9,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hematocrit,32.9,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Hemoglobin,10.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Lymphocytes abs,1,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Neutrophils abs,2.54,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,Platelet,165,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Hematology,WBC,4,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,267,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Alkaline Phosphatase,46,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,BUN,20,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Direct Bilirubin,0.15,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,LDH,118,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Lipase,38,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Potassium,3.95,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Sodium,139,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Total Bilirubin,0.8,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hematocrit,32.6,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Hemoglobin,10.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Lymphocytes abs,1.15,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Neutrophils abs,2.72,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,Platelet,176,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Hematology,WBC,4.7,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.8,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,295,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Alkaline Phosphatase,45,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,BUN,26.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Direct Bilirubin,0.15,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,LDH,107.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Lipase,46.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Potassium,3.82,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Sodium,140,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Total Bilirubin,0.7,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Hematocrit,31.8,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Hemoglobin,10.2,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Lymphocytes abs,0.97,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Neutrophils abs,2.63,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,Platelet,161,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Hematology,WBC,4.3,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.6,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,323,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Alkaline Phosphatase,45,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,BUN,24.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Direct Bilirubin,0.15,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,LDH,101.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Lipase,41.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Potassium,3.79,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Sodium,139,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Hematocrit,32.5,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Hemoglobin,10.4,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Lymphocytes abs,0.92,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Neutrophils abs,2.03,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,Platelet,157,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Hematology,WBC,3.5,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.2,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,351,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,BUN,23.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,LDH,106.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Lipase,42.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Potassium,3.92,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Sodium,139,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Hematocrit,32.8,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Hemoglobin,10.5,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Lymphocytes abs,1.02,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Neutrophils abs,2.59,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,Platelet,164,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.1,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,379,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Alanine Transferase (SGPT),9,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Alkaline Phosphatase,41,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,BUN,27.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Direct Bilirubin,0.26,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,LDH,101.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Lipase,35.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Potassium,3.83,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Sodium,140,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Hematocrit,30.6,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Hemoglobin,9.6,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Lymphocytes abs,1.14,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Neutrophils abs,2.39,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,Platelet,155,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Hematology,WBC,4.1,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,407,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Alkaline Phosphatase,45,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,BUN,24.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,LDH,118.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Lipase,35.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Potassium,3.80,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Sodium,140,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Hematocrit,29.7,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Hemoglobin,9.3,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Lymphocytes abs,0.97,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Neutrophils abs,2.05,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,Platelet,156,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Hematology,WBC,3.6,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.4,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,435,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Alkaline Phosphatase,58,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,BUN,19.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,LDH,149,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Lipase,30,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Potassium,3.70,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Sodium,142,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Total Bilirubin,1.00,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,Hematocrit,28.5,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,Hemoglobin,8.9,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,Lymphocytes abs,0.81,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,Neutrophils abs,2.79,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,Platelet,150,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Hematology,WBC,4.2,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,463,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Alkaline Phosphatase,73,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,BUN,26.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Direct Bilirubin,0.16,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,LDH,131.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Lipase,38.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Potassium,3.66,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Sodium,141,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Total Bilirubin,0.80,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Chemistry,Urea,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Hematocrit,26.2,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Hemoglobin,8.0,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Lymphocytes abs,0.72,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Neutrophils abs,2.10,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,Platelet,143,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Hematology,WBC,3.3,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.3,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,491,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Alanine Transferase (SGPT),19,U/L,7,52
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Alkaline Phosphatase,137,U/L,34,104
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Aspartate Transferase (SGOT),32,U/L,13,39
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,BUN,36.0,mg/dL,7,25
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Direct Bilirubin,0.45,mg/dL,0.03,0.18
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,LDH,201.0,U/L,140,271
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Lipase,52.0,U/L,11,82
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Magnesium,2.6,mg/dL,1.9,2.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Potassium,3.8,mmol/L,3.5,5.1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Sodium,142,mmol/L,136,145
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Total Bilirubin,1.7,mg/dL,0.3,1
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Chemistry,Urea,36.0,,NA,NA
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,Hematocrit,29.6,%,40.1,51
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,Hemoglobin,9.0,g/dL,13.7,17.5
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,Lymphocytes abs,0.67,x10E3/µL,1.18,3.74
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,Neutrophils abs,2.63,x10E3/µL,1.56,6.13
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,Platelet,128,x10E3/µL,163,369
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Hematology,WBC,3.8,x10E3/µL,4,10
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.1,µIU/mL,0.5,6
104-0020,055,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,533,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alanine Transferase (SGPT),15,U/L,7,52
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alkaline Phosphatase,96,U/L,34,104
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,BUN,22,mg/dL,7,25
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Creatinine,0.86,mg/dL,0.6,1.3
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,LDH,218,U/L,140,271
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Lipase,39,U/L,11,82
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Potassium,4.9,mmol/L,3.5,5.1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Sodium,139,mmol/L,136,145
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Urea,,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hematocrit,42.7,%,40.1,51
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hemoglobin,13.7,g/dL,13.7,17.5
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Lymphocytes abs,1.37,x10E3/µL,1.18,3.74
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Neutrophils abs,6.25,x10E3/µL,1.56,6.13
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Platelet,222,x10E3/µL,163,369
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,WBC,8.39,x10E3/µL,4,10
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,60,U/L,34,104
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,25.0,mg/dL,7,25
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.10,mg/dL,0.03,0.18
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,153.0,U/L,140,271
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,40.0,U/L,11,82
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.06,mmol/L,3.5,5.1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mmol/L,136,145
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,40.1,%,40.1,51
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.5,g/dL,13.7,17.5
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.22,x10E3/µL,1.18,3.74
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,6.45,x10E3/µL,1.56,6.13
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,203,x10E3/µL,163,369
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,8.5,x10E3/µL,4,10
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.9,µIU/mL,0.5,6
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,70,U/L,34,104
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,19.0,mg/dL,7,25
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.02,mg/dL,0.03,0.18
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,153.0,U/L,140,271
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,20.0,U/L,11,82
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.03,mmol/L,3.5,5.1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mmol/L,136,145
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,37.8,%,40.1,51
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.6,g/dL,13.7,17.5
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.56,x10E3/µL,1.18,3.74
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,9.37,x10E3/µL,1.56,6.13
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,247,x10E3/µL,163,369
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,12.0,x10E3/µL,4,10
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.0,µIU/mL,0.5,6
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Alkaline Phosphatase,42,U/L,34,104
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Aspartate Transferase (SGOT),10,U/L,13,39
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,BUN,13,mg/dL,7,25
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,LDH,156,U/L,140,271
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Lipase,25,U/L,11,82
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Potassium,3.38,mmol/L,3.5,5.1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Sodium,140,mmol/L,136,145
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Chemistry,Urea,,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,Hematocrit,27.2,%,40.1,51
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,Hemoglobin,8.2,g/dL,13.7,17.5
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,Lymphocytes abs,0.94,x10E3/µL,1.18,3.74
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,Neutrophils abs,6.33,x10E3/µL,1.56,6.13
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,Platelet,280,x10E3/µL,163,369
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Hematology,WBC,7.9,x10E3/µL,4,10
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,71,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,BUN,11,mg/dL,7,25
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Direct Bilirubin,0.02,mg/dL,0.03,0.18
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,LDH,142,U/L,140,271
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Lipase,19,U/L,11,82
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Potassium,3.95,mmol/L,3.5,5.1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Sodium,139,mmol/L,136,145
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Total Bilirubin,0.20,mg/dL,0.3,1
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Chemistry,Urea,,,NA,NA
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,Hematocrit,31.9,%,40.1,51
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,Hemoglobin,9.6,g/dL,13.7,17.5
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,Lymphocytes abs,1.24,x10E3/µL,1.18,3.74
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,Neutrophils abs,6.99,x10E3/µL,1.56,6.13
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,Platelet,417,x10E3/µL,163,369
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Hematology,WBC,9.1,x10E3/µL,4,10
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.67,µIU/mL,0.5,6
104-0021,056,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,92,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Alanine Transferase (SGPT),8,U/L,7,52
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Alkaline Phosphatase,83,U/L,34,104
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,BUN,16,mg/dL,7,25
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Creatinine,0.67,mg/dL,0.6,1.3
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,LDH,191,U/L,140,271
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Lipase,28,U/L,11,82
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Potassium,4.8,mmol/L,3.5,5.1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Sodium,142,mmol/L,136,145
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Chemistry,Urea,,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,Hematocrit,31.6,%,34.1,44.9
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,Hemoglobin,10.5,g/dL,11.2,15.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,Lymphocytes abs,1.44,x10E3/µL,1.18,3.74
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,Neutrophils abs,2.34,x10E3/µL,1.56,6.13
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,Platelet,155,x10E3/µL,163,369
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Hematology,WBC,4.5,x10E3/µL,4,10
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.6,µIU/mL,0.5,6
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-19,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,84,U/L,34,104
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,14,mg/dL,7,25
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.65,mg/dL,0.6,1.3
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,190,U/L,140,271
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,31,U/L,11,82
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,143,mmol/L,136,145
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,14,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,34.0,%,34.1,44.9
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.6,g/dL,11.2,15.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.25,x10E3/µL,1.18,3.74
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.08,x10E3/µL,1.56,6.13
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,187,x10E3/µL,163,369
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.3,x10E3/µL,4,10
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,83,U/L,34,104
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,15,mg/dL,7,25
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.59,mg/dL,0.6,1.3
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,ND,mg/dL,0.03,0.18
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,221,U/L,140,271
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,25,U/L,11,82
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.3,mmol/L,3.5,5.1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,141,mmol/L,136,145
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,15,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,36.0,%,34.1,44.9
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.7,g/dL,11.2,15.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.98,x10E3/µL,1.18,3.74
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.54,x10E3/µL,1.56,6.13
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,153,x10E3/µL,163,369
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,6.4,x10E3/µL,4,10
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,81,U/L,34,104
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),24,U/L,13,39
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,9,mg/dL,7,25
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.56,mg/dL,0.6,1.3
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,389,U/L,140,271
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,25,U/L,11,82
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.9,mmol/L,3.5,5.1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,140,mmol/L,136,145
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,34.2,%,34.1,44.9
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,11.1,g/dL,11.2,15.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.79,x10E3/µL,1.18,3.74
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,4.81,x10E3/µL,1.56,6.13
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,180,x10E3/µL,163,369
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,7.59,x10E3/µL,4,10
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Alanine Transferase (SGPT),7,U/L,7,52
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Alkaline Phosphatase,76,U/L,34,104
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Aspartate Transferase (SGOT),12,U/L,13,39
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,BUN,11,mg/dL,7,25
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Creatinine,0.57,mg/dL,0.6,1.3
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,LDH,311,U/L,140,271
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Lipase,26,U/L,11,82
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Sodium,138,mmol/L,136,145
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Chemistry,Urea,,,NA,NA
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hematocrit,36.7,%,34.1,44.9
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hemoglobin,11.8,g/dL,11.2,15.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Lymphocytes abs,1.49,x10E3/µL,1.18,3.74
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Neutrophils abs,7.02,x10E3/µL,1.56,6.13
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Platelet,199,x10E3/µL,163,369
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,WBC,9.3,x10E3/µL,4,10
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.62,µIU/mL,0.5,6
104-0022,057,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),27,U/L,7,52
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,128,U/L,34,104
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),30,U/L,13,39
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,8.0,mg/dL,7,25
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,205.0,U/L,140,271
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,35.0,U/L,11,82
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.80,mmol/L,3.5,5.1
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,139,mmol/L,136,145
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,32.1,%,34.1,44.9
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.7,g/dL,11.2,15.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.81,x10E3/µL,1.18,3.74
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,3.20,x10E3/µL,1.56,6.13
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,236,x10E3/µL,163,369
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,4.7,x10E3/µL,4,10
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.0,µIU/mL,0.5,6
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),32,U/L,7,52
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,140,U/L,34,104
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),33,U/L,13,39
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,12.0,mg/dL,7,25
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.7,mg/dL,0.6,1.3
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,205.0,U/L,140,271
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,53.0,U/L,11,82
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.86,mmol/L,3.5,5.1
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mmol/L,136,145
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,34.8,%,34.1,44.9
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.5,g/dL,11.2,15.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.88,x10E3/µL,1.18,3.74
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.53,x10E3/µL,1.56,6.13
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,250,x10E3/µL,163,369
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.0,x10E3/µL,4,10
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.0,µIU/mL,0.5,6
104-0023,058,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,SCREENING,-26,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,SCREENING,-26,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,SCREENING,-26,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.6,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,SCREENING,-26,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Alanine Transferase (SGPT),28,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Alkaline Phosphatase,56,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Aspartate Transferase (SGOT),24,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,BUN,25,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,LDH,126,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Lipase,71,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Potassium,4.35,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Sodium,135,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Chemistry,Urea,,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,Hematocrit,38.9,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,Hemoglobin,12.7,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,Lymphocytes abs,0.95,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,Neutrophils abs,4.94,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,Platelet,175,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Hematology,WBC,6.9,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.0,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,11,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Alanine Transferase (SGPT),15,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Alkaline Phosphatase,49,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,BUN,26,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Creatinine,1.0,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,LDH,113,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Lipase,27,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Potassium,3.94,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Sodium,135,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Chemistry,Urea,,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Hematocrit,40.2,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Hemoglobin,13.3,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Lymphocytes abs,1.19,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Neutrophils abs,5.46,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,Platelet,252,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Hematology,WBC,7.4,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.80,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,25,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Alanine Transferase (SGPT),16,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Alkaline Phosphatase,45,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,BUN,21,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Direct Bilirubin,0.09,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,LDH,128,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Lipase,15,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Potassium,3.76,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Sodium,136,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Total Bilirubin,0.50,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Chemistry,Urea,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Hematocrit,38.7,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Hemoglobin,12.8,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Lymphocytes abs,1.00,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Neutrophils abs,4.95,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,Platelet,189,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Hematology,WBC,6.6,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Thyroxine (FT4),1.9,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.23,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,45,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Alanine Transferase (SGPT),23,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Alkaline Phosphatase,60,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Aspartate Transferase (SGOT),20,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,BUN,15,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Direct Bilirubin,0.11,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,LDH,150,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Lipase,22,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Potassium,3.93,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Sodium,135,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Total Bilirubin,0.60,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Chemistry,Urea,,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,Hematocrit,43.1,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,Hemoglobin,14.0,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,Lymphocytes abs,0.98,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,Neutrophils abs,6.89,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,Platelet,211,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Hematology,WBC,8.8,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.96,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,75,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Alkaline Phosphatase,51,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,BUN,21,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,LDH,141,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Lipase,11,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Magnesium,2.0,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Potassium,4.03,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Sodium,135,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Chemistry,Urea,,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,Hematocrit,40,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,Hemoglobin,13.1,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,Lymphocytes abs,0.95,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,Neutrophils abs,5.78,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,Platelet,214,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Hematology,WBC,7.6,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.30,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,88,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Alkaline Phosphatase,48,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,BUN,24,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Direct Bilirubin,0.12,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,LDH,170,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Lipase,11,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Potassium,4.08,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Sodium,133,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Chemistry,Urea,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,Hematocrit,39.6,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,Hemoglobin,12.9,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,Lymphocytes abs,0.98,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,Neutrophils abs,6.4,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,Platelet,216,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Hematology,WBC,8.3,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,109,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Alanine Transferase (SGPT),34,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Alkaline Phosphatase,69,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Aspartate Transferase (SGOT),31,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,BUN,20,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Creatinine,1.1,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,LDH,168,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Lipase,ND,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Magnesium,2,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Potassium,4.16,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Sodium,135,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Total Bilirubin,0.5,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Chemistry,Urea,ND,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,Hematocrit,40,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,Hemoglobin,13.1,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,Lymphocytes abs,0.73,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,Neutrophils abs,6.79,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,Platelet,192,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Hematology,WBC,8.7,x10E3/µL,4,10
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Thyroid Function Testing,Free Thyroxine (FT4),1.6,ng/dL,0.8,1.7
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.4,µIU/mL,0.5,6
104-0024,078,CD8 HIGH,Nivolumab,END OF TREATMENT,131,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Alanine Transferase (SGPT),51,U/L,7,52
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Alkaline Phosphatase,164,U/L,34,104
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Aspartate Transferase (SGOT),65,U/L,13,39
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,BUN,17,mg/dL,7,25
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Creatinine,1.04,mg/dL,0.6,1.3
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Direct Bilirubin,NA,mg/dL,0.03,0.18
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Indirect Bilirubin,NA,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,LDH,NA,U/L,140,271
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Lipase,NA,U/L,11,82
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Magnesium,NA,mg/dL,1.9,2.7
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Potassium,3.9,mmol/L,3.5,5.1
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Sodium,133,mmol/L,136,145
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Total Bilirubin,0.4,mg/dL,0.3,1
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Chemistry,Urea,,,NA,NA
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,Hematocrit,34,%,40.1,51
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,Hemoglobin,10.9,g/dL,13.7,17.5
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,Lymphocytes abs,0.77,x10E3/µL,1.18,3.74
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,Neutrophils abs,4.45,x10E3/µL,1.56,6.13
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,Platelet,215,x10E3/µL,163,369
104-0024,078,CD8 HIGH,Nivolumab,90 DAY FOLLOW-UP,222,Hematology,WBC,7.23,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.4,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-15,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Alkaline Phosphatase,100,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,BUN,17,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,LDH,159,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Lipase,61,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Potassium,3.95,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Sodium,140,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Chemistry,Urea,,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hematocrit,38.1,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Hemoglobin,12.5,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Lymphocytes abs,1.06,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Neutrophils abs,5.03,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,Platelet,238,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Hematology,WBC,6.8,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.4,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,7,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,19,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,141,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,89,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.22,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,140,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,36,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,11.7,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.86,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.64,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,237,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.3,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),2.9,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.05,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alkaline Phosphatase,74,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,BUN,17,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Direct Bilirubin,0.03,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,LDH,156,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Lipase,124,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Magnesium,2.1,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Potassium,4.04,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Sodium,135,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hematocrit,36.3,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hemoglobin,11.5,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Lymphocytes abs,1.15,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Neutrophils abs,5.06,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Platelet,258,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,WBC,7,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),0.8,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),12.4,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Alkaline Phosphatase,82,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,BUN,16,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Direct Bilirubin,0.05,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,LDH,151,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Lipase,94,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Potassium,4,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Sodium,141,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Hematocrit,35.5,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Hemoglobin,11.3,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Lymphocytes abs,1.42,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Neutrophils abs,4.56,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Platelet,242,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,WBC,6.8,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),9.2,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alanine Transferase (SGPT),10,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alkaline Phosphatase,78,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,BUN,13.0,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Creatinine,0.8,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Direct Bilirubin,0.06,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,LDH,147,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Lipase,91.0,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Magnesium,2.3,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Potassium,3.85,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Sodium,138,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Total Bilirubin,0.40,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hematocrit,35.4,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hemoglobin,11.4,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Lymphocytes abs,1.22,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Neutrophils abs,4.58,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Platelet,258,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,WBC,6.6,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.0,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Alkaline Phosphatase,76,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Aspartate Transferase (SGOT),16,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,BUN,20.0,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Direct Bilirubin,0.04,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,LDH,140.0,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Lipase,176.0,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Potassium,4.05,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Sodium,140,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Hematocrit,35.1,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Hemoglobin,11.3,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Lymphocytes abs,1.05,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Neutrophils abs,4.58,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,Platelet,262,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Hematology,WBC,6.4,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.2,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,112,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Alkaline Phosphatase,86,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Aspartate Transferase (SGOT),17,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,BUN,18.0,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Direct Bilirubin,0.08,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,LDH,142.0,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Lipase,135.0,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Magnesium,2.2,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Potassium,3.75,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Sodium,139,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Total Bilirubin,0.30,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Hematocrit,36.5,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Hemoglobin,11.5,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Lymphocytes abs,1.26,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Neutrophils abs,3.92,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,Platelet,271,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Hematology,WBC,5.9,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.9,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,134,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Alkaline Phosphatase,106,U/L,34,104
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,BUN,17,mg/dL,7,25
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Creatinine,0.9,mg/dL,0.6,1.3
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Direct Bilirubin,0.07,mg/dL,0.03,0.18
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,LDH,144,U/L,140,271
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Lipase,56,U/L,11,82
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Magnesium,2.4,mg/dL,1.9,2.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Potassium,4.4,mmol/L,3.5,5.1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Sodium,138,mmol/L,136,145
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Chemistry,Urea,ND,,NA,NA
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Hematocrit,37.2,%,40.1,51
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Hemoglobin,11.8,g/dL,13.7,17.5
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Lymphocytes abs,0.99,x10E3/µL,1.18,3.74
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Neutrophils abs,4.33,x10E3/µL,1.56,6.13
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,Platelet,283,x10E3/µL,163,369
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Hematology,WBC,5.9,x10E3/µL,4,10
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.7,µIU/mL,0.5,6
104-0025,059,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,162,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-35,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-35,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-35,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.4,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-35,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Alkaline Phosphatase,85,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,BUN,22,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Creatinine,1.33,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Direct Bilirubin,<0.2,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,LDH,254,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Lipase,18,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Potassium,4.9,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Sodium,139,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Urea,,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Hematocrit,35.5,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Hemoglobin,11.9,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Lymphocytes abs,1.61,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Neutrophils abs,8.62,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Platelet,225,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,WBC,11.2,x10E3/µL,4,10
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.94,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Alkaline Phosphatase,95,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Aspartate Transferase (SGOT),13,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,BUN,20,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Creatinine,1.26,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Direct Bilirubin,<0.2,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,LDH,227,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Lipase,26,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Magnesium,1.8,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Sodium,142,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Chemistry,Urea,,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,Hematocrit,34.6,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,Hemoglobin,11.2,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,Lymphocytes abs,1.58,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,Neutrophils abs,7.41,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,Platelet,244,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Hematology,WBC,9.71,x10E3/µL,4,10
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.3,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,25,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Alanine Transferase (SGPT),13,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Alkaline Phosphatase,111,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Aspartate Transferase (SGOT),14,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,BUN,25,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Creatinine,1.31,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,LDH,243,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Lipase,26,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Potassium,5.3,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Sodium,139,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Chemistry,Urea,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,Hematocrit,34.5,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,Hemoglobin,11.2,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,Lymphocytes abs,1.95,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,Neutrophils abs,10.07,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,Platelet,278,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Hematology,WBC,13.2,x10E3/µL,4,10
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.6,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,46,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Alanine Transferase (SGPT),11,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Alkaline Phosphatase,109,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Aspartate Transferase (SGOT),15,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,BUN,19,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Creatinine,1.28,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,LDH,219,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Lipase,24,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Magnesium,1.7,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Sodium,139,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Total Bilirubin,0.2,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Chemistry,Urea,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Hematocrit,35.5,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Hemoglobin,11.5,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Lymphocytes abs,1.72,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Neutrophils abs,7.04,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,Platelet,257,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Hematology,WBC,9.53,x10E3/µL,4,10
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.5,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,68,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Alanine Transferase (SGPT),17,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Alkaline Phosphatase,177,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Aspartate Transferase (SGOT),18,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,BUN,16,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Direct Bilirubin,0.2,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,LDH,280,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Lipase,24,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Magnesium,1.6,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Potassium,4.5,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Sodium,139,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Total Bilirubin,0.3,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Chemistry,Urea,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Hematocrit,36.2,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Hemoglobin,11.9,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Lymphocytes abs,1.39,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Neutrophils abs,8.97,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,Platelet,183,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Hematology,WBC,11.66,x10E3/µL,4,10
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.8,1.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,pg/dL,222,383
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.44,µIU/mL,0.5,6
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,88,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,85,185
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Alanine Transferase (SGPT),12,U/L,7,52
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Alkaline Phosphatase,107,U/L,34,104
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Aspartate Transferase (SGOT),23,U/L,13,39
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,BUN,8.0,mg/dL,7,25
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Creatinine,1.2,mg/dL,0.6,1.3
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Direct Bilirubin,0.19,mg/dL,0.03,0.18
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Indirect Bilirubin,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,LDH,308.0,U/L,140,271
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Lipase,40.0,U/L,11,82
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Magnesium,1.9,mg/dL,1.9,2.7
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Potassium,4.37,mmol/L,3.5,5.1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Sodium,136,mmol/L,136,145
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Total Bilirubin,0.70,mg/dL,0.3,1
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Chemistry,Urea,ND,,NA,NA
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,Hematocrit,31.5,%,40.1,51
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,Hemoglobin,10.7,g/dL,13.7,17.5
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,Lymphocytes abs,2.70,x10E3/µL,1.18,3.74
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,Neutrophils abs,5.06,x10E3/µL,1.56,6.13
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,Platelet,273,x10E3/µL,163,369
104-0026,060,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,120,Hematology,WBC,8.7,x10E3/µL,4,10
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),30,U/L,10,50
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,141,U/L,40,130
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),28,U/L,10,35
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,BUN,11,mg/dL,5,25
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Creatinine,1.05,mg/dL,0.5,1.2
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Indirect Bilirubin,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,LDH,479,U/L,0,339
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Lipase,ND,U/L,13,60
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Potassium,4.5,mmol/L,3.5,5.5
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Sodium,139,mmol/L,135,145
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Urea,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hematocrit,40.9,%,40,52
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hemoglobin,13.3,g/dL,13.5,17.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Lymphocytes abs,1.08,K/ul,1,3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Neutrophils abs,5.02,K/ul,1.7,6.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Platelet,215,K/ul,150,400
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,WBC,6.6,K/ul,4,11
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Thyroxine (FT4),,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Thyroid Function Testing,Triidothyronine (T3),,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),43,U/L,10,50
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,244,U/L,40,130
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),29,U/L,10,35
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,14,mg/dL,5,25
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.14,mg/dL,0.5,1.2
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.21,mg/dL,0,0.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,466,U/L,0,339
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.3,mg/dL,1.8,2.4
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,5.3,mmol/L,3.5,5.5
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,133,mmol/L,135,145
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.9,mg/dL,0,1.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,14,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,45.4,%,40,52
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,14.6,g/dL,13.5,17.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.96,K/ul,1,3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,6.22,K/ul,1.7,6.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,224,K/ul,150,400
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,8.0,K/ul,4,11
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),21,U/L,10,50
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,159,U/L,40,130
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),23,U/L,10,35
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,15,mg/dL,5,25
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.99,mg/dL,0.5,1.2
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,419,U/L,0,339
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,ND,U/L,13,60
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,5.8,mmol/L,3.5,5.5
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mmol/L,135,145
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,41.2,%,40,52
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.0,g/dL,13.5,17.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.36,K/ul,1,3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,5.77,K/ul,1.7,6.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,310,K/ul,150,400
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,8.0,K/ul,4,11
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),45,U/L,10,50
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,226,U/L,40,130
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),39,U/L,10,35
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,10,mg/dL,5,25
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.23,mg/dL,0.5,1.2
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,525,U/L,0,339
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,ND,U/L,13,60
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,5.1,mmol/L,3.5,5.5
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,134,mmol/L,135,145
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,41.0,%,40,52
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,13.2,g/dL,13.5,17.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.25,K/ul,1,3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,4.28,K/ul,1.7,6.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,207,K/ul,150,400
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,6.5,K/ul,4,11
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Alanine Transferase (SGPT),62,U/L,10,50
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Alkaline Phosphatase,377,U/L,40,130
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Aspartate Transferase (SGOT),39,U/L,10,35
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,BUN,14,mg/dL,5,25
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Creatinine,1.13,mg/dL,0.5,1.2
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Indirect Bilirubin,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,LDH,449,U/L,0,339
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Lipase,ND,U/L,13,60
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Potassium,5.0,mmol/L,3.5,5.5
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Sodium,137,mmol/L,135,145
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Chemistry,Urea,,,NA,NA
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Hematocrit,42.4,%,40,52
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Hemoglobin,13.8,g/dL,13.5,17.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Lymphocytes abs,1.56,K/ul,1,3
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Neutrophils abs,6.41,K/ul,1.7,6.7
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,Platelet,271,K/ul,150,400
106-0001,061,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,65,Hematology,WBC,9.1,K/ul,4,11
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,87,U/L,40,130
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),33,U/L,10,35
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,BUN,12,mg/dL,5,25
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Creatinine,0.69,mg/dL,0.5,1.2
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Indirect Bilirubin,ND,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,LDH,273,U/L,0,339
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Lipase,ND,U/L,13,60
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Magnesium,2.3,mg/dL,1.8,2.4
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Potassium,4.6,mmol/L,3.5,5.5
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Sodium,139,mmol/L,135,145
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Urea,,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hematocrit,40.8,%,40,52
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hemoglobin,12.9,g/dL,13.5,17.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Lymphocytes abs,1.09,K/ul,1,3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Neutrophils abs,4.92,K/ul,1.7,6.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Platelet,357,K/ul,150,400
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,WBC,7.2,K/ul,4,11
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),30,U/L,10,50
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,103,U/L,40,130
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),38,U/L,10,35
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,10,mg/dL,5,25
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.52,mg/dL,0.5,1.2
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,ND,U/L,0,339
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,ND,mg/dL,1.8,2.4
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.5,mmol/L,3.5,5.5
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,135,mmol/L,135,145
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.6,%,40,52
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,11.8,g/dL,13.5,17.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.57,K/ul,1,3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.91,K/ul,1.7,6.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,306,K/ul,150,400
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.9,K/ul,4,11
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),19,U/L,10,50
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,85,U/L,40,130
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),60,U/L,10,35
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,8,mg/dL,5,25
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.60,mg/dL,0.5,1.2
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,276,U/L,0,339
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,ND,U/L,13,60
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.4,mmol/L,3.5,5.5
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,138,mmol/L,135,145
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,40.5,%,40,52
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,12.6,g/dL,13.5,17.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,0.98,K/ul,1,3
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,5.86,K/ul,1.7,6.7
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,348,K/ul,150,400
106-0002,062,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,8.2,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alanine Transferase (SGPT),22,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Alkaline Phosphatase,175,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Aspartate Transferase (SGOT),43,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,BUN,9,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Creatinine,0.51,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,LDH,478,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Potassium,3.3,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Sodium,137,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hematocrit,32.8,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Hemoglobin,9.6,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Lymphocytes abs,1.61,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Neutrophils abs,6.05,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,Platelet,348,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-20,Hematology,WBC,8.6,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),26,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,264,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),43,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,8,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.54,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,483,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.1,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,135,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,8,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31.5,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.4,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.25,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,6.76,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,352,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,9.1,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),24,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,315,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),38,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,8,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.47,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,368,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.0,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,8,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,29.7,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,8.7,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.10,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,5.81,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,430,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,8.0,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),20,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,176,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),31,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,12,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.52,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,263,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,1.8,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.1,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,136,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,32.7,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,9.6,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.62,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,6.4,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,446,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,9.1,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),17,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,117,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),29,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,9,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.52,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,202,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,3.2,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,138,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,33.0,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,9.7,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.26,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,6.70,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,379,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,8.8,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),17,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,120,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),20,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,11,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.55,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,211,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.8,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,3.5,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,138,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,35.5,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,10.2,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.38,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,7.14,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,369,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,9.5,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),17,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,121,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),26,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,13,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.55,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,211,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,3.8,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,139,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,35.3,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,10.6,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.29,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,4.63,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,327,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,6.7,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,114,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),23,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,10,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,0.55,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,205,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,ND,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,3.3,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,139,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,36.3,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,10.9,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,1.41,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,5.29,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,290,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,7.8,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alkaline Phosphatase,117,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Aspartate Transferase (SGOT),21,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,BUN,11,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Creatinine,0.54,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,LDH,204,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Lipase,30,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Potassium,4.6,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Sodium,142,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hematocrit,37.2,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hemoglobin,11.5,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Lymphocytes abs,1.66,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Neutrophils abs,5.00,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Platelet,286,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,WBC,7.6,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Thyroxine (FT4),1.00,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.54,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Triidothyronine (T3),123,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alanine Transferase (SGPT),12,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Alkaline Phosphatase,114,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Aspartate Transferase (SGOT),21,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,BUN,13,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Creatinine,0.58,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,LDH,207,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Lipase,27,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Potassium,3.7,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Sodium,139,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hematocrit,39.5,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Hemoglobin,11.9,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Lymphocytes abs,1.72,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Neutrophils abs,5.32,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,Platelet,264,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Hematology,WBC,7.8,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Thyroxine (FT4),1.04,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.58,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,183,Thyroid Function Testing,Triidothyronine (T3),127,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Alanine Transferase (SGPT),17,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Alkaline Phosphatase,130,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Aspartate Transferase (SGOT),25,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,BUN,14,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Creatinine,0.58,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,LDH,197,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Lipase,28,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Potassium,4.1,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Sodium,138,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Hematocrit,39.0,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Hemoglobin,11.7,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Lymphocytes abs,1.55,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Neutrophils abs,5.47,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Platelet,272,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,WBC,8.0,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.11,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Triidothyronine (T3),125,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Alkaline Phosphatase,115,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Aspartate Transferase (SGOT),22,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,BUN,9,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Creatinine,0.59,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,LDH,192,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Lipase,25,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Potassium,3.9,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Sodium,136,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,Hematocrit,37.9,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,Hemoglobin,11.4,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,Lymphocytes abs,1.71,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,Neutrophils abs,5.57,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,Platelet,275,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Hematology,WBC,8.4,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.44,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,245,Thyroid Function Testing,Triidothyronine (T3),130,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Alkaline Phosphatase,123,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Aspartate Transferase (SGOT),27,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,BUN,10,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Creatinine,0.53,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,LDH,232,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Lipase,31,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Potassium,3.7,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Sodium,138,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,Hematocrit,36.9,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,Hemoglobin,11.2,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,Lymphocytes abs,1.52,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,Neutrophils abs,6.22,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,Platelet,310,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Hematology,WBC,8.6,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.54,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,274,Thyroid Function Testing,Triidothyronine (T3),132,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Alanine Transferase (SGPT),11,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Alkaline Phosphatase,119,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Aspartate Transferase (SGOT),23,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,BUN,10,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Creatinine,0.59,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,LDH,251,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Lipase,38,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Potassium,3.3,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Sodium,135,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,Hematocrit,37.5,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,Hemoglobin,11.5,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,Lymphocytes abs,1.45,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,Neutrophils abs,6.66,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,Platelet,323,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Hematology,WBC,9.2,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Thyroid Function Testing,Free Triiodothyronine (FT3),3.2,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.30,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,302,Thyroid Function Testing,Triidothyronine (T3),122,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Alanine Transferase (SGPT),13,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Alkaline Phosphatase,102,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Aspartate Transferase (SGOT),27,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,BUN,10,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Creatinine,0.62,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,LDH,217,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Lipase,153,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Potassium,3.5,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Sodium,132,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,Hematocrit,35.2,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,Hemoglobin,10.9,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,Lymphocytes abs,1.00,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,Neutrophils abs,7.59,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,Platelet,363,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Hematology,WBC,9.5,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Thyroid Function Testing,Free Thyroxine (FT4),0.97,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.12,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,330,Thyroid Function Testing,Triidothyronine (T3),94,ng/dL,80,200
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Alkaline Phosphatase,106,U/L,40,130
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Aspartate Transferase (SGOT),27,U/L,10,35
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,BUN,9,mg/dL,5,25
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Creatinine,0.65,mg/dL,0.5,1.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Indirect Bilirubin,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,LDH,262,U/L,0,339
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Lipase,65,U/L,13,60
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Potassium,3.8,mmol/L,3.5,5.5
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Sodium,138,mmol/L,135,145
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Total Bilirubin,0.8,mg/dL,0,1.3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Chemistry,Urea,,,NA,NA
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,Hematocrit,34.8,%,40,52
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,Hemoglobin,10.4,g/dL,13.5,17.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,Lymphocytes abs,0.84,K/ul,1,3
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,Neutrophils abs,6.85,K/ul,1.7,6.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,Platelet,358,K/ul,150,400
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Hematology,WBC,8.9,K/ul,4,11
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.39,µIU/mL,0.27,4.2
106-0003,063,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,366,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,80,200
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alanine Transferase (SGPT),13,U/L,10,50
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Alkaline Phosphatase,65,U/L,40,130
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Aspartate Transferase (SGOT),20,U/L,10,35
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,BUN,11,mg/dL,5,25
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Creatinine,0.78,mg/dL,0.5,1.2
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Indirect Bilirubin,,,NA,NA
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,LDH,308,U/L,0,339
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Lipase,ND,U/L,13,60
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Magnesium,2.4,mg/dL,1.8,2.4
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Potassium,4.2,mmol/L,3.5,5.5
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Sodium,138,mmol/L,135,145
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Chemistry,Urea,,,NA,NA
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hematocrit,37.5,%,40,52
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Hemoglobin,11.5,g/dL,13.5,17.7
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Lymphocytes abs,0.7,K/ul,1,3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Neutrophils abs,6.33,K/ul,1.7,6.7
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,Platelet,386,K/ul,150,400
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-21,Hematology,WBC,7.8,K/ul,4,11
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),19,U/L,10,50
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,102,U/L,40,130
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),33,U/L,10,35
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,10,mg/dL,5,25
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.73,mg/dL,0.5,1.2
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.25,mg/dL,0,0.3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,409,U/L,0,339
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.4,mg/dL,1.8,2.4
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.1,mmol/L,3.5,5.5
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,134,mmol/L,135,145
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.3,%,40,52
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.6,g/dL,13.5,17.7
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.84,K/ul,1,3
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,5.54,K/ul,1.7,6.7
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,297,K/ul,150,400
106-0005,064,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,7.3,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Alanine Transferase (SGPT),40,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Alkaline Phosphatase,73,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Aspartate Transferase (SGOT),27,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Creatinine,0.60,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,LDH,151,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Potassium,4.4,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Sodium,136,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,Hematocrit,36.6,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,Hemoglobin,11.5,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,Lymphocytes abs,1.84,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,Neutrophils abs,2.94,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,Platelet,239,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-26,Hematology,WBC,5.5,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),23,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,66,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),20,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.70,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,139,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,140,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,34.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,10.9,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.32,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,2.05,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,192,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,3.9,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),22,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,69,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),24,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.70,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,174,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.6,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,139,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,37.1,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,12.0,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.82,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,2.00,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,209,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,4.5,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),18,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,60,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),17,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,5,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,0.73,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,163,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.3,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,140,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,37.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,12.1,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.32,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,3.24,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,207,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,5.3,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alanine Transferase (SGPT),18,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Alkaline Phosphatase,67,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Aspartate Transferase (SGOT),21,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,BUN,9,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Creatinine,0.68,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Direct Bilirubin,<0.2,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,LDH,166,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Potassium,4.4,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Sodium,138,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hematocrit,37.8,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Hemoglobin,11.9,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Lymphocytes abs,1.47,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Neutrophils abs,4.85,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,Platelet,215,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Hematology,WBC,7.4,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Free Triiodothyronine (FT3),,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,85,Thyroid Function Testing,Triidothyronine (T3),,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alanine Transferase (SGPT),19,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Alkaline Phosphatase,63,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Aspartate Transferase (SGOT),18,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,BUN,5,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Creatinine,0.69,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,LDH,175,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Lipase,ND,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Potassium,4.3,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Sodium,138,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hematocrit,37.3,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Hemoglobin,11.9,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Lymphocytes abs,1.65,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Neutrophils abs,2.24,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,Platelet,189,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,106,Hematology,WBC,4.6,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alanine Transferase (SGPT),15,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Alkaline Phosphatase,66,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Aspartate Transferase (SGOT),20,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Creatinine,0.70,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,LDH,143,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Lipase,17,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Potassium,4.1,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Sodium,139,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hematocrit,38.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Hemoglobin,12.0,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Lymphocytes abs,1.47,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Neutrophils abs,4.33,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,Platelet,198,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Hematology,WBC,6.7,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.53,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,127,Thyroid Function Testing,Triidothyronine (T3),103,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alanine Transferase (SGPT),16,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Alkaline Phosphatase,71,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Aspartate Transferase (SGOT),22,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,BUN,4,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Creatinine,0.64,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,LDH,164,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Lipase,14,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Potassium,4.2,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Sodium,139,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Total Bilirubin,0.7,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hematocrit,35.8,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Hemoglobin,11.6,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Lymphocytes abs,1.41,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Neutrophils abs,4.37,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,Platelet,189,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Hematology,WBC,6.6,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.25,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,155,Thyroid Function Testing,Triidothyronine (T3),111,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Alanine Transferase (SGPT),14,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Alkaline Phosphatase,71,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Aspartate Transferase (SGOT),22,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,BUN,8,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Creatinine,0.66,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,LDH,178,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Lipase,19,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Sodium,138,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Hematocrit,36.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Hemoglobin,11.4,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Lymphocytes abs,1.78,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Neutrophils abs,3.86,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,Platelet,213,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Hematology,WBC,6.8,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Free Thyroxine (FT4),1.09,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.77,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,190,Thyroid Function Testing,Triidothyronine (T3),122,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Alanine Transferase (SGPT),19,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Alkaline Phosphatase,63,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Aspartate Transferase (SGOT),18,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Creatinine,0.69,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,LDH,142,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Lipase,17,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Sodium,136,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Hematocrit,35.7,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Hemoglobin,11.2,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Lymphocytes abs,1.64,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Neutrophils abs,3.81,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,Platelet,197,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Hematology,WBC,6.2,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Free Thyroxine (FT4),1.10,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Free Triiodothyronine (FT3),3.1,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.41,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,217,Thyroid Function Testing,Triidothyronine (T3),122,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Alanine Transferase (SGPT),20,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Alkaline Phosphatase,67,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Aspartate Transferase (SGOT),22,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,BUN,5,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Creatinine,0.63,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,LDH,145,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Lipase,20,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Sodium,138,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Total Bilirubin,0.6,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Hematocrit,37.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Hemoglobin,11.3,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Lymphocytes abs,2.20,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Neutrophils abs,2.62,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,Platelet,197,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Hematology,WBC,5.7,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Free Triiodothyronine (FT3),3.3,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.79,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,246,Thyroid Function Testing,Triidothyronine (T3),115,ng/dL,80,200
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Alanine Transferase (SGPT),18,U/L,10,50
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Alkaline Phosphatase,59,U/L,40,130
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Aspartate Transferase (SGOT),20,U/L,10,35
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,BUN,6,mg/dL,5,25
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Creatinine,0.65,mg/dL,0.5,1.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Indirect Bilirubin,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,LDH,151,U/L,0,339
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Lipase,18,U/L,13,60
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Potassium,4.3,mmol/L,3.5,5.5
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Sodium,139,mmol/L,135,145
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Chemistry,Urea,,,NA,NA
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,Hematocrit,36.0,%,40,52
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,Hemoglobin,11.0,g/dL,13.5,17.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,Lymphocytes abs,1.47,K/ul,1,3
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,Neutrophils abs,2.48,K/ul,1.7,6.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,Platelet,190,K/ul,150,400
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Hematology,WBC,4.8,K/ul,4,11
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Thyroid Function Testing,Free Thyroxine (FT4),1.06,ng/dL,0.93,1.7
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.11,µIU/mL,0.27,4.2
106-0006,065,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,274,Thyroid Function Testing,Triidothyronine (T3),97,ng/dL,80,200
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Alanine Transferase (SGPT),23,U/L,10,50
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Alkaline Phosphatase,86,U/L,40,130
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Aspartate Transferase (SGOT),23,U/L,10,35
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,BUN,17,mg/dL,5,25
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Creatinine,1.06,mg/dL,0.5,1.2
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Direct Bilirubin,,mg/dL,0,0.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Indirect Bilirubin,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,LDH,291,U/L,0,339
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Lipase,ND,U/L,13,60
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Magnesium,2.4,mg/dL,1.8,2.4
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Potassium,4.2,mmol/L,3.5,5.5
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Sodium,139,mmol/L,135,145
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Chemistry,Urea,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Hematocrit,36.4,%,40,52
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Hemoglobin,10.1,g/dL,13.5,17.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Lymphocytes abs,1.52,K/ul,1,3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Neutrophils abs,5.33,K/ul,1.7,6.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,Platelet,150,K/ul,150,400
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Hematology,WBC,7.8,K/ul,4,11
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),11,U/L,10,50
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,76,U/L,40,130
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),23,U/L,10,35
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,13,mg/dL,5,25
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.12,mg/dL,0.5,1.2
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,266,U/L,0,339
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,13,60
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,3.8,mmol/L,3.5,5.5
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mmol/L,135,145
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,35.3,%,40,52
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,10.3,g/dL,13.5,17.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.13,K/ul,1,3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,5.49,K/ul,1.7,6.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,149,K/ul,150,400
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,7.3,K/ul,4,11
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),18,U/L,10,50
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,74,U/L,40,130
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),25,U/L,10,35
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,17,mg/dL,5,25
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,1.15,mg/dL,0.5,1.2
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,259,U/L,0,339
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,ND,U/L,13,60
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,3.7,mmol/L,3.5,5.5
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,139,mmol/L,135,145
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,34,%,40,52
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,9.9,g/dL,13.5,17.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.62,K/ul,1,3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.52,K/ul,1.7,6.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,171,K/ul,150,400
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,6.1,K/ul,4,11
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),16,U/L,10,50
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,67,U/L,40,130
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),22,U/L,10,35
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,14,mg/dL,5,25
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,1.19,mg/dL,0.5,1.2
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,286,U/L,0,339
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,ND,U/L,13,60
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,3.9,mmol/L,3.5,5.5
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,140,mmol/L,135,145
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,35.5,%,40,52
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,10.1,g/dL,13.5,17.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.64,K/ul,1,3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,4.16,K/ul,1.7,6.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,161,K/ul,150,400
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,8.2,K/ul,4,11
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hematocrit,35.9,%,40,52
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Hemoglobin,10.6,g/dL,13.5,17.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Lymphocytes abs,1.75,K/ul,1,3
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Neutrophils abs,4.85,K/ul,1.7,6.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,Platelet,192,K/ul,150,400
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Hematology,WBC,8.5,K/ul,4,11
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.93,1.7
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Free Triiodothyronine (FT3),,pg/mL,2,4.4
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,µIU/mL,0.27,4.2
106-0008,066,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,64,Thyroid Function Testing,Triidothyronine (T3),,ng/dL,80,200
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Alanine Transferase (SGPT),19,U/L,10,35
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Alkaline Phosphatase,108,U/L,40,130
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Aspartate Transferase (SGOT),24,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,BUN,8,mg/dL,5,25
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Creatinine,0.88,mg/dL,0.4,1
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Indirect Bilirubin,,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,LDH,251,U/L,0,339
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Lipase,16,U/L,13,60
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Potassium,4.4,mmol/L,3.5,5.5
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Sodium,137,mmol/L,135,145
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Urea,,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Hematocrit,38.6,%,35,47
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Hemoglobin,11.7,g/dL,11.7,15.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Lymphocytes abs,1.41,K/ul,1,3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Neutrophils abs,4.41,K/ul,1.7,6.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Platelet,374,K/ul,150,400
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,WBC,6.7,K/ul,4,11
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Free Thyroxine (FT4),1.24,ng/dL,0.93,1.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Free Triiodothyronine (FT3),3.6,pg/mL,2,4.4
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.78,µIU/mL,0.27,4.2
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Triidothyronine (T3),145,ng/dL,80,200
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Alanine Transferase (SGPT),19,U/L,10,35
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Alkaline Phosphatase,108,U/L,40,130
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Aspartate Transferase (SGOT),18,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,BUN,13,mg/dL,5,25
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Creatinine,0.86,mg/dL,0.4,1
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Indirect Bilirubin,,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,LDH,225,U/L,0,339
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Lipase,29,U/L,13,60
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Potassium,3.6,mmol/L,3.5,5.5
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Sodium,141,mmol/L,135,145
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Chemistry,Urea,,,NA,NA
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,Hematocrit,35.2,%,35,47
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,Hemoglobin,10.4,g/dL,11.7,15.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,Lymphocytes abs,2.18,K/ul,1,3
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,Neutrophils abs,4.40,K/ul,1.7,6.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,Platelet,478,K/ul,150,400
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Hematology,WBC,7.8,K/ul,4,11
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Thyroid Function Testing,Free Thyroxine (FT4),1.29,ng/dL,0.93,1.7
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Thyroid Function Testing,Free Triiodothyronine (FT3),3.5,pg/mL,2,4.4
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.69,µIU/mL,0.27,4.2
106-0009,067,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,29,Thyroid Function Testing,Triidothyronine (T3),133,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Alanine Transferase (SGPT),11,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Alkaline Phosphatase,101,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Aspartate Transferase (SGOT),19,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,BUN,11,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Creatinine,0.60,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,LDH,365,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Lipase,25,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Magnesium,1.8,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Potassium,4.3,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Sodium,130,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Hematocrit,31.5,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Hemoglobin,9.9,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Lymphocytes abs,0.50,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Neutrophils abs,3.26,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,Platelet,210,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Hematology,WBC,4.3,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Free Thyroxine (FT4),1.15,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.72,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-12,Thyroid Function Testing,Triidothyronine (T3),102,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),13,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,97,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),26,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,10,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.67,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,374,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,20,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,1.8,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,131,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,31.0,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.8,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.35,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,1.86,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,144,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,2.5,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.21,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.18,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),87,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Free Thyroxine (FT4),1.08,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.18,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,36,Thyroid Function Testing,Triidothyronine (T3),96,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Alanine Transferase (SGPT),9,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Alkaline Phosphatase,93,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Aspartate Transferase (SGOT),19,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,BUN,10,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Creatinine,0.67,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,LDH,217,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Lipase,24,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Magnesium,2.0,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Potassium,3.4,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Sodium,134,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,Hematocrit,31.9,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,Hemoglobin,9.9,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,Lymphocytes abs,0.62,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,Neutrophils abs,2.06,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,Platelet,249,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Hematology,WBC,3.4,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Thyroid Function Testing,Free Thyroxine (FT4),1.07,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Thyroid Function Testing,Free Triiodothyronine (FT3),2.5,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.39,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,57,Thyroid Function Testing,Triidothyronine (T3),98,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alanine Transferase (SGPT),11,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Alkaline Phosphatase,84,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Aspartate Transferase (SGOT),22,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,BUN,14,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Creatinine,0.70,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,LDH,232,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Lipase,33,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Potassium,3.8,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Sodium,134,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hematocrit,32.0,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Hemoglobin,10.2,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Lymphocytes abs,0.61,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Neutrophils abs,1.73,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,Platelet,217,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Hematology,WBC,2.9,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Thyroxine (FT4),1.05,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Free Triiodothyronine (FT3),2.7,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.64,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,77,Thyroid Function Testing,Triidothyronine (T3),102,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Alanine Transferase (SGPT),13,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Alkaline Phosphatase,90,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Aspartate Transferase (SGOT),23,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,BUN,10,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Creatinine,0.61,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,LDH,191,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Lipase,33,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Magnesium,1.8,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Sodium,135,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,Hematocrit,31.6,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,Hemoglobin,9.8,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,Lymphocytes abs,0.74,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,Neutrophils abs,2.20,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,Platelet,217,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Hematology,WBC,3.5,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Thyroid Function Testing,Free Thyroxine (FT4),1.01,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.57,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,99,Thyroid Function Testing,Triidothyronine (T3),97,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Alanine Transferase (SGPT),18,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Alkaline Phosphatase,93,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Aspartate Transferase (SGOT),24,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,BUN,8,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Creatinine,0.65,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,LDH,211,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Lipase,33,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Potassium,3.8,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Sodium,137,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Total Bilirubin,0.4,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,Hematocrit,34.4,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,Hemoglobin,10.8,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,Lymphocytes abs,0.57,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,Neutrophils abs,1.69,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,Platelet,190,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Hematology,WBC,2.7,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Thyroid Function Testing,Free Thyroxine (FT4),1.28,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.20,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,121,Thyroid Function Testing,Triidothyronine (T3),98,ng/dL,80,200
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Alanine Transferase (SGPT),14,U/L,10,35
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Alkaline Phosphatase,100,U/L,40,130
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Aspartate Transferase (SGOT),23,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,BUN,10,mg/dL,5,25
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Creatinine,0.61,mg/dL,0.4,1
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Indirect Bilirubin,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,LDH,200,U/L,0,339
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Lipase,27,U/L,13,60
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Magnesium,1.9,mg/dL,1.8,2.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Potassium,4.0,mmol/L,3.5,5.5
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Sodium,136,mmol/L,135,145
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Total Bilirubin,0.3,mg/dL,0,1.3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Chemistry,Urea,,,NA,NA
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,Hematocrit,32.5,%,35,47
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,Hemoglobin,10.5,g/dL,11.7,15.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,Lymphocytes abs,0.70,K/ul,1,3
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,Neutrophils abs,1.85,K/ul,1.7,6.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,Platelet,214,K/ul,150,400
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Hematology,WBC,3.1,K/ul,4,11
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Thyroid Function Testing,Free Thyroxine (FT4),1.00,ng/dL,0.93,1.7
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Thyroid Function Testing,Free Triiodothyronine (FT3),2.8,pg/mL,2,4.4
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.02,µIU/mL,0.27,4.2
106-0010,068,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,142,Thyroid Function Testing,Triidothyronine (T3),104,ng/dL,80,200
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alanine Transferase (SGPT),41,U/L,10,35
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Alkaline Phosphatase,48,U/L,40,130
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Aspartate Transferase (SGOT),49,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,BUN,10,mg/dL,5,25
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Creatinine,1.20,mg/dL,0.4,1
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Indirect Bilirubin,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,LDH,201,U/L,0,339
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Lipase,32,U/L,13,60
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Magnesium,2.1,mg/dL,1.8,2.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Potassium,4.4,mmol/L,3.5,5.5
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Sodium,139,mmol/L,135,145
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Chemistry,Urea,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hematocrit,30.3,%,35,47
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Hemoglobin,9.4,g/dL,11.7,15.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Lymphocytes abs,1.57,K/ul,1,3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Neutrophils abs,4.33,K/ul,1.7,6.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,Platelet,313,K/ul,150,400
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Hematology,WBC,6.6,K/ul,4,11
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Thyroxine (FT4),1.13,ng/dL,0.93,1.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Free Triiodothyronine (FT3),2.3,pg/mL,2,4.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.79,µIU/mL,0.27,4.2
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-27,Thyroid Function Testing,Triidothyronine (T3),80,ng/dL,80,200
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),31,U/L,10,35
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,50,U/L,40,130
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),37,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,8,mg/dL,5,25
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.90,mg/dL,0.4,1
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,164,U/L,0,339
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,27,U/L,13,60
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.3,mmol/L,3.5,5.5
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,137,mmol/L,135,145
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,29.0,%,35,47
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,9.4,g/dL,11.7,15.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.91,K/ul,1,3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.60,K/ul,1.7,6.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,350,K/ul,150,400
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.3,K/ul,4,11
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),1.11,ng/dL,0.93,1.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),2.4,pg/mL,2,4.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.43,µIU/mL,0.27,4.2
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),84,ng/dL,80,200
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Alanine Transferase (SGPT),19,U/L,10,35
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Alkaline Phosphatase,45,U/L,40,130
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Aspartate Transferase (SGOT),33,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,BUN,10,mg/dL,5,25
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Creatinine,1.25,mg/dL,0.4,1
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Indirect Bilirubin,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,LDH,189,U/L,0,339
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Lipase,44,U/L,13,60
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Magnesium,2.2,mg/dL,1.8,2.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Potassium,4.7,mmol/L,3.5,5.5
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Sodium,135,mmol/L,135,145
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Total Bilirubin,0.2,mg/dL,0,1.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Chemistry,Urea,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,Hematocrit,32.4,%,35,47
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,Hemoglobin,10.1,g/dL,11.7,15.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,Lymphocytes abs,0.70,K/ul,1,3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,Neutrophils abs,6.53,K/ul,1.7,6.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,Platelet,440,K/ul,150,400
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Hematology,WBC,8.0,K/ul,4,11
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Thyroid Function Testing,Free Thyroxine (FT4),1.17,ng/dL,0.93,1.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Thyroid Function Testing,Free Triiodothyronine (FT3),2.0,pg/mL,2,4.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.77,µIU/mL,0.27,4.2
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,30,Thyroid Function Testing,Triidothyronine (T3),77,ng/dL,80,200
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Alanine Transferase (SGPT),32,U/L,10,35
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Alkaline Phosphatase,50,U/L,40,130
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Aspartate Transferase (SGOT),29,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,BUN,24,mg/dL,5,25
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Creatinine,0.94,mg/dL,0.4,1
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Direct Bilirubin,<0.20,mg/dL,0,0.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Indirect Bilirubin,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,LDH,218,U/L,0,339
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Lipase,70,U/L,13,60
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Magnesium,2.4,mg/dL,1.8,2.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Potassium,3.5,mmol/L,3.5,5.5
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Sodium,126,mmol/L,135,145
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Total Bilirubin,0.5,mg/dL,0,1.3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Chemistry,Urea,,,NA,NA
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,Hematocrit,33.9,%,35,47
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,Hemoglobin,11.1,g/dL,11.7,15.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,Lymphocytes abs,0.59,K/ul,1,3
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,Neutrophils abs,9.35,K/ul,1.7,6.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,Platelet,304,K/ul,150,400
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Hematology,WBC,10.7,K/ul,4,11
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Thyroid Function Testing,Free Thyroxine (FT4),218,ng/dL,0.93,1.7
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Thyroid Function Testing,Free Triiodothyronine (FT3),1.8,pg/mL,2,4.4
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.93,µIU/mL,0.27,4.2
106-0012,069,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,51,Thyroid Function Testing,Triidothyronine (T3),59,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.84,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-18,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Alanine Transferase (SGPT),21,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Alkaline Phosphatase,96,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Aspartate Transferase (SGOT),26,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,BUN,14,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Creatinine,1.08,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,LDH,225,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Lipase,ND,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Magnesium,ND,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Potassium,4.0,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Sodium,142,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Total Bilirubin,0.7,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,Hematocrit,42.6,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,Hemoglobin,14.5,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,Lymphocytes abs,4.45,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,Neutrophils abs,3.10,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,Platelet,120,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Hematology,WBC,8.03,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.48,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,9,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Alanine Transferase (SGPT),21,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Alkaline Phosphatase,97,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Aspartate Transferase (SGOT),23,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,BUN,21,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Creatinine,1.25,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Indirect Bilirubin,0.2,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,LDH,148,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Lipase,23,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Magnesium,1.8,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Potassium,4.0,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Total Bilirubin,0.3,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,Hematocrit,40.0,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,Hemoglobin,13.8,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,Lymphocytes abs,4.82,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,Neutrophils abs,3.18,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,Platelet,122,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Hematology,WBC,8.60,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Thyroid Function Testing,Free Thyroxine (FT4),0.5,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),21.34,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,31,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alanine Transferase (SGPT),23,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Alkaline Phosphatase,92,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Aspartate Transferase (SGOT),31,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,BUN,19,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Creatinine,0.98,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Indirect Bilirubin,0.4,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,LDH,190,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Lipase,46,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Potassium,4.1,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Sodium,139,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hematocrit,42.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Hemoglobin,14.3,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Lymphocytes abs,7.54,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Neutrophils abs,3.42,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,Platelet,123,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Hematology,WBC,11.14,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Thyroxine (FT4),0.9,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),63.80,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,50,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Alanine Transferase (SGPT),21,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Alkaline Phosphatase,84,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Aspartate Transferase (SGOT),23,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,BUN,15,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Creatinine,1.10,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Indirect Bilirubin,0.6,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,LDH,151,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Lipase,112,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Potassium,3.9,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Hematocrit,41.3,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Hemoglobin,14.0,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Lymphocytes abs,6.88,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Neutrophils abs,3.74,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,Platelet,107,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Hematology,WBC,11.10,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Free Thyroxine (FT4),1.1,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),26.08,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,71,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alanine Transferase (SGPT),22,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Alkaline Phosphatase,85,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Aspartate Transferase (SGOT),24,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,BUN,17,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Creatinine,1.09,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,LDH,155,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Lipase,15,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Potassium,4.2,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hematocrit,39.8,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Hemoglobin,13.9,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Lymphocytes abs,6.92,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Neutrophils abs,2.90,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,Platelet,129,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Hematology,WBC,10.29,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Thyroxine (FT4),1.1,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),29.97,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 5 DAY 1,92,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Alanine Transferase (SGPT),20,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Alkaline Phosphatase,87,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Aspartate Transferase (SGOT),26,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,BUN,19,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Creatinine,1.05,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,LDH,221,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Lipase,102,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Potassium,4.6,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Sodium,137,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Hematocrit,41.3,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Hemoglobin,13.8,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Lymphocytes abs,9.19,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Neutrophils abs,3.70,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,Platelet,128,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Hematology,WBC,13.50,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),10.67,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 6 DAY 1,113,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Alanine Transferase (SGPT),23,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Alkaline Phosphatase,94,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Aspartate Transferase (SGOT),28,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,BUN,13,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Creatinine,1.05,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,LDH,176,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Lipase,128,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Potassium,3.7,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Sodium,143,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Hematocrit,40.2,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Hemoglobin,13.7,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Lymphocytes abs,7.23,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Neutrophils abs,3.71,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,Platelet,113,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Hematology,WBC,11.52,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.4,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 1,140,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,Hematocrit,38.9,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,Hemoglobin,13.5,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,Lymphocytes abs,7.74,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,Neutrophils abs,1.71,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,Platelet,89,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,156,Hematology,WBC,9.99,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Alanine Transferase (SGPT),25,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Alkaline Phosphatase,74,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Aspartate Transferase (SGOT),21,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,BUN,17,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Creatinine,0.99,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,LDH,178,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Lipase,36,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Potassium,4.1,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Sodium,141,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Hematocrit,40.5,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Hemoglobin,13.3,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Lymphocytes abs,11.41,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Neutrophils abs,4.27,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,Platelet,130,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Hematology,WBC,16.04,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),7.30,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 2,191,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Alanine Transferase (SGPT),16,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Alkaline Phosphatase,77,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Aspartate Transferase (SGOT),ND,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,BUN,13,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Creatinine,1.04,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,LDH,ND,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Lipase,24,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Potassium,4.8,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,Hematocrit,41.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,Hemoglobin,14.0,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,Lymphocytes abs,9.00,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,Neutrophils abs,5.11,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,Platelet,122,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Hematology,WBC,14.65,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),4.17,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 3,218,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Alanine Transferase (SGPT),16,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Alkaline Phosphatase,74,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Aspartate Transferase (SGOT),26,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,BUN,18,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Creatinine,1.06,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,LDH,202,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Lipase,31,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Potassium,4.0,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Sodium,141,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Hematocrit,38.9,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Hemoglobin,13.4,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Lymphocytes abs,11.41,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Neutrophils abs,4.27,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,Platelet,116,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Hematology,WBC,12.67,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.02,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 4,246,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Alanine Transferase (SGPT),19,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Alkaline Phosphatase,71,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Aspartate Transferase (SGOT),26,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,BUN,16,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Creatinine,1.17,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,LDH,179,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Lipase,24,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Potassium,4.0,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Sodium,142,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,Hematocrit,39.5,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,Hemoglobin,13.5,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,Lymphocytes abs,8.89,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,Neutrophils abs,2.68,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,Platelet,144,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Hematology,WBC,11.98,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),6.55,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 5,276,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Alanine Transferase (SGPT),17,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Alkaline Phosphatase,72,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Aspartate Transferase (SGOT),25,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,BUN,15,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Creatinine,1.01,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,LDH,179,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Lipase,33,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Potassium,4.3,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,Hematocrit,39.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,Hemoglobin,13.2,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,Lymphocytes abs,8.93,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,Neutrophils abs,3.12,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,Platelet,107,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Hematology,WBC,12.46,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Thyroid Function Testing,Free Thyroxine (FT4),1.3,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.34,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 6,302,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Alanine Transferase (SGPT),20,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Alkaline Phosphatase,84,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Aspartate Transferase (SGOT),23,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,BUN,18,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Creatinine,1.12,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,LDH,178,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Lipase,29,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Potassium,4.3,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Sodium,139,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Total Bilirubin,0.2,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,Hematocrit,40.4,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,Hemoglobin,13.5,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,Lymphocytes abs,10.05,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,Neutrophils abs,5.17,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,Platelet,137,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Hematology,WBC,15.80,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),12.27,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 7,330,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Alanine Transferase (SGPT),18,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Alkaline Phosphatase,73,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Aspartate Transferase (SGOT),24,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,BUN,14,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Creatinine,1.03,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,LDH,176,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Lipase,31,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Potassium,4.5,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,Hematocrit,41.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,Hemoglobin,13.9,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,Lymphocytes abs,10.68,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,Neutrophils abs,3.75,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,Platelet,117,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Hematology,WBC,14.89,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Thyroid Function Testing,Free Thyroxine (FT4),1.5,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.48,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 8,386,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Alanine Transferase (SGPT),15,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Alkaline Phosphatase,65,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Aspartate Transferase (SGOT),19,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,BUN,14,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Creatinine,1.00,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,LDH,164,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Lipase,30,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Potassium,3.7,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Sodium,142,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,Hematocrit,39.6,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,Hemoglobin,13.0,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,Lymphocytes abs,9.61,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,Neutrophils abs,3.29,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,Platelet,121,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Hematology,WBC,13.42,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Thyroid Function Testing,Free Thyroxine (FT4),1.4,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.90,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 9,415,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Alanine Transferase (SGPT),17,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Alkaline Phosphatase,68,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Aspartate Transferase (SGOT),21,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,BUN,12,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Creatinine,0.99,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,LDH,171,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Lipase,32,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Potassium,3.8,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Sodium,138,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Chemistry,Urea,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,Hematocrit,39.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,Hemoglobin,13.1,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,Lymphocytes abs,9.33,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,Neutrophils abs,2.05,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,Platelet,99,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Hematology,WBC,11.74,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Thyroid Function Testing,Free Thyroxine (FT4),1.2,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),9.08,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 10,442,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Alanine Transferase (SGPT),20,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Alkaline Phosphatase,78,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Aspartate Transferase (SGOT),20,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,BUN,14,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Creatinine,1.05,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,LDH,175,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Lipase,25,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Magnesium,2.3,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Potassium,3.8,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Total Bilirubin,0.7,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,Hematocrit,41.6,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,Hemoglobin,13.9,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,Lymphocytes abs,5.26,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,Neutrophils abs,5.26,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,Platelet,133,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Hematology,WBC,18,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Thyroid Function Testing,Free Thyroxine (FT4),1.6,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.68,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 11,470,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Alanine Transferase (SGPT),18,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Alkaline Phosphatase,70,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Aspartate Transferase (SGOT),23,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,BUN,12,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Creatinine,1.08,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,LDH,216,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Lipase,24,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Potassium,4.1,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Sodium,140,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,Hematocrit,40.9,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,Hemoglobin,13.8,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,Lymphocytes abs,10.51,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,Neutrophils abs,2.62,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,Platelet,116,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Hematology,WBC,13.61,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Thyroid Function Testing,Free Thyroxine (FT4),1.8,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.23,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 12,498,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Alanine Transferase (SGPT),18,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Alkaline Phosphatase,89,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Aspartate Transferase (SGOT),19,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,BUN,14,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Creatinine,1.08,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,LDH,171,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Lipase,122,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Magnesium,2.3,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Potassium,3.7,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Sodium,143,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,Hematocrit,40.5,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,Hemoglobin,13.9,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,Lymphocytes abs,10.49,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,Neutrophils abs,4.43,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,Platelet,114,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Hematology,WBC,15.46,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Thyroid Function Testing,Free Thyroxine (FT4),1.7,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Thyroid Function Testing,Free Triiodothyronine (FT3),3.0,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.14,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 13,525,Thyroid Function Testing,Triidothyronine (T3),94,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Alanine Transferase (SGPT),28,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Alkaline Phosphatase,88,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Aspartate Transferase (SGOT),19,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,BUN,10,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Creatinine,1.0,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,LDH,161,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Lipase,207,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Magnesium,1.8,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Potassium,3.5,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Sodium,139,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,Hematocrit,41.6,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,Hemoglobin,14.1,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,Lymphocytes abs,11.75,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,Neutrophils abs,4.56,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,Platelet,160,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Hematology,WBC,16.98,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),3.4,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 14,554,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Alanine Transferase (SGPT),19,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Alkaline Phosphatase,94,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Aspartate Transferase (SGOT),18,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,BUN,12,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Creatinine,0.93,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Indirect Bilirubin,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,LDH,174,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Lipase,574,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Potassium,4.3,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Sodium,138,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,Hematocrit,39.1,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,Hemoglobin,13.2,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,Lymphocytes abs,9.42,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,Neutrophils abs,5.19,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,Platelet,108,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Hematology,WBC,15.15,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Thyroid Function Testing,Free Thyroxine (FT4),1.5,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.83,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,NIVO MAINTENANCE CYCLE 15,583,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Alanine Transferase (SGPT),10,units/L,7,52
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Alkaline Phosphatase,102,units/L,36,118
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Aspartate Transferase (SGOT),15,units/L,9,30
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,BUN,11,mg/dL,9,25
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Creatinine,0.89,mg/dL,0.7,1.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,LDH,ND,U/L,107,231
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Lipase,156,U/L,3,60
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Magnesium,1.9,mg/dL,1.8,2.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Potassium,3.8,mmol/L,3.5,5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Sodium,139,mmol/L,135,145
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Total Bilirubin,6.1,mg/dL,0.2,1.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Chemistry,Urea,,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,Hematocrit,37.6,%,37.1,49.5
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,Hemoglobin,12.7,g/dL,12.5,16.3
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,Lymphocytes abs,9.3,K/ul,0.21,2.74
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,Neutrophils abs,5.1,K/ul,2.23,6.11
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,Platelet,137,K/ul,152,440
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Hematology,WBC,14.94,K/ul,3.81,8.94
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Thyroid Function Testing,Free Thyroxine (FT4),1.6,ng/dL,0.9,1.7
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),2.54,µIU/mL,0.27,4.2
107-0001,070,CD8 LOW,Nivolumab + Ipilimumab,END OF TREATMENT,612,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Thyroid Function Testing,Free Thyroxine (FT4),,ng/dL,0.9,1.7
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Thyroid Function Testing,Free Triiodothyronine (FT3),,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),,µIU/mL,0.27,4.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 1,1,Thyroid Function Testing,Triidothyronine (T3),,ng/dL,80,200
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Alanine Transferase (SGPT),15,units/L,7,52
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Alkaline Phosphatase,37,units/L,36,118
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Aspartate Transferase (SGOT),38,units/L,9,30
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,BUN,9,mg/dL,9,25
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Creatinine,1.1,mg/dL,0.7,1.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Direct Bilirubin,ND,mg/dL,0,0.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Indirect Bilirubin,,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,LDH,ND,U/L,107,231
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Lipase,92,U/L,3,60
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Magnesium,ND,mg/dL,1.8,2.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Potassium,ND,mmol/L,3.5,5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Sodium,140,mmol/L,135,145
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Total Bilirubin,0.3,mg/dL,0.2,1.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Chemistry,Urea,,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,Hematocrit,35,%,37.1,49.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,Hemoglobin,11.3,g/dL,12.5,16.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,Lymphocytes abs,ND,K/ul,0.21,2.74
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,Neutrophils abs,ND,K/ul,2.23,6.11
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,Platelet,212,K/ul,152,440
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,UNSCHEDULED,7,Hematology,WBC,6.47,K/ul,3.81,8.94
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),16,units/L,7,52
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,38,units/L,36,118
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),47,units/L,9,30
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,BUN,11,mg/dL,9,25
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Creatinine,1.11,mg/dL,0.7,1.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,0.4,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,LDH,244,U/L,107,231
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Lipase,ND,U/L,3,60
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Potassium,4.4,mmol/L,3.5,5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Sodium,138,mmol/L,135,145
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Chemistry,Urea,,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hematocrit,37.5,%,37.1,49.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.0,g/dL,12.5,16.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,1.19,K/ul,0.21,2.74
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,4.59,K/ul,2.23,6.11
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,Platelet,249,K/ul,152,440
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,8,Hematology,WBC,6.76,K/ul,3.81,8.94
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alanine Transferase (SGPT),11,units/L,7,52
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Alkaline Phosphatase,45,units/L,36,118
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Aspartate Transferase (SGOT),29,units/L,9,30
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,BUN,9,mg/dL,9,25
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Creatinine,0.81,mg/dL,0.7,1.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,LDH,214,U/L,107,231
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Lipase,88,U/L,3,60
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Potassium,4.1,mmol/L,3.5,5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Sodium,137,mmol/L,135,145
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Chemistry,Urea,,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hematocrit,39.1,%,37.1,49.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Hemoglobin,13.1,g/dL,12.5,16.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Lymphocytes abs,1.01,K/ul,0.21,2.74
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Neutrophils abs,3.92,K/ul,2.23,6.11
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,Platelet,244,K/ul,152,440
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Hematology,WBC,5.58,K/ul,3.81,8.94
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Thyroxine (FT4),0.8,ng/dL,0.9,1.7
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),>100,µIU/mL,0.27,4.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 2 DAY 1,22,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alanine Transferase (SGPT),10,units/L,7,52
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Alkaline Phosphatase,46,units/L,36,118
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Aspartate Transferase (SGOT),18,units/L,9,30
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,BUN,15,mg/dL,9,25
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Creatinine,0.72,mg/dL,0.7,1.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Indirect Bilirubin,0.3,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,LDH,194,U/L,107,231
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Lipase,43,U/L,3,60
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Potassium,4.0,mmol/L,3.5,5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Sodium,138,mmol/L,135,145
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Chemistry,Urea,,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hematocrit,38.9,%,37.1,49.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Hemoglobin,13.1,g/dL,12.5,16.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Lymphocytes abs,1.30,K/ul,0.21,2.74
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Neutrophils abs,5.20,K/ul,2.23,6.11
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,Platelet,321,K/ul,152,440
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Hematology,WBC,7.29,K/ul,3.81,8.94
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Thyroxine (FT4),1.7,ng/dL,0.9,1.7
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),19.01,µIU/mL,0.27,4.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 3 DAY 1,43,Thyroid Function Testing,Triidothyronine (T3),93,ng/dL,80,200
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alanine Transferase (SGPT),90,units/L,7,52
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Alkaline Phosphatase,111,units/L,36,118
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Aspartate Transferase (SGOT),45,units/L,9,30
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,BUN,24,mg/dL,9,25
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Creatinine,1.09,mg/dL,0.7,1.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,LDH,197,U/L,107,231
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Lipase,11,U/L,3,60
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Magnesium,1.9,mg/dL,1.8,2.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Potassium,4.7,mmol/L,3.5,5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Sodium,135,mmol/L,135,145
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Chemistry,Urea,ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hematocrit,40.6,%,37.1,49.5
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Hemoglobin,13.4,g/dL,12.5,16.3
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Lymphocytes abs,1.06,K/ul,0.21,2.74
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Neutrophils abs,6.95,K/ul,2.23,6.11
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,Platelet,382,K/ul,152,440
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Hematology,WBC,9.42,K/ul,3.81,8.94
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Thyroxine (FT4),2.0,ng/dL,0.9,1.7
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),5.59,µIU/mL,0.27,4.2
107-0003,071,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 4 DAY 1,64,Thyroid Function Testing,Triidothyronine (T3),90,ng/dL,80,200
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alanine Transferase (SGPT),27,units/L,7,52
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Alkaline Phosphatase,71,units/L,36,118
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Aspartate Transferase (SGOT),28,units/L,9,30
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,BUN,10,mg/dL,9,25
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Creatinine,0.46,mg/dL,0.7,1.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Indirect Bilirubin,0.3,,NA,NA
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,LDH,207,U/L,107,231
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Lipase,ND,U/L,3,60
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Potassium,4.9,mmol/L,3.5,5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Sodium,138,mmol/L,135,145
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Total Bilirubin,0.4,mg/dL,0.2,1.2
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Chemistry,Urea,ND,,NA,NA
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hematocrit,38.5,%,37.1,49.5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Hemoglobin,12.7,g/dL,12.5,16.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Lymphocytes abs,0.94,K/ul,0.21,2.74
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Neutrophils abs,7.30,K/ul,2.23,6.11
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,Platelet,277,K/ul,152,440
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,SCREENING,-16,Hematology,WBC,9.26,K/ul,3.81,8.94
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Alanine Transferase (SGPT),65,units/L,7,52
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Alkaline Phosphatase,71,units/L,36,118
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Aspartate Transferase (SGOT),27,units/L,9,30
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,BUN,8,mg/dL,9,25
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Creatinine,0.44,mg/dL,0.7,1.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Direct Bilirubin,0.1,mg/dL,0,0.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Indirect Bilirubin,,,NA,NA
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,LDH,117,U/L,107,231
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Lipase,ND,U/L,3,60
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Potassium,3.7,mmol/L,3.5,5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Sodium,134,mmol/L,135,145
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Chemistry,Urea,,,NA,NA
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Hematocrit,33.4,%,37.1,49.5
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Hemoglobin,11.5,g/dL,12.5,16.3
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Lymphocytes abs,0.57,K/ul,0.21,2.74
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Neutrophils abs,8.52,K/ul,2.23,6.11
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,Platelet,264,K/ul,152,440
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Hematology,WBC,10.18,K/ul,3.81,8.94
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.22,µIU/mL,0.27,4.2
107-0004,072,CD8 LOW,Nivolumab + Ipilimumab,CD8 LOW CYCLE 1 DAY 8,5,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Alanine Transferase (SGPT),14,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Alkaline Phosphatase,93,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Aspartate Transferase (SGOT),22,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,BUN,19,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Creatinine,1.05,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,LDH,170,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Lipase,36,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Potassium,3.8,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Sodium,142,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,Hematocrit,37.1,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,Hemoglobin,12.7,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,Lymphocytes abs,0.64,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,Neutrophils abs,2.25,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,Platelet,193,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Hematology,WBC,3.40,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.58,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,SCREENING,-10,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alanine Transferase (SGPT),16,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Alkaline Phosphatase,109,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Aspartate Transferase (SGOT),24,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,BUN,20,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Creatinine,0.94,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,LDH,198,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Lipase,35,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Potassium,3.9,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Sodium,140,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Total Bilirubin,0.7,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hematocrit,38.5,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Hemoglobin,13.3,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Lymphocytes abs,0.62,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Neutrophils abs,2.24,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,Platelet,169,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Hematology,WBC,3.27,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),1.27,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 1 DAY 8,8,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Alanine Transferase (SGPT),21,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Alkaline Phosphatase,ND,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Aspartate Transferase (SGOT),ND,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,BUN,23,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Creatinine,1.03,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,LDH,216,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Lipase,39,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Potassium,3.9,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Sodium,136,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Hematocrit,36.4,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Hemoglobin,12.6,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Lymphocytes abs,0.56,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Neutrophils abs,2.86,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,Platelet,174,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Hematology,WBC,4.11,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.74,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 2 DAY 1,21,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Alanine Transferase (SGPT),16,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Alkaline Phosphatase,111,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Aspartate Transferase (SGOT),27,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,BUN,20,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Creatinine,0.96,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,LDH,261,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Lipase,41,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Magnesium,2.2,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Potassium,4.2,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Sodium,143,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Hematocrit,38.1,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Hemoglobin,13.1,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Lymphocytes abs,0.91,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Neutrophils abs,2.69,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,Platelet,203,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Hematology,WBC,4.24,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.38,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 HIGH CYCLE 3 DAY 1,42,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,72,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,72,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,72,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.56,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 1 DAY 8,72,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Alanine Transferase (SGPT),13,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Alkaline Phosphatase,97,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Aspartate Transferase (SGOT),21,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,BUN,18,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Creatinine,0.95,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,LDH,200,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Lipase,38,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Magnesium,2.0,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Potassium,4.5,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Sodium,140,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Total Bilirubin,0.8,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,Hematocrit,38.5,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,Hemoglobin,13.2,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,Lymphocytes abs,0.86,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,Neutrophils abs,3.33,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,Platelet,201,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Hematology,WBC,4.84,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.38,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 2 DAY 1,87,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Alanine Transferase (SGPT),14,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Alkaline Phosphatase,98,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Aspartate Transferase (SGOT),21,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,BUN,19,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Creatinine,0.98,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,LDH,198,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Lipase,39,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Potassium,4.2,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Sodium,140,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Total Bilirubin,0.5,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,Hematocrit,37.9,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,Hemoglobin,12.9,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,Lymphocytes abs,0.79,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,Neutrophils abs,3.81,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,Platelet,228,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Hematology,WBC,5.41,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.49,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,CD8 LOW CYCLE 3 DAY 1,107,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Alanine Transferase (SGPT),12,units/L,7,52
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Alkaline Phosphatase,109,units/L,36,118
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Aspartate Transferase (SGOT),19,units/L,9,30
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,BUN,14,mg/dL,9,25
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Creatinine,1.00,mg/dL,0.7,1.3
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Direct Bilirubin,0.2,mg/dL,0,0.3
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Indirect Bilirubin,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,LDH,201,U/L,107,231
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Lipase,41,U/L,3,60
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Magnesium,2.1,mg/dL,1.8,2.5
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Potassium,4.1,mmol/L,3.5,5
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Sodium,141,mmol/L,135,145
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Total Bilirubin,0.6,mg/dL,0.2,1.2
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Chemistry,Urea,ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,Hematocrit,38.7,%,37.1,49.5
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,Hemoglobin,12.8,g/dL,12.5,16.3
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,Lymphocytes abs,1.02,K/ul,0.21,2.74
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,Neutrophils abs,3.38,K/ul,2.23,6.11
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,Platelet,214,K/ul,152,440
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Hematology,WBC,5.20,K/ul,3.81,8.94
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Thyroid Function Testing,Free Thyroxine (FT4),ND,ng/dL,0.9,1.7
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Thyroid Function Testing,Free Triiodothyronine (FT3),ND,,NA,NA
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Thyroid Function Testing,Thyroid stimulating Hormone (TSH),0.47,µIU/mL,0.27,4.2
107-0007,079,CD8 HIGH,Nivolumab,END OF TREATMENT,128,Thyroid Function Testing,Triidothyronine (T3),ND,ng/dL,80,200
